<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/1999/REC-html401-19991224/loose.dtd">
<html><head><title>Report for na_neg 1439144934464 [GSEA]</title><link href='xtools.css' rel='stylesheet'><link href='http://www.broadinstitute.org/gsea/images/XBench.gif' rel='shortcut icon'></head><body><div class='richTable'><table cols='11' border='1'><th class='richTable'></th><th class='richTable'>GS<br> follow link to MSigDB</th><th class='richTable'>GS DETAILS</th><th class='richTable'>SIZE</th><th class='richTable'>ES</th><th class='richTable'>NES</th><th class='richTable'>NOM p-val</th><th class='richTable'>FDR q-val</th><th class='richTable'>FWER p-val</th><th class='richTable'>RANK AT MAX</th><th class='richTable'>LEADING EDGE</th><tr><td class='lessen'>1</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN'>WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN</a></td><td><a href='WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN.html'>Details ...</a></td><td>34</td><td>-0.86</td><td>-2.14</td><td>0.000</td><td>0.000</td><td>0.000</td><td>821</td><td>tags=74%, list=6%, signal=78%</td></tr><tr><td class='lessen'>2</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/MATZUK_SPERMATOZOA'>MATZUK_SPERMATOZOA</a></td><td><a href='MATZUK_SPERMATOZOA.html'>Details ...</a></td><td>102</td><td>-0.75</td><td>-2.13</td><td>0.000</td><td>0.000</td><td>0.000</td><td>804</td><td>tags=35%, list=6%, signal=37%</td></tr><tr><td class='lessen'>3</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/WEBER_METHYLATED_ICP_IN_FIBROBLAST'>WEBER_METHYLATED_ICP_IN_FIBROBLAST</a></td><td><a href='WEBER_METHYLATED_ICP_IN_FIBROBLAST.html'>Details ...</a></td><td>19</td><td>-0.93</td><td>-2.13</td><td>0.000</td><td>0.000</td><td>0.000</td><td>565</td><td>tags=89%, list=4%, signal=93%</td></tr><tr><td class='lessen'>4</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED'>MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED</a></td><td><a href='MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED.html'>Details ...</a></td><td>29</td><td>-0.86</td><td>-2.10</td><td>0.000</td><td>0.000</td><td>0.000</td><td>461</td><td>tags=52%, list=4%, signal=54%</td></tr><tr><td class='lessen'>5</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/SU_TESTIS'>SU_TESTIS</a></td><td><a href='SU_TESTIS.html'>Details ...</a></td><td>65</td><td>-0.77</td><td>-2.09</td><td>0.000</td><td>0.000</td><td>0.000</td><td>1045</td><td>tags=46%, list=8%, signal=50%</td></tr><tr><td class='lessen'>6</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/WEBER_METHYLATED_HCP_IN_SPERM_DN'>WEBER_METHYLATED_HCP_IN_SPERM_DN</a></td><td><a href='WEBER_METHYLATED_HCP_IN_SPERM_DN.html'>Details ...</a></td><td>23</td><td>-0.87</td><td>-2.02</td><td>0.000</td><td>0.000</td><td>0.000</td><td>753</td><td>tags=78%, list=6%, signal=83%</td></tr><tr><td class='lessen'>7</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/MATZUK_SPERMATID_DIFFERENTIATION'>MATZUK_SPERMATID_DIFFERENTIATION</a></td><td><a href='MATZUK_SPERMATID_DIFFERENTIATION.html'>Details ...</a></td><td>34</td><td>-0.80</td><td>-1.97</td><td>0.000</td><td>0.000</td><td>0.006</td><td>585</td><td>tags=41%, list=5%, signal=43%</td></tr><tr><td class='lessen'>8</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/WEBER_METHYLATED_ICP_IN_SPERM_DN'>WEBER_METHYLATED_ICP_IN_SPERM_DN</a></td><td><a href='WEBER_METHYLATED_ICP_IN_SPERM_DN.html'>Details ...</a></td><td>12</td><td>-0.95</td><td>-1.94</td><td>0.000</td><td>0.000</td><td>0.016</td><td>543</td><td>tags=92%, list=4%, signal=96%</td></tr><tr><td class='lessen'>9</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED'>MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED</a></td><td><a href='MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED.html'>Details ...</a></td><td>172</td><td>-0.66</td><td>-1.94</td><td>0.000</td><td>0.000</td><td>0.016</td><td>1348</td><td>tags=40%, list=10%, signal=44%</td></tr><tr><td class='lessen'>10</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/MATZUK_SPERMATOCYTE'>MATZUK_SPERMATOCYTE</a></td><td><a href='MATZUK_SPERMATOCYTE.html'>Details ...</a></td><td>65</td><td>-0.70</td><td>-1.93</td><td>0.000</td><td>0.000</td><td>0.019</td><td>1945</td><td>tags=38%, list=15%, signal=45%</td></tr><tr><td class='lessen'>11</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/WEBER_METHYLATED_LCP_IN_SPERM_UP'>WEBER_METHYLATED_LCP_IN_SPERM_UP</a></td><td><a href='WEBER_METHYLATED_LCP_IN_SPERM_UP.html'>Details ...</a></td><td>14</td><td>-0.90</td><td>-1.92</td><td>0.000</td><td>0.000</td><td>0.020</td><td>1159</td><td>tags=93%, list=9%, signal=102%</td></tr><tr><td class='lessen'>12</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/WEBER_METHYLATED_HCP_IN_SPERM_UP'>WEBER_METHYLATED_HCP_IN_SPERM_UP</a></td><td><a href='WEBER_METHYLATED_HCP_IN_SPERM_UP.html'>Details ...</a></td><td>17</td><td>-0.87</td><td>-1.91</td><td>0.000</td><td>0.000</td><td>0.028</td><td>1057</td><td>tags=76%, list=8%, signal=83%</td></tr><tr><td class='lessen'>13</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/MADAN_DPPA4_TARGETS'>MADAN_DPPA4_TARGETS</a></td><td><a href='MADAN_DPPA4_TARGETS.html'>Details ...</a></td><td>36</td><td>-0.77</td><td>-1.90</td><td>0.000</td><td>0.000</td><td>0.029</td><td>1299</td><td>tags=56%, list=10%, signal=62%</td></tr><tr><td class='lessen'>14</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2'>CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2</a></td><td><a href='CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2.html'>Details ...</a></td><td>257</td><td>-0.62</td><td>-1.87</td><td>0.000</td><td>0.001</td><td>0.096</td><td>2349</td><td>tags=43%, list=18%, signal=52%</td></tr><tr><td class='lessen'>15</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_MULTIPLE_MYELOMA_PR_UP'>ZHAN_MULTIPLE_MYELOMA_PR_UP</a></td><td><a href='ZHAN_MULTIPLE_MYELOMA_PR_UP.html'>Details ...</a></td><td>36</td><td>-0.73</td><td>-1.86</td><td>0.000</td><td>0.001</td><td>0.114</td><td>2456</td><td>tags=72%, list=19%, signal=89%</td></tr><tr><td class='lessen'>16</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/WEBER_METHYLATED_LCP_IN_FIBROBLAST_UP'>WEBER_METHYLATED_LCP_IN_FIBROBLAST_UP</a></td><td><a href='WEBER_METHYLATED_LCP_IN_FIBROBLAST_UP.html'>Details ...</a></td><td>12</td><td>-0.90</td><td>-1.85</td><td>0.000</td><td>0.001</td><td>0.124</td><td>1159</td><td>tags=92%, list=9%, signal=101%</td></tr><tr><td class='lessen'>17</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/KORKOLA_EMBRYONAL_CARCINOMA_DN'>KORKOLA_EMBRYONAL_CARCINOMA_DN</a></td><td><a href='KORKOLA_EMBRYONAL_CARCINOMA_DN.html'>Details ...</a></td><td>12</td><td>-0.87</td><td>-1.80</td><td>0.001</td><td>0.004</td><td>0.347</td><td>1638</td><td>tags=75%, list=13%, signal=86%</td></tr><tr><td class='lessen'>18</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/SU_LIVER'>SU_LIVER</a></td><td><a href='SU_LIVER.html'>Details ...</a></td><td>43</td><td>-0.70</td><td>-1.78</td><td>0.001</td><td>0.007</td><td>0.504</td><td>2508</td><td>tags=74%, list=19%, signal=92%</td></tr><tr><td class='lessen'>19</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER'>ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER</a></td><td><a href='ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER.html'>Details ...</a></td><td>123</td><td>-0.61</td><td>-1.76</td><td>0.000</td><td>0.009</td><td>0.608</td><td>3136</td><td>tags=59%, list=24%, signal=77%</td></tr><tr><td class='lessen'>20</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/KORKOLA_CHORIOCARCINOMA_DN'>KORKOLA_CHORIOCARCINOMA_DN</a></td><td><a href='KORKOLA_CHORIOCARCINOMA_DN.html'>Details ...</a></td><td>11</td><td>-0.87</td><td>-1.76</td><td>0.000</td><td>0.009</td><td>0.614</td><td>1638</td><td>tags=82%, list=13%, signal=94%</td></tr><tr><td class='lessen'>21</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP'>SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP</a></td><td><a href='SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP.html'>Details ...</a></td><td>128</td><td>-0.61</td><td>-1.76</td><td>0.000</td><td>0.009</td><td>0.629</td><td>3106</td><td>tags=49%, list=24%, signal=64%</td></tr><tr><td class='lessen'>22</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER'>MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER</a></td><td><a href='MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER.html'>Details ...</a></td><td>41</td><td>-0.70</td><td>-1.75</td><td>0.000</td><td>0.011</td><td>0.709</td><td>1106</td><td>tags=34%, list=9%, signal=37%</td></tr><tr><td class='lessen'>23</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/OHGUCHI_LIVER_HNF4A_TARGETS_DN'>OHGUCHI_LIVER_HNF4A_TARGETS_DN</a></td><td><a href='OHGUCHI_LIVER_HNF4A_TARGETS_DN.html'>Details ...</a></td><td>117</td><td>-0.60</td><td>-1.75</td><td>0.001</td><td>0.012</td><td>0.745</td><td>3090</td><td>tags=70%, list=24%, signal=91%</td></tr><tr><td class='lessen'>24</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/WANG_THOC1_TARGETS_DN'>WANG_THOC1_TARGETS_DN</a></td><td><a href='WANG_THOC1_TARGETS_DN.html'>Details ...</a></td><td>19</td><td>-0.79</td><td>-1.74</td><td>0.001</td><td>0.014</td><td>0.804</td><td>1162</td><td>tags=47%, list=9%, signal=52%</td></tr><tr><td class='lessen'>25</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/CROONQUIST_IL6_DEPRIVATION_DN'>CROONQUIST_IL6_DEPRIVATION_DN</a></td><td><a href='CROONQUIST_IL6_DEPRIVATION_DN.html'>Details ...</a></td><td>91</td><td>-0.62</td><td>-1.73</td><td>0.000</td><td>0.016</td><td>0.851</td><td>2978</td><td>tags=53%, list=23%, signal=68%</td></tr><tr><td class='lessen'>26</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/KORKOLA_SEMINOMA_DN'>KORKOLA_SEMINOMA_DN</a></td><td><a href='KORKOLA_SEMINOMA_DN.html'>Details ...</a></td><td>11</td><td>-0.87</td><td>-1.73</td><td>0.001</td><td>0.016</td><td>0.861</td><td>1638</td><td>tags=73%, list=13%, signal=83%</td></tr><tr><td class='lessen'>27</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/KUMAMOTO_RESPONSE_TO_NUTLIN_3A_DN'>KUMAMOTO_RESPONSE_TO_NUTLIN_3A_DN</a></td><td><a href='KUMAMOTO_RESPONSE_TO_NUTLIN_3A_DN.html'>Details ...</a></td><td>10</td><td>-0.88</td><td>-1.72</td><td>0.003</td><td>0.017</td><td>0.877</td><td>1160</td><td>tags=80%, list=9%, signal=88%</td></tr><tr><td class='lessen'>28</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/REICHERT_MITOSIS_LIN9_TARGETS'>REICHERT_MITOSIS_LIN9_TARGETS</a></td><td><a href='REICHERT_MITOSIS_LIN9_TARGETS.html'>Details ...</a></td><td>26</td><td>-0.72</td><td>-1.71</td><td>0.001</td><td>0.021</td><td>0.939</td><td>1779</td><td>tags=54%, list=14%, signal=62%</td></tr><tr><td class='lessen'>29</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/LEE_EARLY_T_LYMPHOCYTE_UP'>LEE_EARLY_T_LYMPHOCYTE_UP</a></td><td><a href='LEE_EARLY_T_LYMPHOCYTE_UP.html'>Details ...</a></td><td>78</td><td>-0.61</td><td>-1.71</td><td>0.000</td><td>0.022</td><td>0.943</td><td>2898</td><td>tags=58%, list=22%, signal=74%</td></tr><tr><td class='lessen'>30</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/MATZUK_MALE_REPRODUCTION_SERTOLI'>MATZUK_MALE_REPRODUCTION_SERTOLI</a></td><td><a href='MATZUK_MALE_REPRODUCTION_SERTOLI.html'>Details ...</a></td><td>27</td><td>-0.70</td><td>-1.69</td><td>0.006</td><td>0.028</td><td>0.978</td><td>1784</td><td>tags=37%, list=14%, signal=43%</td></tr><tr><td class='lessen'>31</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/KANG_DOXORUBICIN_RESISTANCE_UP'>KANG_DOXORUBICIN_RESISTANCE_UP</a></td><td><a href='KANG_DOXORUBICIN_RESISTANCE_UP.html'>Details ...</a></td><td>47</td><td>-0.65</td><td>-1.69</td><td>0.002</td><td>0.030</td><td>0.983</td><td>2897</td><td>tags=57%, list=22%, signal=74%</td></tr><tr><td class='lessen'>32</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/FARMER_BREAST_CANCER_CLUSTER_2'>FARMER_BREAST_CANCER_CLUSTER_2</a></td><td><a href='FARMER_BREAST_CANCER_CLUSTER_2.html'>Details ...</a></td><td>29</td><td>-0.69</td><td>-1.67</td><td>0.001</td><td>0.041</td><td>0.997</td><td>2952</td><td>tags=62%, list=23%, signal=80%</td></tr><tr><td class='lessen'>33</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/EGUCHI_CELL_CYCLE_RB1_TARGETS'>EGUCHI_CELL_CYCLE_RB1_TARGETS</a></td><td><a href='EGUCHI_CELL_CYCLE_RB1_TARGETS.html'>Details ...</a></td><td>22</td><td>-0.72</td><td>-1.66</td><td>0.012</td><td>0.044</td><td>0.999</td><td>2609</td><td>tags=55%, list=20%, signal=68%</td></tr><tr><td class='lessen'>34</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN'>SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN</a></td><td><a href='SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN.html'>Details ...</a></td><td>219</td><td>-0.55</td><td>-1.65</td><td>0.000</td><td>0.052</td><td>0.999</td><td>2549</td><td>tags=46%, list=20%, signal=56%</td></tr><tr><td class='lessen'>35</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/CHEN_ETV5_TARGETS_TESTIS'>CHEN_ETV5_TARGETS_TESTIS</a></td><td><a href='CHEN_ETV5_TARGETS_TESTIS.html'>Details ...</a></td><td>19</td><td>-0.74</td><td>-1.64</td><td>0.008</td><td>0.059</td><td>0.999</td><td>1863</td><td>tags=37%, list=14%, signal=43%</td></tr><tr><td class='lessen'>36</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED'>MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED</a></td><td><a href='MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED.html'>Details ...</a></td><td>64</td><td>-0.60</td><td>-1.64</td><td>0.000</td><td>0.059</td><td>0.999</td><td>1441</td><td>tags=33%, list=11%, signal=37%</td></tr><tr><td class='lessen'>37</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/GAVIN_FOXP3_TARGETS_CLUSTER_P6'>GAVIN_FOXP3_TARGETS_CLUSTER_P6</a></td><td><a href='GAVIN_FOXP3_TARGETS_CLUSTER_P6.html'>Details ...</a></td><td>78</td><td>-0.59</td><td>-1.64</td><td>0.001</td><td>0.059</td><td>0.999</td><td>1921</td><td>tags=41%, list=15%, signal=48%</td></tr><tr><td class='lessen'>38</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP'>SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP</a></td><td><a href='SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP.html'>Details ...</a></td><td>64</td><td>-0.60</td><td>-1.63</td><td>0.006</td><td>0.064</td><td>1.000</td><td>2235</td><td>tags=30%, list=17%, signal=36%</td></tr><tr><td class='lessen'>39</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/WHITFIELD_CELL_CYCLE_LITERATURE'>WHITFIELD_CELL_CYCLE_LITERATURE</a></td><td><a href='WHITFIELD_CELL_CYCLE_LITERATURE.html'>Details ...</a></td><td>42</td><td>-0.63</td><td>-1.62</td><td>0.002</td><td>0.071</td><td>1.000</td><td>2943</td><td>tags=52%, list=23%, signal=68%</td></tr><tr><td class='lessen'>40</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/RICKMAN_HEAD_AND_NECK_CANCER_B'>RICKMAN_HEAD_AND_NECK_CANCER_B</a></td><td><a href='RICKMAN_HEAD_AND_NECK_CANCER_B.html'>Details ...</a></td><td>32</td><td>-0.67</td><td>-1.62</td><td>0.008</td><td>0.072</td><td>1.000</td><td>1788</td><td>tags=50%, list=14%, signal=58%</td></tr><tr><td class='lessen'>41</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/WU_APOPTOSIS_BY_CDKN1A_VIA_TP53'>WU_APOPTOSIS_BY_CDKN1A_VIA_TP53</a></td><td><a href='WU_APOPTOSIS_BY_CDKN1A_VIA_TP53.html'>Details ...</a></td><td>45</td><td>-0.62</td><td>-1.61</td><td>0.006</td><td>0.076</td><td>1.000</td><td>2257</td><td>tags=42%, list=17%, signal=51%</td></tr><tr><td class='lessen'>42</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/MIKKELSEN_MEF_HCP_WITH_H3K27ME3'>MIKKELSEN_MEF_HCP_WITH_H3K27ME3</a></td><td><a href='MIKKELSEN_MEF_HCP_WITH_H3K27ME3.html'>Details ...</a></td><td>454</td><td>-0.53</td><td>-1.60</td><td>0.000</td><td>0.090</td><td>1.000</td><td>2708</td><td>tags=48%, list=21%, signal=58%</td></tr><tr><td class='lessen'>43</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/LI_WILMS_TUMOR_ANAPLASTIC_UP'>LI_WILMS_TUMOR_ANAPLASTIC_UP</a></td><td><a href='LI_WILMS_TUMOR_ANAPLASTIC_UP.html'>Details ...</a></td><td>17</td><td>-0.73</td><td>-1.60</td><td>0.016</td><td>0.092</td><td>1.000</td><td>1406</td><td>tags=35%, list=11%, signal=40%</td></tr><tr><td class='lessen'>44</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/ODONNELL_TFRC_TARGETS_DN'>ODONNELL_TFRC_TARGETS_DN</a></td><td><a href='ODONNELL_TFRC_TARGETS_DN.html'>Details ...</a></td><td>106</td><td>-0.56</td><td>-1.60</td><td>0.000</td><td>0.091</td><td>1.000</td><td>2021</td><td>tags=38%, list=16%, signal=44%</td></tr><tr><td class='lessen'>45</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/CONRAD_STEM_CELL'>CONRAD_STEM_CELL</a></td><td><a href='CONRAD_STEM_CELL.html'>Details ...</a></td><td>35</td><td>-0.64</td><td>-1.60</td><td>0.007</td><td>0.090</td><td>1.000</td><td>1130</td><td>tags=26%, list=9%, signal=28%</td></tr><tr><td class='lessen'>46</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/KONG_E2F3_TARGETS'>KONG_E2F3_TARGETS</a></td><td><a href='KONG_E2F3_TARGETS.html'>Details ...</a></td><td>84</td><td>-0.57</td><td>-1.59</td><td>0.003</td><td>0.095</td><td>1.000</td><td>2591</td><td>tags=46%, list=20%, signal=58%</td></tr><tr><td class='lessen'>47</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/AMUNDSON_GAMMA_RADIATION_RESPONSE'>AMUNDSON_GAMMA_RADIATION_RESPONSE</a></td><td><a href='AMUNDSON_GAMMA_RADIATION_RESPONSE.html'>Details ...</a></td><td>36</td><td>-0.63</td><td>-1.59</td><td>0.006</td><td>0.097</td><td>1.000</td><td>1160</td><td>tags=39%, list=9%, signal=43%</td></tr><tr><td class='lessen'>48</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/ZHANG_TLX_TARGETS_UP'>ZHANG_TLX_TARGETS_UP</a></td><td><a href='ZHANG_TLX_TARGETS_UP.html'>Details ...</a></td><td>74</td><td>-0.57</td><td>-1.59</td><td>0.007</td><td>0.096</td><td>1.000</td><td>2817</td><td>tags=47%, list=22%, signal=60%</td></tr><tr><td class='lessen'>49</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/CHANG_CYCLING_GENES'>CHANG_CYCLING_GENES</a></td><td><a href='CHANG_CYCLING_GENES.html'>Details ...</a></td><td>120</td><td>-0.54</td><td>-1.58</td><td>0.002</td><td>0.106</td><td>1.000</td><td>3150</td><td>tags=52%, list=24%, signal=69%</td></tr><tr><td class='lessen'>50</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP'>DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP</a></td><td><a href='DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP.html'>Details ...</a></td><td>276</td><td>-0.53</td><td>-1.58</td><td>0.000</td><td>0.107</td><td>1.000</td><td>3417</td><td>tags=47%, list=26%, signal=63%</td></tr><tr><td class='lessen'>51</td><td>VANDESLUIS_COMMD1_TARGETS_GROUP_4_UP</td><td></td><td>17</td><td>-0.71</td><td>-1.57</td><td>0.008</td><td>0.112</td><td>1.000</td><td>3450</td><td>tags=76%, list=27%, signal=104%</td></tr><tr><td class='lessen'>52</td><td>NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP</td><td></td><td>79</td><td>-0.57</td><td>-1.56</td><td>0.005</td><td>0.125</td><td>1.000</td><td>2591</td><td>tags=49%, list=20%, signal=61%</td></tr><tr><td class='lessen'>53</td><td>ISHIDA_E2F_TARGETS</td><td></td><td>47</td><td>-0.61</td><td>-1.56</td><td>0.007</td><td>0.126</td><td>1.000</td><td>3143</td><td>tags=51%, list=24%, signal=67%</td></tr><tr><td class='lessen'>54</td><td>MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED</td><td></td><td>50</td><td>-0.59</td><td>-1.56</td><td>0.014</td><td>0.127</td><td>1.000</td><td>1342</td><td>tags=32%, list=10%, signal=36%</td></tr><tr><td class='lessen'>55</td><td>KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_DN</td><td></td><td>23</td><td>-0.67</td><td>-1.55</td><td>0.013</td><td>0.133</td><td>1.000</td><td>1891</td><td>tags=39%, list=15%, signal=46%</td></tr><tr><td class='lessen'>56</td><td>HSIAO_LIVER_SPECIFIC_GENES</td><td></td><td>193</td><td>-0.52</td><td>-1.55</td><td>0.000</td><td>0.133</td><td>1.000</td><td>2491</td><td>tags=52%, list=19%, signal=64%</td></tr><tr><td class='lessen'>57</td><td>MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN</td><td></td><td>40</td><td>-0.61</td><td>-1.55</td><td>0.016</td><td>0.136</td><td>1.000</td><td>1779</td><td>tags=40%, list=14%, signal=46%</td></tr><tr><td class='lessen'>58</td><td>SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5</td><td></td><td>77</td><td>-0.56</td><td>-1.55</td><td>0.005</td><td>0.141</td><td>1.000</td><td>1914</td><td>tags=32%, list=15%, signal=38%</td></tr><tr><td class='lessen'>59</td><td>WAGSCHAL_EHMT2_TARGETS_UP</td><td></td><td>10</td><td>-0.78</td><td>-1.55</td><td>0.027</td><td>0.141</td><td>1.000</td><td>2077</td><td>tags=70%, list=16%, signal=83%</td></tr><tr><td class='lessen'>60</td><td>FURUKAWA_DUSP6_TARGETS_PCI35_DN</td><td></td><td>61</td><td>-0.57</td><td>-1.55</td><td>0.005</td><td>0.140</td><td>1.000</td><td>3283</td><td>tags=51%, list=25%, signal=68%</td></tr><tr><td class='lessen'>61</td><td>WONG_ENDMETRIUM_CANCER_UP</td><td></td><td>20</td><td>-0.68</td><td>-1.54</td><td>0.019</td><td>0.141</td><td>1.000</td><td>1438</td><td>tags=45%, list=11%, signal=51%</td></tr><tr><td class='lessen'>62</td><td>FINETTI_BREAST_CANCER_KINOME_RED</td><td></td><td>15</td><td>-0.72</td><td>-1.54</td><td>0.027</td><td>0.147</td><td>1.000</td><td>3106</td><td>tags=73%, list=24%, signal=96%</td></tr><tr><td class='lessen'>63</td><td>LY_AGING_MIDDLE_DN</td><td></td><td>16</td><td>-0.71</td><td>-1.54</td><td>0.023</td><td>0.146</td><td>1.000</td><td>2976</td><td>tags=69%, list=23%, signal=89%</td></tr><tr><td class='lessen'>64</td><td>YU_MYC_TARGETS_UP</td><td></td><td>35</td><td>-0.62</td><td>-1.54</td><td>0.015</td><td>0.147</td><td>1.000</td><td>1833</td><td>tags=46%, list=14%, signal=53%</td></tr><tr><td class='lessen'>65</td><td>FINETTI_BREAST_CANCERS_KINOME_BLUE</td><td></td><td>19</td><td>-0.68</td><td>-1.52</td><td>0.029</td><td>0.184</td><td>1.000</td><td>2562</td><td>tags=58%, list=20%, signal=72%</td></tr><tr><td class='lessen'>66</td><td>YEGNASUBRAMANIAN_PROSTATE_CANCER</td><td></td><td>96</td><td>-0.53</td><td>-1.51</td><td>0.000</td><td>0.193</td><td>1.000</td><td>2440</td><td>tags=41%, list=19%, signal=50%</td></tr><tr><td class='lessen'>67</td><td>KAMMINGA_EZH2_TARGETS</td><td></td><td>40</td><td>-0.61</td><td>-1.51</td><td>0.022</td><td>0.191</td><td>1.000</td><td>3143</td><td>tags=52%, list=24%, signal=69%</td></tr><tr><td class='lessen'>68</td><td>TANG_SENESCENCE_TP53_TARGETS_DN</td><td></td><td>49</td><td>-0.58</td><td>-1.50</td><td>0.015</td><td>0.207</td><td>1.000</td><td>2609</td><td>tags=53%, list=20%, signal=66%</td></tr><tr><td class='lessen'>69</td><td>LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN</td><td></td><td>76</td><td>-0.54</td><td>-1.50</td><td>0.017</td><td>0.211</td><td>1.000</td><td>3238</td><td>tags=59%, list=25%, signal=79%</td></tr><tr><td class='lessen'>70</td><td>LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN</td><td></td><td>42</td><td>-0.59</td><td>-1.49</td><td>0.030</td><td>0.225</td><td>1.000</td><td>1471</td><td>tags=19%, list=11%, signal=21%</td></tr><tr><td class='lessen'>71</td><td>WILLIAMS_ESR2_TARGETS_UP</td><td></td><td>24</td><td>-0.65</td><td>-1.49</td><td>0.038</td><td>0.227</td><td>1.000</td><td>1014</td><td>tags=13%, list=8%, signal=14%</td></tr><tr><td class='lessen'>72</td><td>CROONQUIST_NRAS_SIGNALING_DN</td><td></td><td>67</td><td>-0.56</td><td>-1.49</td><td>0.011</td><td>0.233</td><td>1.000</td><td>2680</td><td>tags=40%, list=21%, signal=51%</td></tr><tr><td class='lessen'>73</td><td>KAUFFMANN_MELANOMA_RELAPSE_UP</td><td></td><td>55</td><td>-0.56</td><td>-1.48</td><td>0.021</td><td>0.242</td><td>1.000</td><td>2909</td><td>tags=38%, list=22%, signal=49%</td></tr><tr><td class='lessen'>74</td><td>MATZUK_MEIOTIC_AND_DNA_REPAIR</td><td></td><td>36</td><td>-0.59</td><td>-1.48</td><td>0.029</td><td>0.248</td><td>1.000</td><td>2909</td><td>tags=36%, list=22%, signal=46%</td></tr><tr><td class='lessen'>75</td><td>BENPORATH_PROLIFERATION</td><td></td><td>122</td><td>-0.51</td><td>-1.48</td><td>0.012</td><td>0.250</td><td>1.000</td><td>1739</td><td>tags=24%, list=13%, signal=27%</td></tr><tr><td class='lessen'>76</td><td>HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP</td><td></td><td>137</td><td>-0.50</td><td>-1.47</td><td>0.005</td><td>0.271</td><td>1.000</td><td>3526</td><td>tags=45%, list=27%, signal=62%</td></tr><tr><td class='lessen'>77</td><td>FOURNIER_ACINAR_DEVELOPMENT_LATE_DN</td><td></td><td>20</td><td>-0.64</td><td>-1.46</td><td>0.051</td><td>0.276</td><td>1.000</td><td>2151</td><td>tags=50%, list=17%, signal=60%</td></tr><tr><td class='lessen'>78</td><td>ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN</td><td></td><td>136</td><td>-0.50</td><td>-1.46</td><td>0.010</td><td>0.275</td><td>1.000</td><td>2236</td><td>tags=26%, list=17%, signal=31%</td></tr><tr><td class='lessen'>79</td><td>AIGNER_ZEB1_TARGETS</td><td></td><td>30</td><td>-0.60</td><td>-1.46</td><td>0.046</td><td>0.277</td><td>1.000</td><td>4323</td><td>tags=80%, list=33%, signal=120%</td></tr><tr><td class='lessen'>80</td><td>WENG_POR_TARGETS_GLOBAL_UP</td><td></td><td>15</td><td>-0.68</td><td>-1.45</td><td>0.068</td><td>0.294</td><td>1.000</td><td>3137</td><td>tags=67%, list=24%, signal=88%</td></tr><tr><td class='lessen'>81</td><td>NIKOLSKY_BREAST_CANCER_22Q13_AMPLICON</td><td></td><td>14</td><td>-0.69</td><td>-1.45</td><td>0.037</td><td>0.295</td><td>1.000</td><td>355</td><td>tags=14%, list=3%, signal=15%</td></tr><tr><td class='lessen'>82</td><td>WINNEPENNINCKX_MELANOMA_METASTASIS_UP</td><td></td><td>127</td><td>-0.50</td><td>-1.45</td><td>0.005</td><td>0.301</td><td>1.000</td><td>2943</td><td>tags=32%, list=23%, signal=41%</td></tr><tr><td class='lessen'>83</td><td>WHITEFORD_PEDIATRIC_CANCER_MARKERS</td><td></td><td>103</td><td>-0.51</td><td>-1.45</td><td>0.013</td><td>0.306</td><td>1.000</td><td>2976</td><td>tags=44%, list=23%, signal=56%</td></tr><tr><td class='lessen'>84</td><td>SMID_BREAST_CANCER_LUMINAL_A_DN</td><td></td><td>15</td><td>-0.67</td><td>-1.44</td><td>0.070</td><td>0.315</td><td>1.000</td><td>1551</td><td>tags=47%, list=12%, signal=53%</td></tr><tr><td class='lessen'>85</td><td>BURTON_ADIPOGENESIS_3</td><td></td><td>93</td><td>-0.51</td><td>-1.44</td><td>0.020</td><td>0.329</td><td>1.000</td><td>2591</td><td>tags=42%, list=20%, signal=52%</td></tr><tr><td class='lessen'>86</td><td>WHITEHURST_PACLITAXEL_SENSITIVITY</td><td></td><td>32</td><td>-0.58</td><td>-1.44</td><td>0.058</td><td>0.326</td><td>1.000</td><td>1486</td><td>tags=31%, list=11%, signal=35%</td></tr><tr><td class='lessen'>87</td><td>MEISSNER_BRAIN_HCP_WITH_H3K27ME3</td><td></td><td>221</td><td>-0.48</td><td>-1.44</td><td>0.003</td><td>0.325</td><td>1.000</td><td>2699</td><td>tags=47%, list=21%, signal=58%</td></tr><tr><td class='lessen'>88</td><td>KOBAYASHI_EGFR_SIGNALING_24HR_DN</td><td></td><td>218</td><td>-0.48</td><td>-1.43</td><td>0.004</td><td>0.325</td><td>1.000</td><td>3617</td><td>tags=46%, list=28%, signal=63%</td></tr><tr><td class='lessen'>89</td><td>GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP</td><td></td><td>16</td><td>-0.67</td><td>-1.43</td><td>0.067</td><td>0.326</td><td>1.000</td><td>1466</td><td>tags=50%, list=11%, signal=56%</td></tr><tr><td class='lessen'>90</td><td>NAKAMURA_CANCER_MICROENVIRONMENT_DN</td><td></td><td>42</td><td>-0.55</td><td>-1.43</td><td>0.052</td><td>0.327</td><td>1.000</td><td>2943</td><td>tags=38%, list=23%, signal=49%</td></tr><tr><td class='lessen'>91</td><td>HU_GENOTOXIC_DAMAGE_4HR</td><td></td><td>34</td><td>-0.57</td><td>-1.42</td><td>0.070</td><td>0.352</td><td>1.000</td><td>1794</td><td>tags=32%, list=14%, signal=37%</td></tr><tr><td class='lessen'>92</td><td>MARSON_BOUND_BY_E2F4_UNSTIMULATED</td><td></td><td>547</td><td>-0.46</td><td>-1.42</td><td>0.000</td><td>0.350</td><td>1.000</td><td>3497</td><td>tags=36%, list=27%, signal=47%</td></tr><tr><td class='lessen'>93</td><td>PYEON_HPV_POSITIVE_TUMORS_UP</td><td></td><td>62</td><td>-0.52</td><td>-1.42</td><td>0.033</td><td>0.355</td><td>1.000</td><td>2943</td><td>tags=37%, list=23%, signal=48%</td></tr><tr><td class='lessen'>94</td><td>MATZUK_SPERMATOGONIA</td><td></td><td>23</td><td>-0.62</td><td>-1.42</td><td>0.068</td><td>0.357</td><td>1.000</td><td>686</td><td>tags=22%, list=5%, signal=23%</td></tr><tr><td class='lessen'>95</td><td>POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP</td><td></td><td>53</td><td>-0.53</td><td>-1.42</td><td>0.040</td><td>0.355</td><td>1.000</td><td>1943</td><td>tags=25%, list=15%, signal=29%</td></tr><tr><td class='lessen'>96</td><td>MIKKELSEN_MEF_ICP_WITH_H3K27ME3</td><td></td><td>150</td><td>-0.49</td><td>-1.42</td><td>0.011</td><td>0.353</td><td>1.000</td><td>2323</td><td>tags=44%, list=18%, signal=53%</td></tr><tr><td class='lessen'>97</td><td>HATADA_METHYLATED_IN_LUNG_CANCER_DN</td><td></td><td>19</td><td>-0.62</td><td>-1.42</td><td>0.076</td><td>0.351</td><td>1.000</td><td>794</td><td>tags=21%, list=6%, signal=22%</td></tr><tr><td class='lessen'>98</td><td>TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN</td><td></td><td>24</td><td>-0.60</td><td>-1.41</td><td>0.067</td><td>0.359</td><td>1.000</td><td>1171</td><td>tags=21%, list=9%, signal=23%</td></tr><tr><td class='lessen'>99</td><td>MIKKELSEN_ES_HCP_WITH_H3K27ME3</td><td></td><td>36</td><td>-0.57</td><td>-1.41</td><td>0.051</td><td>0.380</td><td>1.000</td><td>2232</td><td>tags=39%, list=17%, signal=47%</td></tr><tr><td class='lessen'>100</td><td>SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN</td><td></td><td>22</td><td>-0.61</td><td>-1.40</td><td>0.066</td><td>0.387</td><td>1.000</td><td>2266</td><td>tags=45%, list=18%, signal=55%</td></tr><tr><td class='lessen'>101</td><td>BEIER_GLIOMA_STEM_CELL_UP</td><td></td><td>28</td><td>-0.58</td><td>-1.40</td><td>0.070</td><td>0.394</td><td>1.000</td><td>2369</td><td>tags=36%, list=18%, signal=44%</td></tr><tr><td class='lessen'>102</td><td>MORI_LARGE_PRE_BII_LYMPHOCYTE_UP</td><td></td><td>77</td><td>-0.50</td><td>-1.39</td><td>0.038</td><td>0.413</td><td>1.000</td><td>3143</td><td>tags=42%, list=24%, signal=55%</td></tr><tr><td class='lessen'>103</td><td>ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR</td><td></td><td>105</td><td>-0.48</td><td>-1.39</td><td>0.026</td><td>0.411</td><td>1.000</td><td>3417</td><td>tags=46%, list=26%, signal=62%</td></tr><tr><td class='lessen'>104</td><td>WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP</td><td></td><td>19</td><td>-0.62</td><td>-1.39</td><td>0.092</td><td>0.408</td><td>1.000</td><td>2840</td><td>tags=63%, list=22%, signal=81%</td></tr><tr><td class='lessen'>105</td><td>MEISSNER_NPC_HCP_WITH_H3K27ME3</td><td></td><td>60</td><td>-0.52</td><td>-1.39</td><td>0.051</td><td>0.418</td><td>1.000</td><td>2476</td><td>tags=43%, list=19%, signal=53%</td></tr><tr><td class='lessen'>106</td><td>ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN</td><td></td><td>35</td><td>-0.56</td><td>-1.39</td><td>0.067</td><td>0.416</td><td>1.000</td><td>3283</td><td>tags=54%, list=25%, signal=73%</td></tr><tr><td class='lessen'>107</td><td>ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN</td><td></td><td>74</td><td>-0.50</td><td>-1.38</td><td>0.034</td><td>0.456</td><td>1.000</td><td>1983</td><td>tags=28%, list=15%, signal=33%</td></tr><tr><td class='lessen'>108</td><td>ZHANG_TLX_TARGETS_60HR_DN</td><td></td><td>232</td><td>-0.45</td><td>-1.37</td><td>0.005</td><td>0.467</td><td>1.000</td><td>3146</td><td>tags=36%, list=24%, signal=47%</td></tr><tr><td class='lessen'>109</td><td>ROY_WOUND_BLOOD_VESSEL_DN</td><td></td><td>15</td><td>-0.64</td><td>-1.37</td><td>0.101</td><td>0.470</td><td>1.000</td><td>2634</td><td>tags=53%, list=20%, signal=67%</td></tr><tr><td class='lessen'>110</td><td>CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP</td><td></td><td>143</td><td>-0.47</td><td>-1.37</td><td>0.024</td><td>0.468</td><td>1.000</td><td>2862</td><td>tags=41%, list=22%, signal=52%</td></tr><tr><td class='lessen'>111</td><td>SMID_BREAST_CANCER_LUMINAL_B_UP</td><td></td><td>137</td><td>-0.47</td><td>-1.37</td><td>0.028</td><td>0.473</td><td>1.000</td><td>2394</td><td>tags=38%, list=19%, signal=46%</td></tr><tr><td class='lessen'>112</td><td>HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN</td><td></td><td>29</td><td>-0.57</td><td>-1.36</td><td>0.094</td><td>0.516</td><td>1.000</td><td>2388</td><td>tags=28%, list=18%, signal=34%</td></tr><tr><td class='lessen'>113</td><td>ABE_VEGFA_TARGETS_30MIN</td><td></td><td>25</td><td>-0.59</td><td>-1.35</td><td>0.109</td><td>0.528</td><td>1.000</td><td>1866</td><td>tags=28%, list=14%, signal=33%</td></tr><tr><td class='lessen'>114</td><td>MIKKELSEN_IPS_WITH_HCP_H3K27ME3</td><td></td><td>86</td><td>-0.48</td><td>-1.34</td><td>0.059</td><td>0.558</td><td>1.000</td><td>2232</td><td>tags=31%, list=17%, signal=38%</td></tr><tr><td class='lessen'>115</td><td>JOHANSSON_GLIOMAGENESIS_BY_PDGFB_DN</td><td></td><td>16</td><td>-0.61</td><td>-1.34</td><td>0.124</td><td>0.559</td><td>1.000</td><td>2859</td><td>tags=50%, list=22%, signal=64%</td></tr><tr><td class='lessen'>116</td><td>MIKKELSEN_MCV6_ICP_WITH_H3K27ME3</td><td></td><td>55</td><td>-0.50</td><td>-1.34</td><td>0.079</td><td>0.560</td><td>1.000</td><td>2062</td><td>tags=35%, list=16%, signal=41%</td></tr><tr><td class='lessen'>117</td><td>SHEPARD_CRUSH_AND_BURN_MUTANT_DN</td><td></td><td>153</td><td>-0.46</td><td>-1.34</td><td>0.039</td><td>0.559</td><td>1.000</td><td>2864</td><td>tags=37%, list=22%, signal=46%</td></tr><tr><td class='lessen'>118</td><td>SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP</td><td></td><td>78</td><td>-0.48</td><td>-1.33</td><td>0.071</td><td>0.601</td><td>1.000</td><td>3332</td><td>tags=50%, list=26%, signal=67%</td></tr><tr><td class='lessen'>119</td><td>FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN</td><td></td><td>49</td><td>-0.50</td><td>-1.33</td><td>0.090</td><td>0.601</td><td>1.000</td><td>3417</td><td>tags=49%, list=26%, signal=66%</td></tr><tr><td class='lessen'>120</td><td>NADERI_BREAST_CANCER_PROGNOSIS_UP</td><td></td><td>39</td><td>-0.53</td><td>-1.33</td><td>0.096</td><td>0.602</td><td>1.000</td><td>2219</td><td>tags=44%, list=17%, signal=52%</td></tr><tr><td class='lessen'>121</td><td>SUMI_HNF4A_TARGETS</td><td></td><td>25</td><td>-0.56</td><td>-1.33</td><td>0.132</td><td>0.601</td><td>1.000</td><td>2302</td><td>tags=48%, list=18%, signal=58%</td></tr><tr><td class='lessen'>122</td><td>PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP</td><td></td><td>49</td><td>-0.50</td><td>-1.33</td><td>0.110</td><td>0.598</td><td>1.000</td><td>4089</td><td>tags=47%, list=32%, signal=68%</td></tr><tr><td class='lessen'>123</td><td>MOOTHA_GLYCOLYSIS</td><td></td><td>19</td><td>-0.58</td><td>-1.32</td><td>0.148</td><td>0.612</td><td>1.000</td><td>1805</td><td>tags=26%, list=14%, signal=31%</td></tr><tr><td class='lessen'>124</td><td>ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY</td><td></td><td>1022</td><td>-0.43</td><td>-1.32</td><td>0.000</td><td>0.610</td><td>1.000</td><td>2246</td><td>tags=28%, list=17%, signal=32%</td></tr><tr><td class='lessen'>125</td><td>GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP</td><td></td><td>444</td><td>-0.43</td><td>-1.32</td><td>0.001</td><td>0.617</td><td>1.000</td><td>3106</td><td>tags=36%, list=24%, signal=46%</td></tr><tr><td class='lessen'>126</td><td>YAMAZAKI_TCEB3_TARGETS_DN</td><td></td><td>177</td><td>-0.44</td><td>-1.32</td><td>0.029</td><td>0.623</td><td>1.000</td><td>3674</td><td>tags=44%, list=28%, signal=60%</td></tr><tr><td class='lessen'>127</td><td>STEGMEIER_PRE-MITOTIC_CELL_CYCLE_REGULATORS</td><td></td><td>10</td><td>-0.66</td><td>-1.32</td><td>0.127</td><td>0.624</td><td>1.000</td><td>957</td><td>tags=20%, list=7%, signal=22%</td></tr><tr><td class='lessen'>128</td><td>SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN</td><td></td><td>64</td><td>-0.48</td><td>-1.32</td><td>0.100</td><td>0.622</td><td>1.000</td><td>2749</td><td>tags=38%, list=21%, signal=47%</td></tr><tr><td class='lessen'>129</td><td>ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF</td><td></td><td>39</td><td>-0.51</td><td>-1.31</td><td>0.124</td><td>0.623</td><td>1.000</td><td>1006</td><td>tags=18%, list=8%, signal=19%</td></tr><tr><td class='lessen'>130</td><td>SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER</td><td></td><td>36</td><td>-0.53</td><td>-1.31</td><td>0.112</td><td>0.623</td><td>1.000</td><td>1171</td><td>tags=25%, list=9%, signal=27%</td></tr><tr><td class='lessen'>131</td><td>ZHANG_TLX_TARGETS_36HR_DN</td><td></td><td>147</td><td>-0.45</td><td>-1.31</td><td>0.042</td><td>0.619</td><td>1.000</td><td>2609</td><td>tags=29%, list=20%, signal=36%</td></tr><tr><td class='lessen'>132</td><td>VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN</td><td></td><td>92</td><td>-0.47</td><td>-1.31</td><td>0.084</td><td>0.616</td><td>1.000</td><td>3101</td><td>tags=45%, list=24%, signal=58%</td></tr><tr><td class='lessen'>133</td><td>MISSIAGLIA_REGULATED_BY_METHYLATION_DN</td><td></td><td>101</td><td>-0.47</td><td>-1.31</td><td>0.071</td><td>0.615</td><td>1.000</td><td>4211</td><td>tags=51%, list=33%, signal=76%</td></tr><tr><td class='lessen'>134</td><td>VECCHI_GASTRIC_CANCER_EARLY_UP</td><td></td><td>334</td><td>-0.43</td><td>-1.31</td><td>0.005</td><td>0.612</td><td>1.000</td><td>3285</td><td>tags=38%, list=25%, signal=49%</td></tr><tr><td class='lessen'>135</td><td>CONRAD_GERMLINE_STEM_CELL</td><td></td><td>11</td><td>-0.64</td><td>-1.31</td><td>0.166</td><td>0.609</td><td>1.000</td><td>1483</td><td>tags=45%, list=11%, signal=51%</td></tr><tr><td class='lessen'>136</td><td>LE_NEURONAL_DIFFERENTIATION_DN</td><td></td><td>19</td><td>-0.58</td><td>-1.31</td><td>0.152</td><td>0.615</td><td>1.000</td><td>1777</td><td>tags=32%, list=14%, signal=37%</td></tr><tr><td class='lessen'>137</td><td>WHITFIELD_CELL_CYCLE_S</td><td></td><td>117</td><td>-0.46</td><td>-1.31</td><td>0.060</td><td>0.626</td><td>1.000</td><td>3255</td><td>tags=38%, list=25%, signal=51%</td></tr><tr><td class='lessen'>138</td><td>MIKKELSEN_MCV6_HCP_WITH_H3K27ME3</td><td></td><td>351</td><td>-0.43</td><td>-1.30</td><td>0.002</td><td>0.631</td><td>1.000</td><td>2491</td><td>tags=39%, list=19%, signal=47%</td></tr><tr><td class='lessen'>139</td><td>SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6</td><td></td><td>378</td><td>-0.43</td><td>-1.30</td><td>0.005</td><td>0.636</td><td>1.000</td><td>3133</td><td>tags=31%, list=24%, signal=40%</td></tr><tr><td class='lessen'>140</td><td>TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA</td><td></td><td>82</td><td>-0.48</td><td>-1.30</td><td>0.074</td><td>0.651</td><td>1.000</td><td>2547</td><td>tags=34%, list=20%, signal=42%</td></tr><tr><td class='lessen'>141</td><td>MIKKELSEN_IPS_ICP_WITH_H3K27ME3</td><td></td><td>43</td><td>-0.50</td><td>-1.29</td><td>0.128</td><td>0.669</td><td>1.000</td><td>2057</td><td>tags=42%, list=16%, signal=50%</td></tr><tr><td class='lessen'>142</td><td>DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_UP</td><td></td><td>15</td><td>-0.61</td><td>-1.29</td><td>0.170</td><td>0.666</td><td>1.000</td><td>16</td><td>tags=7%, list=0%, signal=7%</td></tr><tr><td class='lessen'>143</td><td>WHITFIELD_CELL_CYCLE_G2_M</td><td></td><td>174</td><td>-0.43</td><td>-1.29</td><td>0.040</td><td>0.667</td><td>1.000</td><td>2484</td><td>tags=27%, list=19%, signal=33%</td></tr><tr><td class='lessen'>144</td><td>PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP</td><td></td><td>139</td><td>-0.44</td><td>-1.29</td><td>0.058</td><td>0.663</td><td>1.000</td><td>3611</td><td>tags=37%, list=28%, signal=51%</td></tr><tr><td class='lessen'>145</td><td>FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP</td><td></td><td>130</td><td>-0.45</td><td>-1.29</td><td>0.063</td><td>0.669</td><td>1.000</td><td>3283</td><td>tags=36%, list=25%, signal=48%</td></tr><tr><td class='lessen'>146</td><td>FUJII_YBX1_TARGETS_DN</td><td></td><td>184</td><td>-0.44</td><td>-1.29</td><td>0.055</td><td>0.670</td><td>1.000</td><td>3056</td><td>tags=34%, list=24%, signal=43%</td></tr><tr><td class='lessen'>147</td><td>MIKKELSEN_NPC_ICP_WITH_H3K27ME3</td><td></td><td>10</td><td>-0.65</td><td>-1.29</td><td>0.173</td><td>0.668</td><td>1.000</td><td>912</td><td>tags=40%, list=7%, signal=43%</td></tr><tr><td class='lessen'>148</td><td>MARKEY_RB1_ACUTE_LOF_DN</td><td></td><td>196</td><td>-0.43</td><td>-1.29</td><td>0.037</td><td>0.672</td><td>1.000</td><td>2456</td><td>tags=27%, list=19%, signal=33%</td></tr><tr><td class='lessen'>149</td><td>WIKMAN_ASBESTOS_LUNG_CANCER_UP</td><td></td><td>15</td><td>-0.60</td><td>-1.28</td><td>0.186</td><td>0.679</td><td>1.000</td><td>488</td><td>tags=13%, list=4%, signal=14%</td></tr><tr><td class='lessen'>150</td><td>GREENBAUM_E2A_TARGETS_UP</td><td></td><td>30</td><td>-0.52</td><td>-1.28</td><td>0.139</td><td>0.679</td><td>1.000</td><td>2591</td><td>tags=40%, list=20%, signal=50%</td></tr><tr><td class='lessen'>151</td><td>DOANE_BREAST_CANCER_ESR1_UP</td><td></td><td>92</td><td>-0.46</td><td>-1.28</td><td>0.089</td><td>0.681</td><td>1.000</td><td>3328</td><td>tags=48%, list=26%, signal=64%</td></tr><tr><td class='lessen'>152</td><td>LEE_LIVER_CANCER_SURVIVAL_UP</td><td></td><td>136</td><td>-0.44</td><td>-1.28</td><td>0.059</td><td>0.678</td><td>1.000</td><td>2969</td><td>tags=46%, list=23%, signal=59%</td></tr><tr><td class='lessen'>153</td><td>KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP</td><td></td><td>106</td><td>-0.45</td><td>-1.28</td><td>0.090</td><td>0.684</td><td>1.000</td><td>2715</td><td>tags=39%, list=21%, signal=49%</td></tr><tr><td class='lessen'>154</td><td>DODD_NASOPHARYNGEAL_CARCINOMA_UP</td><td></td><td>1136</td><td>-0.42</td><td>-1.28</td><td>0.000</td><td>0.682</td><td>1.000</td><td>2433</td><td>tags=29%, list=19%, signal=33%</td></tr><tr><td class='lessen'>155</td><td>YANG_BREAST_CANCER_ESR1_UP</td><td></td><td>28</td><td>-0.53</td><td>-1.28</td><td>0.151</td><td>0.697</td><td>1.000</td><td>3604</td><td>tags=46%, list=28%, signal=64%</td></tr><tr><td class='lessen'>156</td><td>SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP</td><td></td><td>143</td><td>-0.44</td><td>-1.28</td><td>0.070</td><td>0.694</td><td>1.000</td><td>2683</td><td>tags=31%, list=21%, signal=39%</td></tr><tr><td class='lessen'>157</td><td>CAMPS_COLON_CANCER_COPY_NUMBER_UP</td><td></td><td>67</td><td>-0.47</td><td>-1.27</td><td>0.109</td><td>0.693</td><td>1.000</td><td>2045</td><td>tags=24%, list=16%, signal=28%</td></tr><tr><td class='lessen'>158</td><td>OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN</td><td></td><td>25</td><td>-0.54</td><td>-1.27</td><td>0.172</td><td>0.693</td><td>1.000</td><td>1785</td><td>tags=36%, list=14%, signal=42%</td></tr><tr><td class='lessen'>159</td><td>JAEGER_METASTASIS_UP</td><td></td><td>40</td><td>-0.50</td><td>-1.27</td><td>0.138</td><td>0.691</td><td>1.000</td><td>2296</td><td>tags=43%, list=18%, signal=52%</td></tr><tr><td class='lessen'>160</td><td>OKAWA_NEUROBLASTOMA_1P36_31_DELETION</td><td></td><td>22</td><td>-0.56</td><td>-1.27</td><td>0.182</td><td>0.693</td><td>1.000</td><td>2769</td><td>tags=36%, list=21%, signal=46%</td></tr><tr><td class='lessen'>161</td><td>PIONTEK_PKD1_TARGETS_UP</td><td></td><td>29</td><td>-0.52</td><td>-1.26</td><td>0.167</td><td>0.726</td><td>1.000</td><td>3043</td><td>tags=52%, list=24%, signal=67%</td></tr><tr><td class='lessen'>162</td><td>LY_AGING_OLD_DN</td><td></td><td>52</td><td>-0.48</td><td>-1.26</td><td>0.121</td><td>0.725</td><td>1.000</td><td>2266</td><td>tags=27%, list=18%, signal=33%</td></tr><tr><td class='lessen'>163</td><td>SERVITJA_LIVER_HNF1A_TARGETS_DN</td><td></td><td>134</td><td>-0.44</td><td>-1.26</td><td>0.079</td><td>0.723</td><td>1.000</td><td>2863</td><td>tags=44%, list=22%, signal=56%</td></tr><tr><td class='lessen'>164</td><td>SERVITJA_ISLET_HNF1A_TARGETS_DN</td><td></td><td>94</td><td>-0.44</td><td>-1.26</td><td>0.122</td><td>0.736</td><td>1.000</td><td>2972</td><td>tags=49%, list=23%, signal=63%</td></tr><tr><td class='lessen'>165</td><td>SHEPARD_BMYB_TARGETS</td><td></td><td>61</td><td>-0.47</td><td>-1.26</td><td>0.130</td><td>0.735</td><td>1.000</td><td>2864</td><td>tags=43%, list=22%, signal=54%</td></tr><tr><td class='lessen'>166</td><td>KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN</td><td></td><td>20</td><td>-0.55</td><td>-1.26</td><td>0.182</td><td>0.733</td><td>1.000</td><td>485</td><td>tags=20%, list=4%, signal=21%</td></tr><tr><td class='lessen'>167</td><td>CAIRO_HEPATOBLASTOMA_CLASSES_UP</td><td></td><td>506</td><td>-0.41</td><td>-1.26</td><td>0.014</td><td>0.739</td><td>1.000</td><td>4798</td><td>tags=43%, list=37%, signal=65%</td></tr><tr><td class='lessen'>168</td><td>ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR</td><td></td><td>70</td><td>-0.46</td><td>-1.26</td><td>0.133</td><td>0.740</td><td>1.000</td><td>3417</td><td>tags=44%, list=26%, signal=60%</td></tr><tr><td class='lessen'>169</td><td>CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN</td><td></td><td>140</td><td>-0.43</td><td>-1.25</td><td>0.087</td><td>0.752</td><td>1.000</td><td>2594</td><td>tags=45%, list=20%, signal=56%</td></tr><tr><td class='lessen'>170</td><td>SIMBULAN_PARP1_TARGETS_DN</td><td></td><td>17</td><td>-0.56</td><td>-1.24</td><td>0.224</td><td>0.791</td><td>1.000</td><td>2484</td><td>tags=47%, list=19%, signal=58%</td></tr><tr><td class='lessen'>171</td><td>DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN</td><td></td><td>134</td><td>-0.43</td><td>-1.24</td><td>0.117</td><td>0.790</td><td>1.000</td><td>1060</td><td>tags=13%, list=8%, signal=14%</td></tr><tr><td class='lessen'>172</td><td>CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP</td><td></td><td>113</td><td>-0.43</td><td>-1.24</td><td>0.119</td><td>0.794</td><td>1.000</td><td>2897</td><td>tags=36%, list=22%, signal=46%</td></tr><tr><td class='lessen'>173</td><td>TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_DN</td><td></td><td>15</td><td>-0.58</td><td>-1.24</td><td>0.209</td><td>0.792</td><td>1.000</td><td>1446</td><td>tags=53%, list=11%, signal=60%</td></tr><tr><td class='lessen'>174</td><td>MIKKELSEN_MCV6_LCP_WITH_H3K27ME3</td><td></td><td>19</td><td>-0.56</td><td>-1.24</td><td>0.207</td><td>0.790</td><td>1.000</td><td>1419</td><td>tags=37%, list=11%, signal=41%</td></tr><tr><td class='lessen'>175</td><td>YOKOE_CANCER_TESTIS_ANTIGENS</td><td></td><td>26</td><td>-0.51</td><td>-1.24</td><td>0.206</td><td>0.804</td><td>1.000</td><td>2092</td><td>tags=31%, list=16%, signal=37%</td></tr><tr><td class='lessen'>176</td><td>LANDIS_BREAST_CANCER_PROGRESSION_UP</td><td></td><td>41</td><td>-0.49</td><td>-1.24</td><td>0.183</td><td>0.804</td><td>1.000</td><td>4193</td><td>tags=68%, list=32%, signal=101%</td></tr><tr><td class='lessen'>177</td><td>ODONNELL_METASTASIS_DN</td><td></td><td>23</td><td>-0.53</td><td>-1.24</td><td>0.207</td><td>0.804</td><td>1.000</td><td>2862</td><td>tags=48%, list=22%, signal=61%</td></tr><tr><td class='lessen'>178</td><td>LINDGREN_BLADDER_CANCER_CLUSTER_3_UP</td><td></td><td>263</td><td>-0.41</td><td>-1.24</td><td>0.061</td><td>0.800</td><td>1.000</td><td>3278</td><td>tags=32%, list=25%, signal=41%</td></tr><tr><td class='lessen'>179</td><td>JEON_SMAD6_TARGETS_DN</td><td></td><td>18</td><td>-0.56</td><td>-1.23</td><td>0.198</td><td>0.803</td><td>1.000</td><td>2979</td><td>tags=56%, list=23%, signal=72%</td></tr><tr><td class='lessen'>180</td><td>PUJANA_BRCA2_PCC_NETWORK</td><td></td><td>360</td><td>-0.40</td><td>-1.23</td><td>0.039</td><td>0.802</td><td>1.000</td><td>3303</td><td>tags=28%, list=26%, signal=37%</td></tr><tr><td class='lessen'>181</td><td>INAMURA_LUNG_CANCER_SCC_UP</td><td></td><td>12</td><td>-0.60</td><td>-1.23</td><td>0.216</td><td>0.800</td><td>1.000</td><td>2754</td><td>tags=50%, list=21%, signal=63%</td></tr><tr><td class='lessen'>182</td><td>SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP</td><td></td><td>12</td><td>-0.60</td><td>-1.23</td><td>0.230</td><td>0.796</td><td>1.000</td><td>108</td><td>tags=8%, list=1%, signal=8%</td></tr><tr><td class='lessen'>183</td><td>CERVERA_SDHB_TARGETS_1_DN</td><td></td><td>29</td><td>-0.51</td><td>-1.23</td><td>0.226</td><td>0.793</td><td>1.000</td><td>2789</td><td>tags=59%, list=22%, signal=75%</td></tr><tr><td class='lessen'>184</td><td>MORI_IMMATURE_B_LYMPHOCYTE_DN</td><td></td><td>81</td><td>-0.44</td><td>-1.23</td><td>0.157</td><td>0.793</td><td>1.000</td><td>3898</td><td>tags=47%, list=30%, signal=67%</td></tr><tr><td class='lessen'>185</td><td>MIKKELSEN_MEF_ICP_WITH_H3K4ME3_AND_H3K27ME3</td><td></td><td>34</td><td>-0.50</td><td>-1.23</td><td>0.175</td><td>0.806</td><td>1.000</td><td>1401</td><td>tags=29%, list=11%, signal=33%</td></tr><tr><td class='lessen'>186</td><td>LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN</td><td></td><td>146</td><td>-0.42</td><td>-1.23</td><td>0.095</td><td>0.817</td><td>1.000</td><td>3303</td><td>tags=37%, list=26%, signal=49%</td></tr><tr><td class='lessen'>187</td><td>PIONTEK_PKD1_TARGETS_DN</td><td></td><td>13</td><td>-0.59</td><td>-1.23</td><td>0.247</td><td>0.817</td><td>1.000</td><td>3143</td><td>tags=54%, list=24%, signal=71%</td></tr><tr><td class='lessen'>188</td><td>KORKOLA_CORRELATED_WITH_POU5F1</td><td></td><td>24</td><td>-0.52</td><td>-1.22</td><td>0.217</td><td>0.832</td><td>1.000</td><td>2401</td><td>tags=38%, list=19%, signal=46%</td></tr><tr><td class='lessen'>189</td><td>KIM_MYCL1_AMPLIFICATION_TARGETS_UP</td><td></td><td>10</td><td>-0.61</td><td>-1.22</td><td>0.230</td><td>0.838</td><td>1.000</td><td>2646</td><td>tags=60%, list=20%, signal=75%</td></tr><tr><td class='lessen'>190</td><td>MATZUK_IMPLANTATION_AND_UTERINE</td><td></td><td>17</td><td>-0.56</td><td>-1.22</td><td>0.220</td><td>0.847</td><td>1.000</td><td>3907</td><td>tags=65%, list=30%, signal=93%</td></tr><tr><td class='lessen'>191</td><td>DOANE_BREAST_CANCER_CLASSES_UP</td><td></td><td>55</td><td>-0.46</td><td>-1.22</td><td>0.193</td><td>0.854</td><td>1.000</td><td>3155</td><td>tags=45%, list=24%, signal=60%</td></tr><tr><td class='lessen'>192</td><td>PUJANA_XPRSS_INT_NETWORK</td><td></td><td>146</td><td>-0.41</td><td>-1.21</td><td>0.129</td><td>0.871</td><td>1.000</td><td>4265</td><td>tags=38%, list=33%, signal=56%</td></tr><tr><td class='lessen'>193</td><td>LEE_LIVER_CANCER_ACOX1_DN</td><td></td><td>58</td><td>-0.45</td><td>-1.21</td><td>0.196</td><td>0.885</td><td>1.000</td><td>2365</td><td>tags=43%, list=18%, signal=53%</td></tr><tr><td class='lessen'>194</td><td>KYNG_RESPONSE_TO_H2O2_VIA_ERCC6</td><td></td><td>15</td><td>-0.56</td><td>-1.21</td><td>0.247</td><td>0.889</td><td>1.000</td><td>44</td><td>tags=7%, list=0%, signal=7%</td></tr><tr><td class='lessen'>195</td><td>CAFFAREL_RESPONSE_TO_THC_UP</td><td></td><td>27</td><td>-0.51</td><td>-1.20</td><td>0.232</td><td>0.897</td><td>1.000</td><td>8</td><td>tags=4%, list=0%, signal=4%</td></tr><tr><td class='lessen'>196</td><td>XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN</td><td></td><td>15</td><td>-0.56</td><td>-1.20</td><td>0.262</td><td>0.897</td><td>1.000</td><td>1777</td><td>tags=40%, list=14%, signal=46%</td></tr><tr><td class='lessen'>197</td><td>PUJANA_BRCA_CENTERED_NETWORK</td><td></td><td>107</td><td>-0.42</td><td>-1.20</td><td>0.167</td><td>0.916</td><td>1.000</td><td>4265</td><td>tags=35%, list=33%, signal=51%</td></tr><tr><td class='lessen'>198</td><td>NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON</td><td></td><td>44</td><td>-0.47</td><td>-1.20</td><td>0.224</td><td>0.919</td><td>1.000</td><td>1560</td><td>tags=23%, list=12%, signal=26%</td></tr><tr><td class='lessen'>199</td><td>HORIUCHI_WTAP_TARGETS_DN</td><td></td><td>260</td><td>-0.40</td><td>-1.20</td><td>0.098</td><td>0.916</td><td>1.000</td><td>2976</td><td>tags=31%, list=23%, signal=39%</td></tr><tr><td class='lessen'>200</td><td>SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_UP</td><td></td><td>12</td><td>-0.58</td><td>-1.20</td><td>0.260</td><td>0.915</td><td>1.000</td><td>2452</td><td>tags=33%, list=19%, signal=41%</td></tr><tr><td class='lessen'>201</td><td>SHEN_SMARCA2_TARGETS_DN</td><td></td><td>239</td><td>-0.40</td><td>-1.20</td><td>0.107</td><td>0.912</td><td>1.000</td><td>2446</td><td>tags=33%, list=19%, signal=40%</td></tr><tr><td class='lessen'>202</td><td>FARMER_BREAST_CANCER_CLUSTER_6</td><td></td><td>12</td><td>-0.58</td><td>-1.20</td><td>0.250</td><td>0.913</td><td>1.000</td><td>3562</td><td>tags=58%, list=28%, signal=80%</td></tr><tr><td class='lessen'>203</td><td>MUELLER_PLURINET</td><td></td><td>252</td><td>-0.39</td><td>-1.19</td><td>0.108</td><td>0.930</td><td>1.000</td><td>3495</td><td>tags=26%, list=27%, signal=35%</td></tr><tr><td class='lessen'>204</td><td>LE_EGR2_TARGETS_UP</td><td></td><td>97</td><td>-0.42</td><td>-1.19</td><td>0.192</td><td>0.927</td><td>1.000</td><td>2817</td><td>tags=38%, list=22%, signal=48%</td></tr><tr><td class='lessen'>205</td><td>KAMMINGA_SENESCENCE</td><td></td><td>32</td><td>-0.48</td><td>-1.19</td><td>0.248</td><td>0.929</td><td>1.000</td><td>3082</td><td>tags=31%, list=24%, signal=41%</td></tr><tr><td class='lessen'>206</td><td>HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_UP</td><td></td><td>22</td><td>-0.52</td><td>-1.19</td><td>0.254</td><td>0.932</td><td>1.000</td><td>2147</td><td>tags=27%, list=17%, signal=33%</td></tr><tr><td class='lessen'>207</td><td>YAMASHITA_LIVER_CANCER_STEM_CELL_DN</td><td></td><td>62</td><td>-0.44</td><td>-1.19</td><td>0.212</td><td>0.930</td><td>1.000</td><td>2994</td><td>tags=48%, list=23%, signal=63%</td></tr><tr><td class='lessen'>208</td><td>NUYTTEN_EZH2_TARGETS_DN</td><td></td><td>758</td><td>-0.39</td><td>-1.18</td><td>0.020</td><td>0.950</td><td>1.000</td><td>3475</td><td>tags=31%, list=27%, signal=40%</td></tr><tr><td class='lessen'>209</td><td>RHODES_UNDIFFERENTIATED_CANCER</td><td></td><td>63</td><td>-0.43</td><td>-1.18</td><td>0.220</td><td>0.949</td><td>1.000</td><td>4277</td><td>tags=46%, list=33%, signal=68%</td></tr><tr><td class='lessen'>210</td><td>CAIRO_LIVER_DEVELOPMENT_DN</td><td></td><td>200</td><td>-0.40</td><td>-1.18</td><td>0.154</td><td>0.954</td><td>1.000</td><td>2771</td><td>tags=44%, list=21%, signal=55%</td></tr><tr><td class='lessen'>211</td><td>MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_8</td><td></td><td>12</td><td>-0.58</td><td>-1.18</td><td>0.279</td><td>0.954</td><td>1.000</td><td>2406</td><td>tags=33%, list=19%, signal=41%</td></tr><tr><td class='lessen'>212</td><td>PETRETTO_BLOOD_PRESSURE_UP</td><td></td><td>11</td><td>-0.58</td><td>-1.18</td><td>0.262</td><td>0.961</td><td>1.000</td><td>538</td><td>tags=18%, list=4%, signal=19%</td></tr><tr><td class='lessen'>213</td><td>REN_BOUND_BY_E2F</td><td></td><td>53</td><td>-0.44</td><td>-1.18</td><td>0.224</td><td>0.958</td><td>1.000</td><td>3417</td><td>tags=34%, list=26%, signal=46%</td></tr><tr><td class='lessen'>214</td><td>MOOTHA_GLUCONEOGENESIS</td><td></td><td>28</td><td>-0.49</td><td>-1.18</td><td>0.247</td><td>0.957</td><td>1.000</td><td>2006</td><td>tags=21%, list=16%, signal=25%</td></tr><tr><td class='lessen'>215</td><td>XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN</td><td></td><td>73</td><td>-0.43</td><td>-1.18</td><td>0.214</td><td>0.959</td><td>1.000</td><td>1936</td><td>tags=25%, list=15%, signal=29%</td></tr><tr><td class='lessen'>216</td><td>MANTOVANI_VIRAL_GPCR_SIGNALING_DN</td><td></td><td>38</td><td>-0.47</td><td>-1.18</td><td>0.228</td><td>0.956</td><td>1.000</td><td>3355</td><td>tags=34%, list=26%, signal=46%</td></tr><tr><td class='lessen'>217</td><td>LOPEZ_MESOTELIOMA_SURVIVAL_TIME_UP</td><td></td><td>12</td><td>-0.57</td><td>-1.18</td><td>0.291</td><td>0.953</td><td>1.000</td><td>2748</td><td>tags=58%, list=21%, signal=74%</td></tr><tr><td class='lessen'>218</td><td>FOSTER_KDM1A_TARGETS_UP</td><td></td><td>208</td><td>-0.39</td><td>-1.17</td><td>0.147</td><td>0.965</td><td>1.000</td><td>2741</td><td>tags=36%, list=21%, signal=44%</td></tr><tr><td class='lessen'>219</td><td>ROVERSI_GLIOMA_COPY_NUMBER_DN</td><td></td><td>46</td><td>-0.45</td><td>-1.17</td><td>0.239</td><td>0.966</td><td>1.000</td><td>1905</td><td>tags=24%, list=15%, signal=28%</td></tr><tr><td class='lessen'>220</td><td>DARWICHE_PAPILLOMA_RISK_LOW_DN</td><td></td><td>121</td><td>-0.40</td><td>-1.17</td><td>0.178</td><td>0.967</td><td>1.000</td><td>1632</td><td>tags=17%, list=13%, signal=19%</td></tr><tr><td class='lessen'>221</td><td>STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN</td><td></td><td>37</td><td>-0.46</td><td>-1.17</td><td>0.271</td><td>0.967</td><td>1.000</td><td>3276</td><td>tags=43%, list=25%, signal=58%</td></tr><tr><td class='lessen'>222</td><td>WILCOX_RESPONSE_TO_PROGESTERONE_UP</td><td></td><td>111</td><td>-0.41</td><td>-1.17</td><td>0.220</td><td>0.971</td><td>1.000</td><td>2563</td><td>tags=32%, list=20%, signal=39%</td></tr><tr><td class='lessen'>223</td><td>MIKKELSEN_NPC_HCP_WITH_H3K27ME3</td><td></td><td>277</td><td>-0.39</td><td>-1.17</td><td>0.117</td><td>0.967</td><td>1.000</td><td>2589</td><td>tags=38%, list=20%, signal=46%</td></tr><tr><td class='lessen'>224</td><td>GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN</td><td></td><td>75</td><td>-0.43</td><td>-1.17</td><td>0.238</td><td>0.973</td><td>1.000</td><td>2943</td><td>tags=41%, list=23%, signal=53%</td></tr><tr><td class='lessen'>225</td><td>SCHMIDT_POR_TARGETS_IN_LIMB_BUD_UP</td><td></td><td>23</td><td>-0.50</td><td>-1.17</td><td>0.276</td><td>0.971</td><td>1.000</td><td>4897</td><td>tags=70%, list=38%, signal=112%</td></tr><tr><td class='lessen'>226</td><td>MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3</td><td></td><td>290</td><td>-0.39</td><td>-1.17</td><td>0.124</td><td>0.972</td><td>1.000</td><td>2689</td><td>tags=39%, list=21%, signal=49%</td></tr><tr><td class='lessen'>227</td><td>PACHER_TARGETS_OF_IGF1_AND_IGF2_UP</td><td></td><td>30</td><td>-0.48</td><td>-1.16</td><td>0.277</td><td>0.980</td><td>1.000</td><td>3674</td><td>tags=50%, list=28%, signal=70%</td></tr><tr><td class='lessen'>228</td><td>XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN</td><td></td><td>15</td><td>-0.54</td><td>-1.16</td><td>0.291</td><td>0.976</td><td>1.000</td><td>1471</td><td>tags=33%, list=11%, signal=38%</td></tr><tr><td class='lessen'>229</td><td>CAFFAREL_RESPONSE_TO_THC_24HR_5_DN</td><td></td><td>46</td><td>-0.46</td><td>-1.16</td><td>0.242</td><td>0.983</td><td>1.000</td><td>2930</td><td>tags=28%, list=23%, signal=36%</td></tr><tr><td class='lessen'>230</td><td>LEE_LIVER_CANCER</td><td></td><td>34</td><td>-0.47</td><td>-1.16</td><td>0.267</td><td>0.983</td><td>1.000</td><td>2422</td><td>tags=50%, list=19%, signal=61%</td></tr><tr><td class='lessen'>231</td><td>ABE_VEGFA_TARGETS_2HR</td><td></td><td>29</td><td>-0.46</td><td>-1.16</td><td>0.284</td><td>0.987</td><td>1.000</td><td>1061</td><td>tags=14%, list=8%, signal=15%</td></tr><tr><td class='lessen'>232</td><td>ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN</td><td></td><td>530</td><td>-0.38</td><td>-1.16</td><td>0.078</td><td>0.988</td><td>1.000</td><td>1866</td><td>tags=20%, list=14%, signal=23%</td></tr><tr><td class='lessen'>233</td><td>ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP</td><td></td><td>151</td><td>-0.39</td><td>-1.16</td><td>0.189</td><td>0.986</td><td>1.000</td><td>1161</td><td>tags=10%, list=9%, signal=11%</td></tr><tr><td class='lessen'>234</td><td>PASINI_SUZ12_TARGETS_UP</td><td></td><td>91</td><td>-0.41</td><td>-1.16</td><td>0.220</td><td>0.989</td><td>1.000</td><td>1867</td><td>tags=24%, list=14%, signal=28%</td></tr><tr><td class='lessen'>235</td><td>MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED</td><td></td><td>413</td><td>-0.38</td><td>-1.16</td><td>0.093</td><td>0.992</td><td>1.000</td><td>2366</td><td>tags=30%, list=18%, signal=35%</td></tr><tr><td class='lessen'>236</td><td>WU_HBX_TARGETS_2_UP</td><td></td><td>21</td><td>-0.51</td><td>-1.16</td><td>0.289</td><td>0.989</td><td>1.000</td><td>564</td><td>tags=10%, list=4%, signal=10%</td></tr><tr><td class='lessen'>237</td><td>SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_DN</td><td></td><td>15</td><td>-0.53</td><td>-1.15</td><td>0.299</td><td>0.997</td><td>1.000</td><td>22</td><td>tags=7%, list=0%, signal=7%</td></tr><tr><td class='lessen'>238</td><td>BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP</td><td></td><td>31</td><td>-0.47</td><td>-1.15</td><td>0.289</td><td>0.998</td><td>1.000</td><td>2925</td><td>tags=39%, list=23%, signal=50%</td></tr><tr><td class='lessen'>239</td><td>SONG_TARGETS_OF_IE86_CMV_PROTEIN</td><td></td><td>56</td><td>-0.43</td><td>-1.15</td><td>0.268</td><td>0.996</td><td>1.000</td><td>3571</td><td>tags=38%, list=28%, signal=52%</td></tr><tr><td class='lessen'>240</td><td>ZEMBUTSU_SENSITIVITY_TO_FLUOROURACIL</td><td></td><td>13</td><td>-0.55</td><td>-1.15</td><td>0.298</td><td>0.993</td><td>1.000</td><td>878</td><td>tags=15%, list=7%, signal=16%</td></tr><tr><td class='lessen'>241</td><td>SHEPARD_BMYB_MORPHOLINO_DN</td><td></td><td>171</td><td>-0.38</td><td>-1.15</td><td>0.198</td><td>1.000</td><td>1.000</td><td>2879</td><td>tags=33%, list=22%, signal=42%</td></tr><tr><td class='lessen'>242</td><td>CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70</td><td></td><td>54</td><td>-0.43</td><td>-1.15</td><td>0.270</td><td>1.000</td><td>1.000</td><td>836</td><td>tags=7%, list=6%, signal=8%</td></tr><tr><td class='lessen'>243</td><td>TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA</td><td></td><td>62</td><td>-0.42</td><td>-1.15</td><td>0.260</td><td>1.000</td><td>1.000</td><td>2683</td><td>tags=29%, list=21%, signal=36%</td></tr><tr><td class='lessen'>244</td><td>KONDO_COLON_CANCER_HCP_WITH_H3K27ME1</td><td></td><td>19</td><td>-0.51</td><td>-1.15</td><td>0.295</td><td>1.000</td><td>1.000</td><td>571</td><td>tags=16%, list=4%, signal=16%</td></tr><tr><td class='lessen'>245</td><td>BURTON_ADIPOGENESIS_PEAK_AT_24HR</td><td></td><td>36</td><td>-0.46</td><td>-1.15</td><td>0.271</td><td>1.000</td><td>1.000</td><td>3876</td><td>tags=72%, list=30%, signal=103%</td></tr><tr><td class='lessen'>246</td><td>IWANAGA_CARCINOGENESIS_BY_KRAS_UP</td><td></td><td>129</td><td>-0.40</td><td>-1.14</td><td>0.231</td><td>1.000</td><td>1.000</td><td>3481</td><td>tags=35%, list=27%, signal=47%</td></tr><tr><td class='lessen'>247</td><td>MOHANKUMAR_TLX1_TARGETS_DN</td><td></td><td>137</td><td>-0.39</td><td>-1.14</td><td>0.247</td><td>1.000</td><td>1.000</td><td>2277</td><td>tags=27%, list=18%, signal=32%</td></tr><tr><td class='lessen'>248</td><td>ROLEF_GLIS3_TARGETS</td><td></td><td>30</td><td>-0.47</td><td>-1.14</td><td>0.306</td><td>1.000</td><td>1.000</td><td>1263</td><td>tags=27%, list=10%, signal=29%</td></tr><tr><td class='lessen'>249</td><td>MANALO_HYPOXIA_DN</td><td></td><td>237</td><td>-0.38</td><td>-1.14</td><td>0.202</td><td>1.000</td><td>1.000</td><td>4470</td><td>tags=40%, list=35%, signal=59%</td></tr><tr><td class='lessen'>250</td><td>DARWICHE_PAPILLOMA_RISK_HIGH_DN</td><td></td><td>133</td><td>-0.39</td><td>-1.14</td><td>0.228</td><td>1.000</td><td>1.000</td><td>1645</td><td>tags=17%, list=13%, signal=19%</td></tr><tr><td class='lessen'>251</td><td>KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3</td><td></td><td>70</td><td>-0.42</td><td>-1.14</td><td>0.258</td><td>1.000</td><td>1.000</td><td>1955</td><td>tags=26%, list=15%, signal=30%</td></tr><tr><td class='lessen'>252</td><td>BOYAULT_LIVER_CANCER_SUBCLASS_G12_DN</td><td></td><td>11</td><td>-0.57</td><td>-1.14</td><td>0.333</td><td>1.000</td><td>1.000</td><td>3387</td><td>tags=45%, list=26%, signal=62%</td></tr><tr><td class='lessen'>253</td><td>FERRANDO_HOX11_NEIGHBORS</td><td></td><td>16</td><td>-0.52</td><td>-1.14</td><td>0.311</td><td>1.000</td><td>1.000</td><td>4218</td><td>tags=56%, list=33%, signal=83%</td></tr><tr><td class='lessen'>254</td><td>DELPUECH_FOXO3_TARGETS_DN</td><td></td><td>37</td><td>-0.45</td><td>-1.14</td><td>0.295</td><td>1.000</td><td>1.000</td><td>3844</td><td>tags=43%, list=30%, signal=61%</td></tr><tr><td class='lessen'>255</td><td>WEST_ADRENOCORTICAL_TUMOR_UP</td><td></td><td>252</td><td>-0.38</td><td>-1.13</td><td>0.174</td><td>1.000</td><td>1.000</td><td>4604</td><td>tags=45%, list=36%, signal=68%</td></tr><tr><td class='lessen'>256</td><td>RICKMAN_HEAD_AND_NECK_CANCER_E</td><td></td><td>65</td><td>-0.42</td><td>-1.13</td><td>0.255</td><td>1.000</td><td>1.000</td><td>2837</td><td>tags=51%, list=22%, signal=65%</td></tr><tr><td class='lessen'>257</td><td>COLDREN_GEFITINIB_RESISTANCE_DN</td><td></td><td>176</td><td>-0.38</td><td>-1.13</td><td>0.227</td><td>1.000</td><td>1.000</td><td>4345</td><td>tags=56%, list=34%, signal=83%</td></tr><tr><td class='lessen'>258</td><td>GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP</td><td></td><td>159</td><td>-0.39</td><td>-1.13</td><td>0.227</td><td>1.000</td><td>1.000</td><td>3208</td><td>tags=42%, list=25%, signal=55%</td></tr><tr><td class='lessen'>259</td><td>ULE_SPLICING_VIA_NOVA2</td><td></td><td>37</td><td>-0.45</td><td>-1.13</td><td>0.299</td><td>1.000</td><td>1.000</td><td>958</td><td>tags=16%, list=7%, signal=17%</td></tr><tr><td class='lessen'>260</td><td>WHITE_NEUROBLASTOMA_WITH_1P36.3_DELETION</td><td></td><td>20</td><td>-0.49</td><td>-1.13</td><td>0.320</td><td>1.000</td><td>1.000</td><td>2769</td><td>tags=30%, list=21%, signal=38%</td></tr><tr><td class='lessen'>261</td><td>MATHEW_FANCONI_ANEMIA_GENES</td><td></td><td>11</td><td>-0.56</td><td>-1.13</td><td>0.337</td><td>1.000</td><td>1.000</td><td>2909</td><td>tags=36%, list=22%, signal=47%</td></tr><tr><td class='lessen'>262</td><td>KUUSELO_PANCREATIC_CANCER_19Q13_AMPLIFICATION</td><td></td><td>17</td><td>-0.51</td><td>-1.12</td><td>0.330</td><td>1.000</td><td>1.000</td><td>383</td><td>tags=12%, list=3%, signal=12%</td></tr><tr><td class='lessen'>263</td><td>BENPORATH_CYCLING_GENES</td><td></td><td>515</td><td>-0.37</td><td>-1.12</td><td>0.132</td><td>1.000</td><td>1.000</td><td>3027</td><td>tags=26%, list=23%, signal=33%</td></tr><tr><td class='lessen'>264</td><td>CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP</td><td></td><td>338</td><td>-0.37</td><td>-1.12</td><td>0.192</td><td>1.000</td><td>1.000</td><td>4264</td><td>tags=50%, list=33%, signal=72%</td></tr><tr><td class='lessen'>265</td><td>VERNELL_RETINOBLASTOMA_PATHWAY_UP</td><td></td><td>61</td><td>-0.41</td><td>-1.11</td><td>0.297</td><td>1.000</td><td>1.000</td><td>3655</td><td>tags=39%, list=28%, signal=55%</td></tr><tr><td class='lessen'>266</td><td>WANG_RECURRENT_LIVER_CANCER_DN</td><td></td><td>16</td><td>-0.51</td><td>-1.11</td><td>0.338</td><td>1.000</td><td>1.000</td><td>2784</td><td>tags=31%, list=22%, signal=40%</td></tr><tr><td class='lessen'>267</td><td>BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN</td><td></td><td>46</td><td>-0.43</td><td>-1.11</td><td>0.307</td><td>1.000</td><td>1.000</td><td>2508</td><td>tags=41%, list=19%, signal=51%</td></tr><tr><td class='lessen'>268</td><td>MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3</td><td></td><td>120</td><td>-0.38</td><td>-1.11</td><td>0.283</td><td>1.000</td><td>1.000</td><td>3370</td><td>tags=47%, list=26%, signal=63%</td></tr><tr><td class='lessen'>269</td><td>MONTERO_THYROID_CANCER_POOR_SURVIVAL_UP</td><td></td><td>11</td><td>-0.54</td><td>-1.11</td><td>0.360</td><td>1.000</td><td>1.000</td><td>2456</td><td>tags=64%, list=19%, signal=78%</td></tr><tr><td class='lessen'>270</td><td>MARTENS_TRETINOIN_RESPONSE_UP</td><td></td><td>595</td><td>-0.36</td><td>-1.10</td><td>0.167</td><td>1.000</td><td>1.000</td><td>1857</td><td>tags=25%, list=14%, signal=28%</td></tr><tr><td class='lessen'>271</td><td>MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN</td><td></td><td>19</td><td>-0.49</td><td>-1.10</td><td>0.359</td><td>1.000</td><td>1.000</td><td>1551</td><td>tags=16%, list=12%, signal=18%</td></tr><tr><td class='lessen'>272</td><td>NIELSEN_SCHWANNOMA_UP</td><td></td><td>15</td><td>-0.52</td><td>-1.10</td><td>0.370</td><td>1.000</td><td>1.000</td><td>3477</td><td>tags=47%, list=27%, signal=64%</td></tr><tr><td class='lessen'>273</td><td>HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2</td><td></td><td>17</td><td>-0.50</td><td>-1.10</td><td>0.376</td><td>1.000</td><td>1.000</td><td>2754</td><td>tags=47%, list=21%, signal=60%</td></tr><tr><td class='lessen'>274</td><td>VERHAAK_GLIOBLASTOMA_PRONEURAL</td><td></td><td>135</td><td>-0.38</td><td>-1.10</td><td>0.285</td><td>1.000</td><td>1.000</td><td>3495</td><td>tags=39%, list=27%, signal=52%</td></tr><tr><td class='lessen'>275</td><td>ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_DN</td><td></td><td>34</td><td>-0.44</td><td>-1.10</td><td>0.332</td><td>1.000</td><td>1.000</td><td>2920</td><td>tags=47%, list=23%, signal=61%</td></tr><tr><td class='lessen'>276</td><td>JAZAG_TGFB1_SIGNALING_DN</td><td></td><td>29</td><td>-0.46</td><td>-1.10</td><td>0.354</td><td>1.000</td><td>1.000</td><td>2675</td><td>tags=34%, list=21%, signal=43%</td></tr><tr><td class='lessen'>277</td><td>RICKMAN_HEAD_AND_NECK_CANCER_A</td><td></td><td>78</td><td>-0.40</td><td>-1.10</td><td>0.333</td><td>1.000</td><td>1.000</td><td>3210</td><td>tags=42%, list=25%, signal=56%</td></tr><tr><td class='lessen'>278</td><td>CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP</td><td></td><td>62</td><td>-0.41</td><td>-1.09</td><td>0.338</td><td>1.000</td><td>1.000</td><td>3194</td><td>tags=50%, list=25%, signal=66%</td></tr><tr><td class='lessen'>279</td><td>MUELLER_METHYLATED_IN_GLIOBLASTOMA</td><td></td><td>33</td><td>-0.45</td><td>-1.09</td><td>0.362</td><td>1.000</td><td>1.000</td><td>2689</td><td>tags=36%, list=21%, signal=46%</td></tr><tr><td class='lessen'>280</td><td>GAZIN_EPIGENETIC_SILENCING_BY_KRAS</td><td></td><td>24</td><td>-0.47</td><td>-1.09</td><td>0.355</td><td>1.000</td><td>1.000</td><td>3918</td><td>tags=42%, list=30%, signal=60%</td></tr><tr><td class='lessen'>281</td><td>MELLMAN_TUT1_TARGETS_UP</td><td></td><td>16</td><td>-0.50</td><td>-1.09</td><td>0.376</td><td>1.000</td><td>1.000</td><td>369</td><td>tags=6%, list=3%, signal=6%</td></tr><tr><td class='lessen'>282</td><td>ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP</td><td></td><td>79</td><td>-0.39</td><td>-1.09</td><td>0.333</td><td>1.000</td><td>1.000</td><td>1192</td><td>tags=22%, list=9%, signal=24%</td></tr><tr><td class='lessen'>283</td><td>STEIN_ESR1_TARGETS</td><td></td><td>74</td><td>-0.40</td><td>-1.09</td><td>0.355</td><td>1.000</td><td>1.000</td><td>3358</td><td>tags=38%, list=26%, signal=51%</td></tr><tr><td class='lessen'>284</td><td>TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C</td><td></td><td>318</td><td>-0.36</td><td>-1.09</td><td>0.267</td><td>1.000</td><td>1.000</td><td>3757</td><td>tags=33%, list=29%, signal=45%</td></tr><tr><td class='lessen'>285</td><td>GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN</td><td></td><td>21</td><td>-0.47</td><td>-1.08</td><td>0.367</td><td>1.000</td><td>1.000</td><td>328</td><td>tags=10%, list=3%, signal=10%</td></tr><tr><td class='lessen'>286</td><td>RAO_BOUND_BY_SALL4_ISOFORM_B</td><td></td><td>419</td><td>-0.35</td><td>-1.08</td><td>0.248</td><td>1.000</td><td>1.000</td><td>3082</td><td>tags=25%, list=24%, signal=31%</td></tr><tr><td class='lessen'>287</td><td>YUAN_ZNF143_PARTNERS</td><td></td><td>19</td><td>-0.48</td><td>-1.08</td><td>0.396</td><td>1.000</td><td>1.000</td><td>2678</td><td>tags=21%, list=21%, signal=27%</td></tr><tr><td class='lessen'>288</td><td>PEDRIOLI_MIR31_TARGETS_UP</td><td></td><td>138</td><td>-0.37</td><td>-1.08</td><td>0.339</td><td>1.000</td><td>1.000</td><td>1349</td><td>tags=15%, list=10%, signal=17%</td></tr><tr><td class='lessen'>289</td><td>MIKKELSEN_MEF_LCP_WITH_H3K27ME3</td><td></td><td>54</td><td>-0.41</td><td>-1.08</td><td>0.362</td><td>1.000</td><td>1.000</td><td>2426</td><td>tags=35%, list=19%, signal=43%</td></tr><tr><td class='lessen'>290</td><td>LANDIS_ERBB2_BREAST_TUMORS_324_UP</td><td></td><td>128</td><td>-0.37</td><td>-1.08</td><td>0.343</td><td>1.000</td><td>1.000</td><td>4573</td><td>tags=55%, list=35%, signal=84%</td></tr><tr><td class='lessen'>291</td><td>CHO_NR4A1_TARGETS</td><td></td><td>29</td><td>-0.45</td><td>-1.08</td><td>0.392</td><td>1.000</td><td>1.000</td><td>18</td><td>tags=3%, list=0%, signal=3%</td></tr><tr><td class='lessen'>292</td><td>GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN</td><td></td><td>135</td><td>-0.37</td><td>-1.08</td><td>0.338</td><td>1.000</td><td>1.000</td><td>3281</td><td>tags=27%, list=25%, signal=35%</td></tr><tr><td class='lessen'>293</td><td>POOLA_INVASIVE_BREAST_CANCER_DN</td><td></td><td>117</td><td>-0.37</td><td>-1.08</td><td>0.353</td><td>1.000</td><td>1.000</td><td>3338</td><td>tags=37%, list=26%, signal=49%</td></tr><tr><td class='lessen'>294</td><td>WATTEL_AUTONOMOUS_THYROID_ADENOMA_UP</td><td></td><td>56</td><td>-0.40</td><td>-1.07</td><td>0.359</td><td>1.000</td><td>1.000</td><td>3077</td><td>tags=34%, list=24%, signal=44%</td></tr><tr><td class='lessen'>295</td><td>BOYERINAS_ONCOFETAL_TARGETS_OF_LET7A1</td><td></td><td>12</td><td>-0.51</td><td>-1.07</td><td>0.377</td><td>1.000</td><td>1.000</td><td>2448</td><td>tags=42%, list=19%, signal=51%</td></tr><tr><td class='lessen'>296</td><td>LABBE_WNT3A_TARGETS_DN</td><td></td><td>84</td><td>-0.38</td><td>-1.07</td><td>0.384</td><td>1.000</td><td>1.000</td><td>2661</td><td>tags=31%, list=21%, signal=39%</td></tr><tr><td class='lessen'>297</td><td>WILLIAMS_ESR1_TARGETS_UP</td><td></td><td>23</td><td>-0.46</td><td>-1.07</td><td>0.370</td><td>1.000</td><td>1.000</td><td>1812</td><td>tags=39%, list=14%, signal=45%</td></tr><tr><td class='lessen'>298</td><td>BIDUS_METASTASIS_UP</td><td></td><td>164</td><td>-0.36</td><td>-1.07</td><td>0.358</td><td>1.000</td><td>1.000</td><td>2960</td><td>tags=25%, list=23%, signal=32%</td></tr><tr><td class='lessen'>299</td><td>WALLACE_PROSTATE_CANCER_UP</td><td></td><td>18</td><td>-0.48</td><td>-1.07</td><td>0.393</td><td>1.000</td><td>1.000</td><td>3624</td><td>tags=61%, list=28%, signal=85%</td></tr><tr><td class='lessen'>300</td><td>NOUSHMEHR_GBM_SILENCED_BY_METHYLATION</td><td></td><td>38</td><td>-0.43</td><td>-1.07</td><td>0.385</td><td>1.000</td><td>1.000</td><td>403</td><td>tags=11%, list=3%, signal=11%</td></tr><tr><td class='lessen'>301</td><td>KAUFFMANN_DNA_REPAIR_GENES</td><td></td><td>206</td><td>-0.36</td><td>-1.07</td><td>0.326</td><td>1.000</td><td>1.000</td><td>4515</td><td>tags=34%, list=35%, signal=52%</td></tr><tr><td class='lessen'>302</td><td>RICKMAN_HEAD_AND_NECK_CANCER_D</td><td></td><td>23</td><td>-0.46</td><td>-1.07</td><td>0.382</td><td>1.000</td><td>1.000</td><td>2369</td><td>tags=48%, list=18%, signal=58%</td></tr><tr><td class='lessen'>303</td><td>WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP</td><td></td><td>14</td><td>-0.50</td><td>-1.07</td><td>0.403</td><td>1.000</td><td>1.000</td><td>912</td><td>tags=14%, list=7%, signal=15%</td></tr><tr><td class='lessen'>304</td><td>KONDO_PROSTATE_CANCER_WITH_H3K27ME3</td><td></td><td>125</td><td>-0.37</td><td>-1.07</td><td>0.354</td><td>1.000</td><td>1.000</td><td>1926</td><td>tags=30%, list=15%, signal=35%</td></tr><tr><td class='lessen'>305</td><td>ZHENG_GLIOBLASTOMA_PLASTICITY_UP</td><td></td><td>213</td><td>-0.36</td><td>-1.07</td><td>0.347</td><td>1.000</td><td>1.000</td><td>2006</td><td>tags=26%, list=16%, signal=31%</td></tr><tr><td class='lessen'>306</td><td>LANDIS_ERBB2_BREAST_PRENEOPLASTIC_UP</td><td></td><td>17</td><td>-0.49</td><td>-1.07</td><td>0.385</td><td>1.000</td><td>1.000</td><td>4528</td><td>tags=76%, list=35%, signal=118%</td></tr><tr><td class='lessen'>307</td><td>SMIRNOV_RESPONSE_TO_IR_2HR_DN</td><td></td><td>46</td><td>-0.41</td><td>-1.07</td><td>0.387</td><td>1.000</td><td>1.000</td><td>1177</td><td>tags=17%, list=9%, signal=19%</td></tr><tr><td class='lessen'>308</td><td>RICKMAN_HEAD_AND_NECK_CANCER_C</td><td></td><td>77</td><td>-0.38</td><td>-1.06</td><td>0.381</td><td>1.000</td><td>1.000</td><td>2123</td><td>tags=35%, list=16%, signal=42%</td></tr><tr><td class='lessen'>309</td><td>IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR</td><td></td><td>109</td><td>-0.38</td><td>-1.06</td><td>0.370</td><td>1.000</td><td>1.000</td><td>1694</td><td>tags=10%, list=13%, signal=12%</td></tr><tr><td class='lessen'>310</td><td>MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3</td><td></td><td>181</td><td>-0.36</td><td>-1.06</td><td>0.372</td><td>1.000</td><td>1.000</td><td>2921</td><td>tags=41%, list=23%, signal=52%</td></tr><tr><td class='lessen'>311</td><td>HATADA_METHYLATED_IN_LUNG_CANCER_UP</td><td></td><td>296</td><td>-0.35</td><td>-1.06</td><td>0.329</td><td>1.000</td><td>1.000</td><td>1706</td><td>tags=20%, list=13%, signal=23%</td></tr><tr><td class='lessen'>312</td><td>BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS</td><td></td><td>22</td><td>-0.46</td><td>-1.06</td><td>0.401</td><td>1.000</td><td>1.000</td><td>1499</td><td>tags=27%, list=12%, signal=31%</td></tr><tr><td class='lessen'>313</td><td>CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_DN</td><td></td><td>13</td><td>-0.52</td><td>-1.06</td><td>0.407</td><td>1.000</td><td>1.000</td><td>1824</td><td>tags=38%, list=14%, signal=45%</td></tr><tr><td class='lessen'>314</td><td>SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_DN</td><td></td><td>17</td><td>-0.48</td><td>-1.05</td><td>0.409</td><td>1.000</td><td>1.000</td><td>2369</td><td>tags=41%, list=18%, signal=50%</td></tr><tr><td class='lessen'>315</td><td>DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY</td><td></td><td>25</td><td>-0.45</td><td>-1.05</td><td>0.410</td><td>1.000</td><td>1.000</td><td>2491</td><td>tags=24%, list=19%, signal=30%</td></tr><tr><td class='lessen'>316</td><td>KUMAR_AUTOPHAGY_NETWORK</td><td></td><td>50</td><td>-0.40</td><td>-1.05</td><td>0.392</td><td>1.000</td><td>1.000</td><td>2640</td><td>tags=26%, list=20%, signal=33%</td></tr><tr><td class='lessen'>317</td><td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN</td><td></td><td>39</td><td>-0.41</td><td>-1.05</td><td>0.410</td><td>1.000</td><td>1.000</td><td>3011</td><td>tags=38%, list=23%, signal=50%</td></tr><tr><td class='lessen'>318</td><td>BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN</td><td></td><td>30</td><td>-0.44</td><td>-1.05</td><td>0.402</td><td>1.000</td><td>1.000</td><td>3938</td><td>tags=50%, list=30%, signal=72%</td></tr><tr><td class='lessen'>319</td><td>PUJANA_BREAST_CANCER_LIT_INT_NETWORK</td><td></td><td>93</td><td>-0.37</td><td>-1.05</td><td>0.395</td><td>1.000</td><td>1.000</td><td>2909</td><td>tags=22%, list=22%, signal=28%</td></tr><tr><td class='lessen'>320</td><td>LIM_MAMMARY_STEM_CELL_DN</td><td></td><td>360</td><td>-0.34</td><td>-1.05</td><td>0.380</td><td>1.000</td><td>1.000</td><td>4273</td><td>tags=44%, list=33%, signal=64%</td></tr><tr><td class='lessen'>321</td><td>NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON</td><td></td><td>102</td><td>-0.37</td><td>-1.05</td><td>0.395</td><td>1.000</td><td>1.000</td><td>2878</td><td>tags=25%, list=22%, signal=33%</td></tr><tr><td class='lessen'>322</td><td>NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON</td><td></td><td>106</td><td>-0.37</td><td>-1.05</td><td>0.390</td><td>1.000</td><td>1.000</td><td>3095</td><td>tags=25%, list=24%, signal=33%</td></tr><tr><td class='lessen'>323</td><td>HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP</td><td></td><td>359</td><td>-0.35</td><td>-1.05</td><td>0.377</td><td>1.000</td><td>1.000</td><td>2802</td><td>tags=27%, list=22%, signal=33%</td></tr><tr><td class='lessen'>324</td><td>LEE_LIVER_CANCER_MYC_TGFA_DN</td><td></td><td>54</td><td>-0.39</td><td>-1.04</td><td>0.424</td><td>1.000</td><td>1.000</td><td>2508</td><td>tags=43%, list=19%, signal=53%</td></tr><tr><td class='lessen'>325</td><td>WAESCH_ANAPHASE_PROMOTING_COMPLEX</td><td></td><td>12</td><td>-0.50</td><td>-1.04</td><td>0.414</td><td>1.000</td><td>1.000</td><td>817</td><td>tags=8%, list=6%, signal=9%</td></tr><tr><td class='lessen'>326</td><td>DUAN_PRDM5_TARGETS</td><td></td><td>61</td><td>-0.39</td><td>-1.04</td><td>0.394</td><td>1.000</td><td>1.000</td><td>2805</td><td>tags=28%, list=22%, signal=35%</td></tr><tr><td class='lessen'>327</td><td>LEE_NEURAL_CREST_STEM_CELL_DN</td><td></td><td>97</td><td>-0.36</td><td>-1.04</td><td>0.419</td><td>1.000</td><td>1.000</td><td>3098</td><td>tags=32%, list=24%, signal=42%</td></tr><tr><td class='lessen'>328</td><td>NAGY_TFTC_COMPONENTS_HUMAN</td><td></td><td>14</td><td>-0.50</td><td>-1.04</td><td>0.431</td><td>1.000</td><td>1.000</td><td>5173</td><td>tags=71%, list=40%, signal=119%</td></tr><tr><td class='lessen'>329</td><td>JAZAG_TGFB1_SIGNALING_UP</td><td></td><td>91</td><td>-0.37</td><td>-1.04</td><td>0.408</td><td>1.000</td><td>1.000</td><td>1935</td><td>tags=19%, list=15%, signal=22%</td></tr><tr><td class='lessen'>330</td><td>WONG_EMBRYONIC_STEM_CELL_CORE</td><td></td><td>291</td><td>-0.34</td><td>-1.04</td><td>0.410</td><td>1.000</td><td>1.000</td><td>3143</td><td>tags=23%, list=24%, signal=29%</td></tr><tr><td class='lessen'>331</td><td>BENPORATH_ES_WITH_H3K27ME3</td><td></td><td>894</td><td>-0.34</td><td>-1.04</td><td>0.334</td><td>1.000</td><td>1.000</td><td>2241</td><td>tags=27%, list=17%, signal=31%</td></tr><tr><td class='lessen'>332</td><td>VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP</td><td></td><td>78</td><td>-0.37</td><td>-1.04</td><td>0.414</td><td>1.000</td><td>1.000</td><td>3456</td><td>tags=46%, list=27%, signal=63%</td></tr><tr><td class='lessen'>333</td><td>BENPORATH_ES_CORE_NINE_CORRELATED</td><td></td><td>93</td><td>-0.37</td><td>-1.03</td><td>0.427</td><td>1.000</td><td>1.000</td><td>1755</td><td>tags=13%, list=14%, signal=15%</td></tr><tr><td class='lessen'>334</td><td>RIZ_ERYTHROID_DIFFERENTIATION_CCNE1</td><td></td><td>35</td><td>-0.41</td><td>-1.03</td><td>0.440</td><td>1.000</td><td>1.000</td><td>1549</td><td>tags=14%, list=12%, signal=16%</td></tr><tr><td class='lessen'>335</td><td>WATANABE_COLON_CANCER_MSI_VS_MSS_UP</td><td></td><td>23</td><td>-0.44</td><td>-1.03</td><td>0.432</td><td>1.000</td><td>1.000</td><td>2749</td><td>tags=39%, list=21%, signal=50%</td></tr><tr><td class='lessen'>336</td><td>ZEMBUTSU_SENSITIVITY_TO_VINCRISTINE</td><td></td><td>16</td><td>-0.48</td><td>-1.03</td><td>0.447</td><td>1.000</td><td>1.000</td><td>18</td><td>tags=6%, list=0%, signal=6%</td></tr><tr><td class='lessen'>337</td><td>BENPORATH_PRC2_TARGETS</td><td></td><td>514</td><td>-0.34</td><td>-1.03</td><td>0.415</td><td>1.000</td><td>1.000</td><td>2639</td><td>tags=33%, list=20%, signal=40%</td></tr><tr><td class='lessen'>338</td><td>FARMER_BREAST_CANCER_BASAL_VS_LULMINAL</td><td></td><td>273</td><td>-0.34</td><td>-1.03</td><td>0.413</td><td>1.000</td><td>1.000</td><td>3116</td><td>tags=30%, list=24%, signal=39%</td></tr><tr><td class='lessen'>339</td><td>VANTVEER_BREAST_CANCER_ESR1_UP</td><td></td><td>126</td><td>-0.36</td><td>-1.03</td><td>0.446</td><td>1.000</td><td>1.000</td><td>3367</td><td>tags=32%, list=26%, signal=42%</td></tr><tr><td class='lessen'>340</td><td>FEVR_CTNNB1_TARGETS_DN</td><td></td><td>435</td><td>-0.34</td><td>-1.03</td><td>0.410</td><td>1.000</td><td>1.000</td><td>4433</td><td>tags=36%, list=34%, signal=53%</td></tr><tr><td class='lessen'>341</td><td>SHIPP_DLBCL_CURED_VS_FATAL_UP</td><td></td><td>33</td><td>-0.41</td><td>-1.03</td><td>0.449</td><td>1.000</td><td>1.000</td><td>2491</td><td>tags=36%, list=19%, signal=45%</td></tr><tr><td class='lessen'>342</td><td>YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN</td><td></td><td>63</td><td>-0.38</td><td>-1.03</td><td>0.434</td><td>1.000</td><td>1.000</td><td>2392</td><td>tags=25%, list=18%, signal=31%</td></tr><tr><td class='lessen'>343</td><td>ZHANG_BREAST_CANCER_PROGENITORS_UP</td><td></td><td>329</td><td>-0.34</td><td>-1.03</td><td>0.432</td><td>1.000</td><td>1.000</td><td>4557</td><td>tags=38%, list=35%, signal=58%</td></tr><tr><td class='lessen'>344</td><td>FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_UP</td><td></td><td>18</td><td>-0.46</td><td>-1.02</td><td>0.463</td><td>1.000</td><td>1.000</td><td>513</td><td>tags=11%, list=4%, signal=12%</td></tr><tr><td class='lessen'>345</td><td>KIM_MYCN_AMPLIFICATION_TARGETS_UP</td><td></td><td>80</td><td>-0.37</td><td>-1.02</td><td>0.447</td><td>1.000</td><td>1.000</td><td>1135</td><td>tags=15%, list=9%, signal=16%</td></tr><tr><td class='lessen'>346</td><td>YOSHIMURA_MAPK8_TARGETS_UP</td><td></td><td>1137</td><td>-0.33</td><td>-1.02</td><td>0.413</td><td>1.000</td><td>1.000</td><td>2157</td><td>tags=24%, list=17%, signal=26%</td></tr><tr><td class='lessen'>347</td><td>CAIRO_HEPATOBLASTOMA_DN</td><td></td><td>217</td><td>-0.34</td><td>-1.02</td><td>0.456</td><td>1.000</td><td>1.000</td><td>2872</td><td>tags=38%, list=22%, signal=48%</td></tr><tr><td class='lessen'>348</td><td>COLLIS_PRKDC_REGULATORS</td><td></td><td>15</td><td>-0.47</td><td>-1.02</td><td>0.448</td><td>1.000</td><td>1.000</td><td>6216</td><td>tags=87%, list=48%, signal=167%</td></tr><tr><td class='lessen'>349</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11</td><td></td><td>82</td><td>-0.36</td><td>-1.02</td><td>0.448</td><td>1.000</td><td>1.000</td><td>4667</td><td>tags=41%, list=36%, signal=64%</td></tr><tr><td class='lessen'>350</td><td>NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER</td><td></td><td>18</td><td>-0.45</td><td>-1.02</td><td>0.437</td><td>1.000</td><td>1.000</td><td>1998</td><td>tags=22%, list=15%, signal=26%</td></tr><tr><td class='lessen'>351</td><td>BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP</td><td></td><td>42</td><td>-0.40</td><td>-1.01</td><td>0.469</td><td>1.000</td><td>1.000</td><td>3587</td><td>tags=36%, list=28%, signal=49%</td></tr><tr><td class='lessen'>352</td><td>YANG_BREAST_CANCER_ESR1_DN</td><td></td><td>24</td><td>-0.44</td><td>-1.01</td><td>0.474</td><td>1.000</td><td>1.000</td><td>2530</td><td>tags=38%, list=20%, signal=47%</td></tr><tr><td class='lessen'>353</td><td>CHOW_RASSF1_TARGETS_DN</td><td></td><td>25</td><td>-0.43</td><td>-1.01</td><td>0.443</td><td>1.000</td><td>1.000</td><td>5191</td><td>tags=56%, list=40%, signal=93%</td></tr><tr><td class='lessen'>354</td><td>SASAI_TARGETS_OF_CXCR6_AND_PTCH1_UP</td><td></td><td>10</td><td>-0.52</td><td>-1.01</td><td>0.480</td><td>1.000</td><td>1.000</td><td>1367</td><td>tags=30%, list=11%, signal=34%</td></tr><tr><td class='lessen'>355</td><td>WANG_RESPONSE_TO_BEXAROTENE_UP</td><td></td><td>27</td><td>-0.43</td><td>-1.01</td><td>0.465</td><td>1.000</td><td>1.000</td><td>3512</td><td>tags=44%, list=27%, signal=61%</td></tr><tr><td class='lessen'>356</td><td>CHYLA_CBFA2T3_TARGETS_DN</td><td></td><td>172</td><td>-0.34</td><td>-1.01</td><td>0.481</td><td>1.000</td><td>1.000</td><td>1927</td><td>tags=21%, list=15%, signal=24%</td></tr><tr><td class='lessen'>357</td><td>WAKASUGI_HAVE_ZNF143_BINDING_SITES</td><td></td><td>55</td><td>-0.39</td><td>-1.01</td><td>0.464</td><td>1.000</td><td>1.000</td><td>5156</td><td>tags=47%, list=40%, signal=78%</td></tr><tr><td class='lessen'>358</td><td>LEE_LIVER_CANCER_CIPROFIBRATE_DN</td><td></td><td>58</td><td>-0.38</td><td>-1.01</td><td>0.465</td><td>1.000</td><td>1.000</td><td>2339</td><td>tags=43%, list=18%, signal=52%</td></tr><tr><td class='lessen'>359</td><td>WHITFIELD_CELL_CYCLE_G1_S</td><td></td><td>103</td><td>-0.35</td><td>-1.01</td><td>0.466</td><td>1.000</td><td>1.000</td><td>3285</td><td>tags=25%, list=25%, signal=34%</td></tr><tr><td class='lessen'>360</td><td>BLUM_RESPONSE_TO_SALIRASIB_DN</td><td></td><td>303</td><td>-0.33</td><td>-1.00</td><td>0.487</td><td>1.000</td><td>1.000</td><td>2976</td><td>tags=28%, list=23%, signal=36%</td></tr><tr><td class='lessen'>361</td><td>OUYANG_PROSTATE_CANCER_MARKERS</td><td></td><td>19</td><td>-0.45</td><td>-1.00</td><td>0.476</td><td>1.000</td><td>1.000</td><td>43</td><td>tags=5%, list=0%, signal=5%</td></tr><tr><td class='lessen'>362</td><td>AFFAR_YY1_TARGETS_DN</td><td></td><td>214</td><td>-0.34</td><td>-1.00</td><td>0.506</td><td>1.000</td><td>1.000</td><td>2413</td><td>tags=29%, list=19%, signal=34%</td></tr><tr><td class='lessen'>363</td><td>BARIS_THYROID_CANCER_UP</td><td></td><td>22</td><td>-0.44</td><td>-1.00</td><td>0.478</td><td>1.000</td><td>1.000</td><td>1690</td><td>tags=14%, list=13%, signal=16%</td></tr><tr><td class='lessen'>364</td><td>SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP</td><td></td><td>388</td><td>-0.33</td><td>-1.00</td><td>0.494</td><td>1.000</td><td>1.000</td><td>3980</td><td>tags=45%, list=31%, signal=64%</td></tr><tr><td class='lessen'>365</td><td>MORI_PRE_BI_LYMPHOCYTE_UP</td><td></td><td>70</td><td>-0.36</td><td>-1.00</td><td>0.471</td><td>1.000</td><td>1.000</td><td>3143</td><td>tags=39%, list=24%, signal=51%</td></tr><tr><td class='lessen'>366</td><td>MORI_PLASMA_CELL_UP</td><td></td><td>40</td><td>-0.39</td><td>-1.00</td><td>0.486</td><td>1.000</td><td>1.000</td><td>4464</td><td>tags=45%, list=35%, signal=69%</td></tr><tr><td class='lessen'>367</td><td>DARWICHE_SKIN_TUMOR_PROMOTER_DN</td><td></td><td>131</td><td>-0.35</td><td>-1.00</td><td>0.488</td><td>1.000</td><td>1.000</td><td>1060</td><td>tags=11%, list=8%, signal=12%</td></tr><tr><td class='lessen'>368</td><td>CHIN_BREAST_CANCER_COPY_NUMBER_UP</td><td></td><td>22</td><td>-0.43</td><td>-1.00</td><td>0.476</td><td>1.000</td><td>1.000</td><td>1176</td><td>tags=18%, list=9%, signal=20%</td></tr><tr><td class='lessen'>369</td><td>LIU_TARGETS_OF_VMYB_VS_CMYB_UP</td><td></td><td>14</td><td>-0.47</td><td>-1.00</td><td>0.485</td><td>1.000</td><td>1.000</td><td>2510</td><td>tags=29%, list=19%, signal=35%</td></tr><tr><td class='lessen'>370</td><td>HOEGERKORP_CD44_TARGETS_TEMPORAL_DN</td><td></td><td>22</td><td>-0.44</td><td>-1.00</td><td>0.486</td><td>1.000</td><td>1.000</td><td>3080</td><td>tags=36%, list=24%, signal=48%</td></tr><tr><td class='lessen'>371</td><td>KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES</td><td></td><td>180</td><td>-0.33</td><td>-0.99</td><td>0.502</td><td>1.000</td><td>1.000</td><td>2005</td><td>tags=18%, list=16%, signal=21%</td></tr><tr><td class='lessen'>372</td><td>ROVERSI_GLIOMA_COPY_NUMBER_UP</td><td></td><td>82</td><td>-0.36</td><td>-0.99</td><td>0.484</td><td>1.000</td><td>1.000</td><td>3484</td><td>tags=33%, list=27%, signal=45%</td></tr><tr><td class='lessen'>373</td><td>ABRAMSON_INTERACT_WITH_AIRE</td><td></td><td>38</td><td>-0.39</td><td>-0.99</td><td>0.476</td><td>1.000</td><td>1.000</td><td>6999</td><td>tags=79%, list=54%, signal=172%</td></tr><tr><td class='lessen'>374</td><td>YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN</td><td></td><td>208</td><td>-0.34</td><td>-0.99</td><td>0.523</td><td>1.000</td><td>1.000</td><td>2434</td><td>tags=29%, list=19%, signal=36%</td></tr><tr><td class='lessen'>375</td><td>BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN</td><td></td><td>139</td><td>-0.34</td><td>-0.99</td><td>0.508</td><td>1.000</td><td>1.000</td><td>2713</td><td>tags=26%, list=21%, signal=32%</td></tr><tr><td class='lessen'>376</td><td>ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_DN</td><td></td><td>18</td><td>-0.45</td><td>-0.99</td><td>0.494</td><td>1.000</td><td>1.000</td><td>1088</td><td>tags=22%, list=8%, signal=24%</td></tr><tr><td class='lessen'>377</td><td>SILIGAN_BOUND_BY_EWS_FLT1_FUSION</td><td></td><td>39</td><td>-0.39</td><td>-0.99</td><td>0.509</td><td>1.000</td><td>1.000</td><td>2477</td><td>tags=31%, list=19%, signal=38%</td></tr><tr><td class='lessen'>378</td><td>COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN</td><td></td><td>25</td><td>-0.42</td><td>-0.98</td><td>0.522</td><td>1.000</td><td>1.000</td><td>1471</td><td>tags=16%, list=11%, signal=18%</td></tr><tr><td class='lessen'>379</td><td>HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN</td><td></td><td>22</td><td>-0.43</td><td>-0.98</td><td>0.503</td><td>1.000</td><td>1.000</td><td>876</td><td>tags=14%, list=7%, signal=15%</td></tr><tr><td class='lessen'>380</td><td>RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN</td><td></td><td>27</td><td>-0.41</td><td>-0.98</td><td>0.512</td><td>1.000</td><td>1.000</td><td>2755</td><td>tags=41%, list=21%, signal=52%</td></tr><tr><td class='lessen'>381</td><td>BENPORATH_SUZ12_TARGETS</td><td></td><td>825</td><td>-0.32</td><td>-0.98</td><td>0.591</td><td>1.000</td><td>1.000</td><td>2639</td><td>tags=30%, list=20%, signal=35%</td></tr><tr><td class='lessen'>382</td><td>MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_DN</td><td></td><td>11</td><td>-0.49</td><td>-0.98</td><td>0.481</td><td>1.000</td><td>1.000</td><td>4466</td><td>tags=64%, list=35%, signal=97%</td></tr><tr><td class='lessen'>383</td><td>NAGY_STAGA_COMPONENTS_HUMAN</td><td></td><td>10</td><td>-0.50</td><td>-0.98</td><td>0.520</td><td>1.000</td><td>1.000</td><td>5173</td><td>tags=70%, list=40%, signal=117%</td></tr><tr><td class='lessen'>384</td><td>PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP</td><td></td><td>116</td><td>-0.34</td><td>-0.98</td><td>0.510</td><td>1.000</td><td>1.000</td><td>2859</td><td>tags=29%, list=22%, signal=37%</td></tr><tr><td class='lessen'>385</td><td>MEISSNER_NPC_HCP_WITH_H3K4ME2</td><td></td><td>412</td><td>-0.32</td><td>-0.98</td><td>0.557</td><td>1.000</td><td>1.000</td><td>2139</td><td>tags=21%, list=17%, signal=24%</td></tr><tr><td class='lessen'>386</td><td>ZWANG_EGF_INTERVAL_UP</td><td></td><td>57</td><td>-0.37</td><td>-0.98</td><td>0.511</td><td>1.000</td><td>1.000</td><td>2407</td><td>tags=26%, list=19%, signal=32%</td></tr><tr><td class='lessen'>387</td><td>LANDEMAINE_LUNG_METASTASIS</td><td></td><td>16</td><td>-0.45</td><td>-0.98</td><td>0.501</td><td>1.000</td><td>1.000</td><td>2566</td><td>tags=38%, list=20%, signal=47%</td></tr><tr><td class='lessen'>388</td><td>HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN</td><td></td><td>44</td><td>-0.38</td><td>-0.98</td><td>0.527</td><td>1.000</td><td>1.000</td><td>869</td><td>tags=11%, list=7%, signal=12%</td></tr><tr><td class='lessen'>389</td><td>BASAKI_YBX1_TARGETS_UP</td><td></td><td>232</td><td>-0.33</td><td>-0.98</td><td>0.562</td><td>1.000</td><td>1.000</td><td>2584</td><td>tags=23%, list=20%, signal=29%</td></tr><tr><td class='lessen'>390</td><td>ABE_VEGFA_TARGETS</td><td></td><td>17</td><td>-0.44</td><td>-0.97</td><td>0.515</td><td>1.000</td><td>1.000</td><td>925</td><td>tags=18%, list=7%, signal=19%</td></tr><tr><td class='lessen'>391</td><td>SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_DN</td><td></td><td>14</td><td>-0.46</td><td>-0.97</td><td>0.515</td><td>1.000</td><td>1.000</td><td>3353</td><td>tags=43%, list=26%, signal=58%</td></tr><tr><td class='lessen'>392</td><td>HU_ANGIOGENESIS_DN</td><td></td><td>29</td><td>-0.40</td><td>-0.97</td><td>0.511</td><td>1.000</td><td>1.000</td><td>1160</td><td>tags=7%, list=9%, signal=8%</td></tr><tr><td class='lessen'>393</td><td>GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN</td><td></td><td>31</td><td>-0.40</td><td>-0.97</td><td>0.491</td><td>1.000</td><td>1.000</td><td>665</td><td>tags=6%, list=5%, signal=7%</td></tr><tr><td class='lessen'>394</td><td>HUTTMANN_B_CLL_POOR_SURVIVAL_DN</td><td></td><td>49</td><td>-0.37</td><td>-0.97</td><td>0.516</td><td>1.000</td><td>1.000</td><td>2809</td><td>tags=29%, list=22%, signal=36%</td></tr><tr><td class='lessen'>395</td><td>MARKS_ACETYLATED_NON_HISTONE_PROTEINS</td><td></td><td>14</td><td>-0.46</td><td>-0.97</td><td>0.511</td><td>1.000</td><td>1.000</td><td>92</td><td>tags=7%, list=1%, signal=7%</td></tr><tr><td class='lessen'>396</td><td>DE_YY1_TARGETS_UP</td><td></td><td>18</td><td>-0.44</td><td>-0.97</td><td>0.536</td><td>1.000</td><td>1.000</td><td>1864</td><td>tags=33%, list=14%, signal=39%</td></tr><tr><td class='lessen'>397</td><td>LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q</td><td></td><td>92</td><td>-0.34</td><td>-0.97</td><td>0.549</td><td>1.000</td><td>1.000</td><td>4638</td><td>tags=35%, list=36%, signal=54%</td></tr><tr><td class='lessen'>398</td><td>MATZUK_PREOVULATORY_FOLLICLE</td><td></td><td>10</td><td>-0.50</td><td>-0.97</td><td>0.515</td><td>1.000</td><td>1.000</td><td>193</td><td>tags=10%, list=1%, signal=10%</td></tr><tr><td class='lessen'>399</td><td>KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP</td><td></td><td>982</td><td>-0.31</td><td>-0.97</td><td>0.643</td><td>1.000</td><td>1.000</td><td>2997</td><td>tags=24%, list=23%, signal=28%</td></tr><tr><td class='lessen'>400</td><td>LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT</td><td></td><td>80</td><td>-0.35</td><td>-0.97</td><td>0.546</td><td>1.000</td><td>1.000</td><td>3936</td><td>tags=48%, list=30%, signal=68%</td></tr><tr><td class='lessen'>401</td><td>KIM_ALL_DISORDERS_CALB1_CORR_DN</td><td></td><td>30</td><td>-0.40</td><td>-0.97</td><td>0.517</td><td>1.000</td><td>1.000</td><td>1500</td><td>tags=23%, list=12%, signal=26%</td></tr><tr><td class='lessen'>402</td><td>BENPORATH_EED_TARGETS</td><td></td><td>829</td><td>-0.31</td><td>-0.97</td><td>0.643</td><td>1.000</td><td>1.000</td><td>2639</td><td>tags=29%, list=20%, signal=34%</td></tr><tr><td class='lessen'>403</td><td>TAVAZOIE_METASTASIS</td><td></td><td>75</td><td>-0.36</td><td>-0.97</td><td>0.555</td><td>1.000</td><td>1.000</td><td>2240</td><td>tags=29%, list=17%, signal=35%</td></tr><tr><td class='lessen'>404</td><td>LEE_TARGETS_OF_PTCH1_AND_SUFU_DN</td><td></td><td>74</td><td>-0.35</td><td>-0.97</td><td>0.540</td><td>1.000</td><td>1.000</td><td>2681</td><td>tags=31%, list=21%, signal=39%</td></tr><tr><td class='lessen'>405</td><td>MCBRYAN_PUBERTAL_BREAST_4_5WK_UP</td><td></td><td>236</td><td>-0.32</td><td>-0.97</td><td>0.582</td><td>1.000</td><td>1.000</td><td>4001</td><td>tags=51%, list=31%, signal=72%</td></tr><tr><td class='lessen'>406</td><td>MIKKELSEN_ES_ICP_WITH_H3K4ME3</td><td></td><td>539</td><td>-0.32</td><td>-0.97</td><td>0.633</td><td>1.000</td><td>1.000</td><td>2869</td><td>tags=27%, list=22%, signal=33%</td></tr><tr><td class='lessen'>407</td><td>MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP</td><td></td><td>111</td><td>-0.34</td><td>-0.97</td><td>0.557</td><td>1.000</td><td>1.000</td><td>1905</td><td>tags=19%, list=15%, signal=22%</td></tr><tr><td class='lessen'>408</td><td>BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES</td><td></td><td>61</td><td>-0.35</td><td>-0.96</td><td>0.537</td><td>1.000</td><td>1.000</td><td>6718</td><td>tags=82%, list=52%, signal=170%</td></tr><tr><td class='lessen'>409</td><td>KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION</td><td></td><td>69</td><td>-0.35</td><td>-0.96</td><td>0.546</td><td>1.000</td><td>1.000</td><td>1165</td><td>tags=13%, list=9%, signal=14%</td></tr><tr><td class='lessen'>410</td><td>WOO_LIVER_CANCER_RECURRENCE_DN</td><td></td><td>62</td><td>-0.36</td><td>-0.96</td><td>0.544</td><td>1.000</td><td>1.000</td><td>3730</td><td>tags=48%, list=29%, signal=68%</td></tr><tr><td class='lessen'>411</td><td>FIRESTEIN_PROLIFERATION</td><td></td><td>155</td><td>-0.33</td><td>-0.96</td><td>0.574</td><td>1.000</td><td>1.000</td><td>2426</td><td>tags=20%, list=19%, signal=24%</td></tr><tr><td class='lessen'>412</td><td>NIKOLSKY_BREAST_CANCER_16Q24_AMPLICON</td><td></td><td>33</td><td>-0.38</td><td>-0.95</td><td>0.546</td><td>1.000</td><td>1.000</td><td>2773</td><td>tags=27%, list=21%, signal=35%</td></tr><tr><td class='lessen'>413</td><td>ZHOU_INFLAMMATORY_RESPONSE_LPS_UP</td><td></td><td>301</td><td>-0.31</td><td>-0.95</td><td>0.623</td><td>1.000</td><td>1.000</td><td>2143</td><td>tags=20%, list=17%, signal=24%</td></tr><tr><td class='lessen'>414</td><td>CHEN_LUNG_CANCER_SURVIVAL</td><td></td><td>25</td><td>-0.41</td><td>-0.95</td><td>0.535</td><td>1.000</td><td>1.000</td><td>3651</td><td>tags=48%, list=28%, signal=67%</td></tr><tr><td class='lessen'>415</td><td>SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4</td><td></td><td>216</td><td>-0.32</td><td>-0.95</td><td>0.607</td><td>1.000</td><td>1.000</td><td>2461</td><td>tags=31%, list=19%, signal=37%</td></tr><tr><td class='lessen'>416</td><td>NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON</td><td></td><td>263</td><td>-0.31</td><td>-0.95</td><td>0.629</td><td>1.000</td><td>1.000</td><td>2886</td><td>tags=22%, list=22%, signal=28%</td></tr><tr><td class='lessen'>417</td><td>MCCABE_BOUND_BY_HOXC6</td><td></td><td>280</td><td>-0.31</td><td>-0.95</td><td>0.603</td><td>1.000</td><td>1.000</td><td>2360</td><td>tags=19%, list=18%, signal=23%</td></tr><tr><td class='lessen'>418</td><td>WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP</td><td></td><td>113</td><td>-0.33</td><td>-0.95</td><td>0.608</td><td>1.000</td><td>1.000</td><td>4378</td><td>tags=50%, list=34%, signal=74%</td></tr><tr><td class='lessen'>419</td><td>DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP</td><td></td><td>22</td><td>-0.41</td><td>-0.95</td><td>0.571</td><td>1.000</td><td>1.000</td><td>2419</td><td>tags=23%, list=19%, signal=28%</td></tr><tr><td class='lessen'>420</td><td>LEE_LIVER_CANCER_E2F1_DN</td><td></td><td>53</td><td>-0.36</td><td>-0.95</td><td>0.545</td><td>1.000</td><td>1.000</td><td>2530</td><td>tags=38%, list=20%, signal=47%</td></tr><tr><td class='lessen'>421</td><td>IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP</td><td></td><td>143</td><td>-0.32</td><td>-0.95</td><td>0.593</td><td>1.000</td><td>1.000</td><td>3452</td><td>tags=31%, list=27%, signal=42%</td></tr><tr><td class='lessen'>422</td><td>BENPORATH_ES_1</td><td></td><td>306</td><td>-0.31</td><td>-0.94</td><td>0.653</td><td>1.000</td><td>1.000</td><td>3138</td><td>tags=27%, list=24%, signal=35%</td></tr><tr><td class='lessen'>423</td><td>PIEPOLI_LGI1_TARGETS_DN</td><td></td><td>10</td><td>-0.48</td><td>-0.94</td><td>0.569</td><td>1.000</td><td>1.000</td><td>1002</td><td>tags=20%, list=8%, signal=22%</td></tr><tr><td class='lessen'>424</td><td>LEE_METASTASIS_AND_RNA_PROCESSING_UP</td><td></td><td>15</td><td>-0.44</td><td>-0.94</td><td>0.556</td><td>1.000</td><td>1.000</td><td>6314</td><td>tags=73%, list=49%, signal=143%</td></tr><tr><td class='lessen'>425</td><td>DAZARD_UV_RESPONSE_CLUSTER_G3</td><td></td><td>13</td><td>-0.45</td><td>-0.94</td><td>0.570</td><td>1.000</td><td>1.000</td><td>386</td><td>tags=15%, list=3%, signal=16%</td></tr><tr><td class='lessen'>426</td><td>PRAMOONJAGO_SOX4_TARGETS_DN</td><td></td><td>44</td><td>-0.36</td><td>-0.94</td><td>0.563</td><td>1.000</td><td>1.000</td><td>2431</td><td>tags=23%, list=19%, signal=28%</td></tr><tr><td class='lessen'>427</td><td>MITSIADES_RESPONSE_TO_APLIDIN_DN</td><td></td><td>207</td><td>-0.32</td><td>-0.94</td><td>0.638</td><td>1.000</td><td>1.000</td><td>4798</td><td>tags=40%, list=37%, signal=62%</td></tr><tr><td class='lessen'>428</td><td>MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS</td><td></td><td>12</td><td>-0.45</td><td>-0.94</td><td>0.552</td><td>1.000</td><td>1.000</td><td>2575</td><td>tags=33%, list=20%, signal=42%</td></tr><tr><td class='lessen'>429</td><td>FIGUEROA_AML_METHYLATION_CLUSTER_6_UP</td><td></td><td>100</td><td>-0.33</td><td>-0.94</td><td>0.597</td><td>1.000</td><td>1.000</td><td>1158</td><td>tags=11%, list=9%, signal=12%</td></tr><tr><td class='lessen'>430</td><td>VALK_AML_CLUSTER_6</td><td></td><td>26</td><td>-0.40</td><td>-0.94</td><td>0.550</td><td>1.000</td><td>1.000</td><td>1837</td><td>tags=23%, list=14%, signal=27%</td></tr><tr><td class='lessen'>431</td><td>RIZ_ERYTHROID_DIFFERENTIATION</td><td></td><td>70</td><td>-0.34</td><td>-0.94</td><td>0.580</td><td>1.000</td><td>1.000</td><td>3422</td><td>tags=26%, list=26%, signal=35%</td></tr><tr><td class='lessen'>432</td><td>CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP</td><td></td><td>272</td><td>-0.31</td><td>-0.94</td><td>0.668</td><td>1.000</td><td>1.000</td><td>3246</td><td>tags=28%, list=25%, signal=37%</td></tr><tr><td class='lessen'>433</td><td>VISALA_AGING_LYMPHOCYTE_DN</td><td></td><td>15</td><td>-0.44</td><td>-0.94</td><td>0.533</td><td>1.000</td><td>1.000</td><td>3347</td><td>tags=40%, list=26%, signal=54%</td></tr><tr><td class='lessen'>434</td><td>ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN</td><td></td><td>207</td><td>-0.31</td><td>-0.94</td><td>0.627</td><td>1.000</td><td>1.000</td><td>2778</td><td>tags=27%, list=21%, signal=34%</td></tr><tr><td class='lessen'>435</td><td>SANSOM_APC_TARGETS_UP</td><td></td><td>104</td><td>-0.33</td><td>-0.94</td><td>0.606</td><td>1.000</td><td>1.000</td><td>3677</td><td>tags=33%, list=28%, signal=45%</td></tr><tr><td class='lessen'>436</td><td>XU_GH1_AUTOCRINE_TARGETS_UP</td><td></td><td>177</td><td>-0.32</td><td>-0.94</td><td>0.638</td><td>1.000</td><td>1.000</td><td>1415</td><td>tags=12%, list=11%, signal=13%</td></tr><tr><td class='lessen'>437</td><td>WU_ALZHEIMER_DISEASE_UP</td><td></td><td>11</td><td>-0.46</td><td>-0.94</td><td>0.563</td><td>1.000</td><td>1.000</td><td>1444</td><td>tags=27%, list=11%, signal=31%</td></tr><tr><td class='lessen'>438</td><td>BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A</td><td></td><td>690</td><td>-0.31</td><td>-0.93</td><td>0.758</td><td>1.000</td><td>1.000</td><td>2145</td><td>tags=19%, list=17%, signal=22%</td></tr><tr><td class='lessen'>439</td><td>ZEMBUTSU_SENSITIVITY_TO_METHOTREXATE</td><td></td><td>15</td><td>-0.44</td><td>-0.93</td><td>0.560</td><td>1.000</td><td>1.000</td><td>3405</td><td>tags=60%, list=26%, signal=81%</td></tr><tr><td class='lessen'>440</td><td>LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP</td><td></td><td>70</td><td>-0.34</td><td>-0.93</td><td>0.619</td><td>1.000</td><td>1.000</td><td>614</td><td>tags=11%, list=5%, signal=12%</td></tr><tr><td class='lessen'>441</td><td>DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP</td><td></td><td>201</td><td>-0.31</td><td>-0.93</td><td>0.645</td><td>1.000</td><td>1.000</td><td>4021</td><td>tags=33%, list=31%, signal=48%</td></tr><tr><td class='lessen'>442</td><td>BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS</td><td></td><td>153</td><td>-0.32</td><td>-0.93</td><td>0.627</td><td>1.000</td><td>1.000</td><td>2016</td><td>tags=13%, list=16%, signal=15%</td></tr><tr><td class='lessen'>443</td><td>YANG_BREAST_CANCER_ESR1_BULK_DN</td><td></td><td>20</td><td>-0.41</td><td>-0.93</td><td>0.551</td><td>1.000</td><td>1.000</td><td>3797</td><td>tags=50%, list=29%, signal=71%</td></tr><tr><td class='lessen'>444</td><td>KYNG_WERNER_SYNDROM_DN</td><td></td><td>19</td><td>-0.42</td><td>-0.93</td><td>0.561</td><td>1.000</td><td>1.000</td><td>3803</td><td>tags=37%, list=29%, signal=52%</td></tr><tr><td class='lessen'>445</td><td>WANG_METASTASIS_OF_BREAST_CANCER</td><td></td><td>10</td><td>-0.46</td><td>-0.93</td><td>0.570</td><td>1.000</td><td>1.000</td><td>893</td><td>tags=20%, list=7%, signal=21%</td></tr><tr><td class='lessen'>446</td><td>MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP</td><td></td><td>43</td><td>-0.36</td><td>-0.93</td><td>0.563</td><td>1.000</td><td>1.000</td><td>4572</td><td>tags=53%, list=35%, signal=82%</td></tr><tr><td class='lessen'>447</td><td>TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN</td><td></td><td>75</td><td>-0.34</td><td>-0.93</td><td>0.588</td><td>1.000</td><td>1.000</td><td>3115</td><td>tags=35%, list=24%, signal=45%</td></tr><tr><td class='lessen'>448</td><td>WATANABE_COLON_CANCER_MSI_VS_MSS_DN</td><td></td><td>62</td><td>-0.35</td><td>-0.93</td><td>0.615</td><td>1.000</td><td>1.000</td><td>3424</td><td>tags=40%, list=26%, signal=55%</td></tr><tr><td class='lessen'>449</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2</td><td></td><td>75</td><td>-0.34</td><td>-0.93</td><td>0.610</td><td>1.000</td><td>1.000</td><td>193</td><td>tags=7%, list=1%, signal=7%</td></tr><tr><td class='lessen'>450</td><td>SMITH_LIVER_CANCER</td><td></td><td>38</td><td>-0.37</td><td>-0.93</td><td>0.583</td><td>1.000</td><td>1.000</td><td>3624</td><td>tags=42%, list=28%, signal=58%</td></tr><tr><td class='lessen'>451</td><td>RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP</td><td></td><td>89</td><td>-0.33</td><td>-0.93</td><td>0.601</td><td>1.000</td><td>1.000</td><td>2269</td><td>tags=27%, list=18%, signal=32%</td></tr><tr><td class='lessen'>452</td><td>FIGUEROA_AML_METHYLATION_CLUSTER_3_UP</td><td></td><td>123</td><td>-0.32</td><td>-0.92</td><td>0.625</td><td>1.000</td><td>1.000</td><td>2171</td><td>tags=15%, list=17%, signal=17%</td></tr><tr><td class='lessen'>453</td><td>LEIN_CEREBELLUM_MARKERS</td><td></td><td>68</td><td>-0.34</td><td>-0.92</td><td>0.622</td><td>1.000</td><td>1.000</td><td>1759</td><td>tags=18%, list=14%, signal=20%</td></tr><tr><td class='lessen'>454</td><td>BENPORATH_ES_2</td><td></td><td>27</td><td>-0.40</td><td>-0.92</td><td>0.593</td><td>1.000</td><td>1.000</td><td>3898</td><td>tags=56%, list=30%, signal=79%</td></tr><tr><td class='lessen'>455</td><td>BOCHKIS_FOXA2_TARGETS</td><td></td><td>347</td><td>-0.30</td><td>-0.92</td><td>0.720</td><td>1.000</td><td>1.000</td><td>3388</td><td>tags=29%, list=26%, signal=38%</td></tr><tr><td class='lessen'>456</td><td>LI_CISPLATIN_RESISTANCE_DN</td><td></td><td>23</td><td>-0.39</td><td>-0.92</td><td>0.602</td><td>1.000</td><td>1.000</td><td>1148</td><td>tags=17%, list=9%, signal=19%</td></tr><tr><td class='lessen'>457</td><td>TCGA_GLIOBLASTOMA_COPY_NUMBER_UP</td><td></td><td>57</td><td>-0.35</td><td>-0.92</td><td>0.602</td><td>1.000</td><td>1.000</td><td>2811</td><td>tags=18%, list=22%, signal=22%</td></tr><tr><td class='lessen'>458</td><td>PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN</td><td></td><td>16</td><td>-0.42</td><td>-0.92</td><td>0.572</td><td>1.000</td><td>1.000</td><td>3446</td><td>tags=50%, list=27%, signal=68%</td></tr><tr><td class='lessen'>459</td><td>MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3</td><td></td><td>112</td><td>-0.32</td><td>-0.92</td><td>0.634</td><td>1.000</td><td>1.000</td><td>2110</td><td>tags=28%, list=16%, signal=33%</td></tr><tr><td class='lessen'>460</td><td>ROPERO_HDAC2_TARGETS</td><td></td><td>82</td><td>-0.33</td><td>-0.92</td><td>0.618</td><td>1.000</td><td>1.000</td><td>1174</td><td>tags=11%, list=9%, signal=12%</td></tr><tr><td class='lessen'>461</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_4</td><td></td><td>14</td><td>-0.43</td><td>-0.92</td><td>0.590</td><td>1.000</td><td>1.000</td><td>2391</td><td>tags=36%, list=18%, signal=44%</td></tr><tr><td class='lessen'>462</td><td>LANDIS_ERBB2_BREAST_TUMORS_65_UP</td><td></td><td>20</td><td>-0.41</td><td>-0.92</td><td>0.593</td><td>1.000</td><td>1.000</td><td>5657</td><td>tags=70%, list=44%, signal=124%</td></tr><tr><td class='lessen'>463</td><td>KAYO_CALORIE_RESTRICTION_MUSCLE_DN</td><td></td><td>73</td><td>-0.33</td><td>-0.92</td><td>0.609</td><td>1.000</td><td>1.000</td><td>1008</td><td>tags=8%, list=8%, signal=9%</td></tr><tr><td class='lessen'>464</td><td>YAMASHITA_LIVER_CANCER_WITH_EPCAM_DN</td><td></td><td>12</td><td>-0.45</td><td>-0.92</td><td>0.598</td><td>1.000</td><td>1.000</td><td>2461</td><td>tags=42%, list=19%, signal=51%</td></tr><tr><td class='lessen'>465</td><td>NIKOLSKY_BREAST_CANCER_12Q24_AMPLICON</td><td></td><td>13</td><td>-0.44</td><td>-0.92</td><td>0.572</td><td>1.000</td><td>1.000</td><td>5307</td><td>tags=62%, list=41%, signal=104%</td></tr><tr><td class='lessen'>466</td><td>HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP</td><td></td><td>19</td><td>-0.40</td><td>-0.92</td><td>0.574</td><td>1.000</td><td>1.000</td><td>2238</td><td>tags=26%, list=17%, signal=32%</td></tr><tr><td class='lessen'>467</td><td>MIZUSHIMA_AUTOPHAGOSOME_FORMATION</td><td></td><td>15</td><td>-0.42</td><td>-0.92</td><td>0.572</td><td>1.000</td><td>1.000</td><td>2952</td><td>tags=20%, list=23%, signal=26%</td></tr><tr><td class='lessen'>468</td><td>FOURNIER_ACINAR_DEVELOPMENT_LATE_2</td><td></td><td>234</td><td>-0.30</td><td>-0.91</td><td>0.677</td><td>1.000</td><td>1.000</td><td>3655</td><td>tags=28%, list=28%, signal=39%</td></tr><tr><td class='lessen'>469</td><td>MAEKAWA_ATF2_TARGETS</td><td></td><td>21</td><td>-0.40</td><td>-0.91</td><td>0.600</td><td>1.000</td><td>1.000</td><td>1977</td><td>tags=24%, list=15%, signal=28%</td></tr><tr><td class='lessen'>470</td><td>KORKOLA_YOLK_SAC_TUMOR</td><td></td><td>45</td><td>-0.35</td><td>-0.91</td><td>0.600</td><td>1.000</td><td>1.000</td><td>2063</td><td>tags=27%, list=16%, signal=32%</td></tr><tr><td class='lessen'>471</td><td>JIANG_AGING_CEREBRAL_CORTEX_DN</td><td></td><td>48</td><td>-0.34</td><td>-0.91</td><td>0.609</td><td>1.000</td><td>1.000</td><td>1401</td><td>tags=8%, list=11%, signal=9%</td></tr><tr><td class='lessen'>472</td><td>LEE_AGING_NEOCORTEX_DN</td><td></td><td>69</td><td>-0.34</td><td>-0.91</td><td>0.624</td><td>1.000</td><td>1.000</td><td>2067</td><td>tags=19%, list=16%, signal=22%</td></tr><tr><td class='lessen'>473</td><td>GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION</td><td></td><td>21</td><td>-0.40</td><td>-0.91</td><td>0.610</td><td>1.000</td><td>1.000</td><td>1523</td><td>tags=19%, list=12%, signal=22%</td></tr><tr><td class='lessen'>474</td><td>SMIRNOV_RESPONSE_TO_IR_6HR_DN</td><td></td><td>94</td><td>-0.33</td><td>-0.91</td><td>0.622</td><td>1.000</td><td>1.000</td><td>1551</td><td>tags=20%, list=12%, signal=23%</td></tr><tr><td class='lessen'>475</td><td>YEMELYANOV_GR_TARGETS_DN</td><td></td><td>10</td><td>-0.46</td><td>-0.91</td><td>0.586</td><td>1.000</td><td>1.000</td><td>780</td><td>tags=10%, list=6%, signal=11%</td></tr><tr><td class='lessen'>476</td><td>SMID_BREAST_CANCER_BASAL_UP</td><td></td><td>541</td><td>-0.30</td><td>-0.91</td><td>0.803</td><td>1.000</td><td>1.000</td><td>2560</td><td>tags=26%, list=20%, signal=31%</td></tr><tr><td class='lessen'>477</td><td>RAO_BOUND_BY_SALL4</td><td></td><td>174</td><td>-0.31</td><td>-0.91</td><td>0.681</td><td>1.000</td><td>1.000</td><td>2198</td><td>tags=13%, list=17%, signal=16%</td></tr><tr><td class='lessen'>478</td><td>HOELZEL_NF1_TARGETS_UP</td><td></td><td>116</td><td>-0.31</td><td>-0.91</td><td>0.650</td><td>1.000</td><td>1.000</td><td>2693</td><td>tags=28%, list=21%, signal=36%</td></tr><tr><td class='lessen'>479</td><td>AIYAR_COBRA1_TARGETS_UP</td><td></td><td>33</td><td>-0.37</td><td>-0.91</td><td>0.613</td><td>1.000</td><td>1.000</td><td>1946</td><td>tags=18%, list=15%, signal=21%</td></tr><tr><td class='lessen'>480</td><td>MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_DN</td><td></td><td>24</td><td>-0.39</td><td>-0.91</td><td>0.576</td><td>1.000</td><td>1.000</td><td>3260</td><td>tags=42%, list=25%, signal=56%</td></tr><tr><td class='lessen'>481</td><td>TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP</td><td></td><td>78</td><td>-0.33</td><td>-0.91</td><td>0.634</td><td>1.000</td><td>1.000</td><td>3115</td><td>tags=31%, list=24%, signal=40%</td></tr><tr><td class='lessen'>482</td><td>CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP</td><td></td><td>45</td><td>-0.35</td><td>-0.91</td><td>0.613</td><td>1.000</td><td>1.000</td><td>7137</td><td>tags=82%, list=55%, signal=183%</td></tr><tr><td class='lessen'>483</td><td>SCIBETTA_KDM5B_TARGETS_DN</td><td></td><td>62</td><td>-0.34</td><td>-0.91</td><td>0.631</td><td>1.000</td><td>1.000</td><td>2932</td><td>tags=31%, list=23%, signal=39%</td></tr><tr><td class='lessen'>484</td><td>IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM</td><td></td><td>243</td><td>-0.30</td><td>-0.91</td><td>0.724</td><td>1.000</td><td>1.000</td><td>2873</td><td>tags=23%, list=22%, signal=30%</td></tr><tr><td class='lessen'>485</td><td>DAZARD_UV_RESPONSE_CLUSTER_G4</td><td></td><td>14</td><td>-0.43</td><td>-0.91</td><td>0.582</td><td>1.000</td><td>1.000</td><td>2275</td><td>tags=21%, list=18%, signal=26%</td></tr><tr><td class='lessen'>486</td><td>LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP</td><td></td><td>34</td><td>-0.37</td><td>-0.91</td><td>0.617</td><td>1.000</td><td>1.000</td><td>3303</td><td>tags=32%, list=26%, signal=43%</td></tr><tr><td class='lessen'>487</td><td>WANG_CISPLATIN_RESPONSE_AND_XPC_UP</td><td></td><td>167</td><td>-0.31</td><td>-0.91</td><td>0.691</td><td>1.000</td><td>1.000</td><td>2609</td><td>tags=28%, list=20%, signal=34%</td></tr><tr><td class='lessen'>488</td><td>WANG_LSD1_TARGETS_DN</td><td></td><td>36</td><td>-0.36</td><td>-0.91</td><td>0.608</td><td>1.000</td><td>1.000</td><td>1401</td><td>tags=22%, list=11%, signal=25%</td></tr><tr><td class='lessen'>489</td><td>ROME_INSULIN_TARGETS_IN_MUSCLE_DN</td><td></td><td>127</td><td>-0.31</td><td>-0.91</td><td>0.669</td><td>1.000</td><td>1.000</td><td>3286</td><td>tags=31%, list=25%, signal=42%</td></tr><tr><td class='lessen'>490</td><td>STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_DN</td><td></td><td>17</td><td>-0.42</td><td>-0.91</td><td>0.604</td><td>1.000</td><td>1.000</td><td>449</td><td>tags=12%, list=3%, signal=12%</td></tr><tr><td class='lessen'>491</td><td>KYNG_NORMAL_AGING_UP</td><td></td><td>11</td><td>-0.44</td><td>-0.91</td><td>0.582</td><td>1.000</td><td>1.000</td><td>3252</td><td>tags=36%, list=25%, signal=49%</td></tr><tr><td class='lessen'>492</td><td>HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN</td><td></td><td>42</td><td>-0.35</td><td>-0.91</td><td>0.618</td><td>1.000</td><td>1.000</td><td>3109</td><td>tags=36%, list=24%, signal=47%</td></tr><tr><td class='lessen'>493</td><td>MIKKELSEN_IPS_LCP_WITH_H3K27ME3</td><td></td><td>10</td><td>-0.45</td><td>-0.91</td><td>0.609</td><td>1.000</td><td>1.000</td><td>1783</td><td>tags=40%, list=14%, signal=46%</td></tr><tr><td class='lessen'>494</td><td>VANASSE_BCL2_TARGETS_UP</td><td></td><td>32</td><td>-0.37</td><td>-0.90</td><td>0.618</td><td>1.000</td><td>1.000</td><td>2786</td><td>tags=44%, list=22%, signal=56%</td></tr><tr><td class='lessen'>495</td><td>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_24</td><td></td><td>12</td><td>-0.44</td><td>-0.90</td><td>0.621</td><td>1.000</td><td>1.000</td><td>1274</td><td>tags=17%, list=10%, signal=18%</td></tr><tr><td class='lessen'>496</td><td>KOHOUTEK_CCNT2_TARGETS</td><td></td><td>46</td><td>-0.35</td><td>-0.90</td><td>0.615</td><td>1.000</td><td>1.000</td><td>3233</td><td>tags=35%, list=25%, signal=46%</td></tr><tr><td class='lessen'>497</td><td>KENNY_CTNNB1_TARGETS_DN</td><td></td><td>41</td><td>-0.36</td><td>-0.90</td><td>0.602</td><td>1.000</td><td>1.000</td><td>1042</td><td>tags=7%, list=8%, signal=8%</td></tr><tr><td class='lessen'>498</td><td>KIM_WT1_TARGETS_8HR_DN</td><td></td><td>99</td><td>-0.32</td><td>-0.90</td><td>0.655</td><td>1.000</td><td>1.000</td><td>1051</td><td>tags=9%, list=8%, signal=10%</td></tr><tr><td class='lessen'>499</td><td>SHEPARD_BMYB_MORPHOLINO_UP</td><td></td><td>171</td><td>-0.31</td><td>-0.90</td><td>0.706</td><td>1.000</td><td>1.000</td><td>2806</td><td>tags=20%, list=22%, signal=26%</td></tr><tr><td class='lessen'>500</td><td>PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP</td><td></td><td>272</td><td>-0.30</td><td>-0.90</td><td>0.739</td><td>1.000</td><td>1.000</td><td>2167</td><td>tags=15%, list=17%, signal=18%</td></tr><tr><td class='lessen'>501</td><td>MACLACHLAN_BRCA1_TARGETS_DN</td><td></td><td>15</td><td>-0.42</td><td>-0.90</td><td>0.606</td><td>1.000</td><td>1.000</td><td>869</td><td>tags=13%, list=7%, signal=14%</td></tr><tr><td class='lessen'>502</td><td>RIZ_ERYTHROID_DIFFERENTIATION_HBZ</td><td></td><td>36</td><td>-0.36</td><td>-0.90</td><td>0.606</td><td>1.000</td><td>1.000</td><td>2786</td><td>tags=33%, list=22%, signal=42%</td></tr><tr><td class='lessen'>503</td><td>GHANDHI_DIRECT_IRRADIATION_DN</td><td></td><td>22</td><td>-0.40</td><td>-0.90</td><td>0.612</td><td>1.000</td><td>1.000</td><td>1710</td><td>tags=23%, list=13%, signal=26%</td></tr><tr><td class='lessen'>504</td><td>NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN</td><td></td><td>68</td><td>-0.33</td><td>-0.90</td><td>0.625</td><td>1.000</td><td>1.000</td><td>2157</td><td>tags=24%, list=17%, signal=28%</td></tr><tr><td class='lessen'>505</td><td>BURTON_ADIPOGENESIS_PEAK_AT_16HR</td><td></td><td>37</td><td>-0.35</td><td>-0.90</td><td>0.629</td><td>1.000</td><td>1.000</td><td>4301</td><td>tags=43%, list=33%, signal=65%</td></tr><tr><td class='lessen'>506</td><td>RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP</td><td></td><td>501</td><td>-0.29</td><td>-0.90</td><td>0.799</td><td>1.000</td><td>1.000</td><td>2897</td><td>tags=19%, list=22%, signal=24%</td></tr><tr><td class='lessen'>507</td><td>YANG_BREAST_CANCER_ESR1_LASER_UP</td><td></td><td>26</td><td>-0.38</td><td>-0.90</td><td>0.601</td><td>1.000</td><td>1.000</td><td>4388</td><td>tags=46%, list=34%, signal=70%</td></tr><tr><td class='lessen'>508</td><td>LEE_LIVER_CANCER_DENA_DN</td><td></td><td>66</td><td>-0.33</td><td>-0.90</td><td>0.651</td><td>1.000</td><td>1.000</td><td>2443</td><td>tags=39%, list=19%, signal=48%</td></tr><tr><td class='lessen'>509</td><td>FARMER_BREAST_CANCER_CLUSTER_7</td><td></td><td>16</td><td>-0.42</td><td>-0.90</td><td>0.614</td><td>1.000</td><td>1.000</td><td>1058</td><td>tags=19%, list=8%, signal=20%</td></tr><tr><td class='lessen'>510</td><td>MASSARWEH_RESPONSE_TO_ESTRADIOL</td><td></td><td>51</td><td>-0.34</td><td>-0.90</td><td>0.627</td><td>1.000</td><td>1.000</td><td>2088</td><td>tags=20%, list=16%, signal=23%</td></tr><tr><td class='lessen'>511</td><td>ZWANG_TRANSIENTLY_UP_BY_1ST_EGF_PULSE_ONLY</td><td></td><td>1120</td><td>-0.29</td><td>-0.90</td><td>0.909</td><td>1.000</td><td>1.000</td><td>2638</td><td>tags=22%, list=20%, signal=25%</td></tr><tr><td class='lessen'>512</td><td>KIM_MYC_AMPLIFICATION_TARGETS_DN</td><td></td><td>70</td><td>-0.33</td><td>-0.89</td><td>0.666</td><td>1.000</td><td>1.000</td><td>3630</td><td>tags=41%, list=28%, signal=57%</td></tr><tr><td class='lessen'>513</td><td>SHANK_TAL1_TARGETS_DN</td><td></td><td>10</td><td>-0.46</td><td>-0.89</td><td>0.635</td><td>1.000</td><td>1.000</td><td>2784</td><td>tags=40%, list=22%, signal=51%</td></tr><tr><td class='lessen'>514</td><td>STEIN_ESTROGEN_RESPONSE_NOT_VIA_ESRRA</td><td></td><td>17</td><td>-0.40</td><td>-0.89</td><td>0.611</td><td>1.000</td><td>1.000</td><td>4493</td><td>tags=65%, list=35%, signal=99%</td></tr><tr><td class='lessen'>515</td><td>HOSHIDA_LIVER_CANCER_SUBCLASS_S3</td><td></td><td>229</td><td>-0.30</td><td>-0.89</td><td>0.753</td><td>1.000</td><td>1.000</td><td>3150</td><td>tags=36%, list=24%, signal=46%</td></tr><tr><td class='lessen'>516</td><td>NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON</td><td></td><td>100</td><td>-0.31</td><td>-0.89</td><td>0.662</td><td>1.000</td><td>1.000</td><td>2220</td><td>tags=22%, list=17%, signal=26%</td></tr><tr><td class='lessen'>517</td><td>TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP</td><td></td><td>14</td><td>-0.42</td><td>-0.89</td><td>0.626</td><td>1.000</td><td>1.000</td><td>2979</td><td>tags=57%, list=23%, signal=74%</td></tr><tr><td class='lessen'>518</td><td>ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_UP</td><td></td><td>10</td><td>-0.45</td><td>-0.89</td><td>0.615</td><td>1.000</td><td>1.000</td><td>4298</td><td>tags=50%, list=33%, signal=75%</td></tr><tr><td class='lessen'>519</td><td>ALCALAY_AML_BY_NPM1_LOCALIZATION_DN</td><td></td><td>164</td><td>-0.30</td><td>-0.89</td><td>0.716</td><td>1.000</td><td>1.000</td><td>2608</td><td>tags=24%, list=20%, signal=29%</td></tr><tr><td class='lessen'>520</td><td>WAGNER_APO2_SENSITIVITY</td><td></td><td>19</td><td>-0.40</td><td>-0.89</td><td>0.632</td><td>1.000</td><td>1.000</td><td>1090</td><td>tags=11%, list=8%, signal=11%</td></tr><tr><td class='lessen'>521</td><td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_DN</td><td></td><td>11</td><td>-0.44</td><td>-0.89</td><td>0.633</td><td>1.000</td><td>1.000</td><td>583</td><td>tags=9%, list=5%, signal=10%</td></tr><tr><td class='lessen'>522</td><td>SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP</td><td></td><td>25</td><td>-0.37</td><td>-0.89</td><td>0.635</td><td>1.000</td><td>1.000</td><td>3355</td><td>tags=28%, list=26%, signal=38%</td></tr><tr><td class='lessen'>523</td><td>CUI_GLUCOSE_DEPRIVATION</td><td></td><td>56</td><td>-0.34</td><td>-0.88</td><td>0.658</td><td>1.000</td><td>1.000</td><td>3789</td><td>tags=43%, list=29%, signal=60%</td></tr><tr><td class='lessen'>524</td><td>DORMOY_ELAVL1_TARGETS</td><td></td><td>16</td><td>-0.41</td><td>-0.88</td><td>0.642</td><td>1.000</td><td>1.000</td><td>2614</td><td>tags=31%, list=20%, signal=39%</td></tr><tr><td class='lessen'>525</td><td>ZHAN_V1_LATE_DIFFERENTIATION_GENES_DN</td><td></td><td>15</td><td>-0.41</td><td>-0.88</td><td>0.633</td><td>1.000</td><td>1.000</td><td>1160</td><td>tags=20%, list=9%, signal=22%</td></tr><tr><td class='lessen'>526</td><td>HEIDENBLAD_AMPLIFIED_IN_SOFT_TISSUE_CANCER</td><td></td><td>12</td><td>-0.43</td><td>-0.88</td><td>0.644</td><td>1.000</td><td>1.000</td><td>2150</td><td>tags=33%, list=17%, signal=40%</td></tr><tr><td class='lessen'>527</td><td>YU_BAP1_TARGETS</td><td></td><td>23</td><td>-0.38</td><td>-0.88</td><td>0.635</td><td>1.000</td><td>1.000</td><td>4436</td><td>tags=48%, list=34%, signal=73%</td></tr><tr><td class='lessen'>528</td><td>CHEOK_RESPONSE_TO_MERCAPTOPURINE_UP</td><td></td><td>10</td><td>-0.46</td><td>-0.88</td><td>0.631</td><td>1.000</td><td>1.000</td><td>1991</td><td>tags=20%, list=15%, signal=24%</td></tr><tr><td class='lessen'>529</td><td>MORI_MATURE_B_LYMPHOCYTE_DN</td><td></td><td>69</td><td>-0.32</td><td>-0.88</td><td>0.678</td><td>1.000</td><td>1.000</td><td>3210</td><td>tags=29%, list=25%, signal=38%</td></tr><tr><td class='lessen'>530</td><td>RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP</td><td></td><td>183</td><td>-0.29</td><td>-0.88</td><td>0.752</td><td>1.000</td><td>1.000</td><td>3014</td><td>tags=19%, list=23%, signal=25%</td></tr><tr><td class='lessen'>531</td><td>MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER</td><td></td><td>39</td><td>-0.35</td><td>-0.88</td><td>0.665</td><td>1.000</td><td>1.000</td><td>1965</td><td>tags=18%, list=15%, signal=21%</td></tr><tr><td class='lessen'>532</td><td>NOUZOVA_METHYLATED_IN_APL</td><td></td><td>44</td><td>-0.34</td><td>-0.88</td><td>0.671</td><td>1.000</td><td>1.000</td><td>2307</td><td>tags=25%, list=18%, signal=30%</td></tr><tr><td class='lessen'>533</td><td>ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP</td><td></td><td>359</td><td>-0.29</td><td>-0.88</td><td>0.831</td><td>1.000</td><td>1.000</td><td>1834</td><td>tags=15%, list=14%, signal=17%</td></tr><tr><td class='lessen'>534</td><td>VANTVEER_BREAST_CANCER_POOR_PROGNOSIS</td><td></td><td>40</td><td>-0.34</td><td>-0.88</td><td>0.659</td><td>1.000</td><td>1.000</td><td>1219</td><td>tags=18%, list=9%, signal=19%</td></tr><tr><td class='lessen'>535</td><td>DAWSON_METHYLATED_IN_LYMPHOMA_TCL1</td><td></td><td>44</td><td>-0.34</td><td>-0.88</td><td>0.666</td><td>1.000</td><td>1.000</td><td>2691</td><td>tags=34%, list=21%, signal=43%</td></tr><tr><td class='lessen'>536</td><td>MODY_HIPPOCAMPUS_PRENATAL</td><td></td><td>37</td><td>-0.35</td><td>-0.87</td><td>0.670</td><td>1.000</td><td>1.000</td><td>1176</td><td>tags=11%, list=9%, signal=12%</td></tr><tr><td class='lessen'>537</td><td>SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN</td><td></td><td>120</td><td>-0.30</td><td>-0.87</td><td>0.723</td><td>1.000</td><td>1.000</td><td>1935</td><td>tags=23%, list=15%, signal=27%</td></tr><tr><td class='lessen'>538</td><td>WANG_RESPONSE_TO_FORSKOLIN_UP</td><td></td><td>19</td><td>-0.39</td><td>-0.87</td><td>0.640</td><td>1.000</td><td>1.000</td><td>5074</td><td>tags=53%, list=39%, signal=86%</td></tr><tr><td class='lessen'>539</td><td>GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION</td><td></td><td>12</td><td>-0.42</td><td>-0.87</td><td>0.663</td><td>1.000</td><td>1.000</td><td>6384</td><td>tags=75%, list=49%, signal=148%</td></tr><tr><td class='lessen'>540</td><td>MEISSNER_BRAIN_HCP_WITH_H3K4ME2</td><td></td><td>15</td><td>-0.41</td><td>-0.87</td><td>0.647</td><td>1.000</td><td>1.000</td><td>3039</td><td>tags=33%, list=23%, signal=44%</td></tr><tr><td class='lessen'>541</td><td>KRASNOSELSKAYA_ILF3_TARGETS_DN</td><td></td><td>38</td><td>-0.35</td><td>-0.87</td><td>0.682</td><td>1.000</td><td>1.000</td><td>2092</td><td>tags=24%, list=16%, signal=28%</td></tr><tr><td class='lessen'>542</td><td>BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_UP</td><td></td><td>16</td><td>-0.41</td><td>-0.87</td><td>0.640</td><td>1.000</td><td>1.000</td><td>336</td><td>tags=6%, list=3%, signal=6%</td></tr><tr><td class='lessen'>543</td><td>MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3</td><td></td><td>27</td><td>-0.36</td><td>-0.87</td><td>0.646</td><td>1.000</td><td>1.000</td><td>1889</td><td>tags=22%, list=15%, signal=26%</td></tr><tr><td class='lessen'>544</td><td>CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4</td><td></td><td>229</td><td>-0.29</td><td>-0.87</td><td>0.792</td><td>1.000</td><td>1.000</td><td>2088</td><td>tags=16%, list=16%, signal=19%</td></tr><tr><td class='lessen'>545</td><td>CROONQUIST_STROMAL_STIMULATION_DN</td><td></td><td>10</td><td>-0.43</td><td>-0.87</td><td>0.653</td><td>1.000</td><td>1.000</td><td>1475</td><td>tags=20%, list=11%, signal=23%</td></tr><tr><td class='lessen'>546</td><td>PHESSE_TARGETS_OF_APC_AND_MBD2_DN</td><td></td><td>10</td><td>-0.44</td><td>-0.87</td><td>0.648</td><td>1.000</td><td>1.000</td><td>322</td><td>tags=10%, list=2%, signal=10%</td></tr><tr><td class='lessen'>547</td><td>NIKOLSKY_BREAST_CANCER_5P15_AMPLICON</td><td></td><td>21</td><td>-0.38</td><td>-0.87</td><td>0.639</td><td>1.000</td><td>1.000</td><td>1755</td><td>tags=24%, list=14%, signal=28%</td></tr><tr><td class='lessen'>548</td><td>ODONNELL_TFRC_TARGETS_UP</td><td></td><td>304</td><td>-0.29</td><td>-0.87</td><td>0.828</td><td>1.000</td><td>1.000</td><td>2433</td><td>tags=19%, list=19%, signal=23%</td></tr><tr><td class='lessen'>549</td><td>HELLER_SILENCED_BY_METHYLATION_UP</td><td></td><td>222</td><td>-0.29</td><td>-0.86</td><td>0.780</td><td>1.000</td><td>1.000</td><td>1470</td><td>tags=13%, list=11%, signal=14%</td></tr><tr><td class='lessen'>550</td><td>TOMLINS_METASTASIS_UP</td><td></td><td>13</td><td>-0.41</td><td>-0.86</td><td>0.643</td><td>1.000</td><td>1.000</td><td>3997</td><td>tags=38%, list=31%, signal=56%</td></tr><tr><td class='lessen'>551</td><td>IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN</td><td></td><td>22</td><td>-0.38</td><td>-0.86</td><td>0.648</td><td>1.000</td><td>1.000</td><td>4990</td><td>tags=41%, list=39%, signal=66%</td></tr><tr><td class='lessen'>552</td><td>HUNSBERGER_EXERCISE_REGULATED_GENES</td><td></td><td>29</td><td>-0.36</td><td>-0.86</td><td>0.664</td><td>1.000</td><td>1.000</td><td>3847</td><td>tags=48%, list=30%, signal=69%</td></tr><tr><td class='lessen'>553</td><td>ZHAN_MULTIPLE_MYELOMA_CD2_UP</td><td></td><td>37</td><td>-0.34</td><td>-0.86</td><td>0.681</td><td>1.000</td><td>1.000</td><td>1730</td><td>tags=19%, list=13%, signal=22%</td></tr><tr><td class='lessen'>554</td><td>LU_AGING_BRAIN_DN</td><td></td><td>134</td><td>-0.30</td><td>-0.86</td><td>0.756</td><td>1.000</td><td>1.000</td><td>1393</td><td>tags=12%, list=11%, signal=13%</td></tr><tr><td class='lessen'>555</td><td>PUJANA_CHEK2_PCC_NETWORK</td><td></td><td>645</td><td>-0.28</td><td>-0.86</td><td>0.900</td><td>1.000</td><td>1.000</td><td>4560</td><td>tags=30%, list=35%, signal=44%</td></tr><tr><td class='lessen'>556</td><td>MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6</td><td></td><td>41</td><td>-0.33</td><td>-0.86</td><td>0.684</td><td>1.000</td><td>1.000</td><td>4040</td><td>tags=37%, list=31%, signal=53%</td></tr><tr><td class='lessen'>557</td><td>NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON</td><td></td><td>123</td><td>-0.30</td><td>-0.86</td><td>0.749</td><td>1.000</td><td>1.000</td><td>525</td><td>tags=6%, list=4%, signal=6%</td></tr><tr><td class='lessen'>558</td><td>ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP</td><td></td><td>36</td><td>-0.34</td><td>-0.86</td><td>0.665</td><td>1.000</td><td>1.000</td><td>4077</td><td>tags=44%, list=32%, signal=65%</td></tr><tr><td class='lessen'>559</td><td>PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN</td><td></td><td>356</td><td>-0.28</td><td>-0.86</td><td>0.865</td><td>1.000</td><td>1.000</td><td>2606</td><td>tags=19%, list=20%, signal=23%</td></tr><tr><td class='lessen'>560</td><td>LABBE_TGFB1_TARGETS_DN</td><td></td><td>91</td><td>-0.30</td><td>-0.86</td><td>0.743</td><td>1.000</td><td>1.000</td><td>3265</td><td>tags=36%, list=25%, signal=48%</td></tr><tr><td class='lessen'>561</td><td>MATZUK_EMBRYONIC_GERM_CELL</td><td></td><td>18</td><td>-0.38</td><td>-0.85</td><td>0.669</td><td>1.000</td><td>1.000</td><td>211</td><td>tags=6%, list=2%, signal=6%</td></tr><tr><td class='lessen'>562</td><td>HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN</td><td></td><td>63</td><td>-0.31</td><td>-0.85</td><td>0.729</td><td>1.000</td><td>1.000</td><td>2263</td><td>tags=22%, list=17%, signal=27%</td></tr><tr><td class='lessen'>563</td><td>ACEVEDO_LIVER_CANCER_DN</td><td></td><td>419</td><td>-0.28</td><td>-0.85</td><td>0.877</td><td>1.000</td><td>1.000</td><td>2896</td><td>tags=26%, list=22%, signal=32%</td></tr><tr><td class='lessen'>564</td><td>CHICAS_RB1_TARGETS_GROWING</td><td></td><td>204</td><td>-0.29</td><td>-0.85</td><td>0.795</td><td>1.000</td><td>1.000</td><td>2864</td><td>tags=28%, list=22%, signal=36%</td></tr><tr><td class='lessen'>565</td><td>NIKOLSKY_BREAST_CANCER_1Q21_AMPLICON</td><td></td><td>32</td><td>-0.34</td><td>-0.85</td><td>0.719</td><td>1.000</td><td>1.000</td><td>3744</td><td>tags=34%, list=29%, signal=48%</td></tr><tr><td class='lessen'>566</td><td>IGLESIAS_E2F_TARGETS_DN</td><td></td><td>10</td><td>-0.43</td><td>-0.85</td><td>0.680</td><td>1.000</td><td>1.000</td><td>4346</td><td>tags=70%, list=34%, signal=105%</td></tr><tr><td class='lessen'>567</td><td>NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER</td><td></td><td>70</td><td>-0.31</td><td>-0.85</td><td>0.721</td><td>1.000</td><td>1.000</td><td>1998</td><td>tags=17%, list=15%, signal=20%</td></tr><tr><td class='lessen'>568</td><td>BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP</td><td></td><td>41</td><td>-0.34</td><td>-0.85</td><td>0.709</td><td>1.000</td><td>1.000</td><td>2897</td><td>tags=22%, list=22%, signal=28%</td></tr><tr><td class='lessen'>569</td><td>BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP</td><td></td><td>95</td><td>-0.30</td><td>-0.85</td><td>0.750</td><td>1.000</td><td>1.000</td><td>3551</td><td>tags=35%, list=27%, signal=48%</td></tr><tr><td class='lessen'>570</td><td>WHITFIELD_CELL_CYCLE_G2</td><td></td><td>135</td><td>-0.29</td><td>-0.85</td><td>0.783</td><td>1.000</td><td>1.000</td><td>2609</td><td>tags=24%, list=20%, signal=30%</td></tr><tr><td class='lessen'>571</td><td>LABBE_TGFB1_TARGETS_UP</td><td></td><td>91</td><td>-0.30</td><td>-0.85</td><td>0.745</td><td>1.000</td><td>1.000</td><td>2448</td><td>tags=26%, list=19%, signal=32%</td></tr><tr><td class='lessen'>572</td><td>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_12</td><td></td><td>10</td><td>-0.43</td><td>-0.85</td><td>0.689</td><td>1.000</td><td>1.000</td><td>3588</td><td>tags=40%, list=28%, signal=55%</td></tr><tr><td class='lessen'>573</td><td>GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN</td><td></td><td>69</td><td>-0.31</td><td>-0.85</td><td>0.733</td><td>1.000</td><td>1.000</td><td>1359</td><td>tags=16%, list=11%, signal=18%</td></tr><tr><td class='lessen'>574</td><td>YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP</td><td></td><td>121</td><td>-0.29</td><td>-0.85</td><td>0.790</td><td>1.000</td><td>1.000</td><td>2736</td><td>tags=26%, list=21%, signal=32%</td></tr><tr><td class='lessen'>575</td><td>ENGELMANN_CANCER_PROGENITORS_DN</td><td></td><td>51</td><td>-0.32</td><td>-0.85</td><td>0.714</td><td>1.000</td><td>1.000</td><td>3056</td><td>tags=31%, list=24%, signal=41%</td></tr><tr><td class='lessen'>576</td><td>ALONSO_METASTASIS_DN</td><td></td><td>19</td><td>-0.37</td><td>-0.85</td><td>0.692</td><td>1.000</td><td>1.000</td><td>1909</td><td>tags=32%, list=15%, signal=37%</td></tr><tr><td class='lessen'>577</td><td>GUO_TARGETS_OF_IRS1_AND_IRS2</td><td></td><td>84</td><td>-0.30</td><td>-0.85</td><td>0.732</td><td>1.000</td><td>1.000</td><td>4328</td><td>tags=43%, list=33%, signal=64%</td></tr><tr><td class='lessen'>578</td><td>IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM</td><td></td><td>24</td><td>-0.36</td><td>-0.84</td><td>0.673</td><td>1.000</td><td>1.000</td><td>2950</td><td>tags=33%, list=23%, signal=43%</td></tr><tr><td class='lessen'>579</td><td>ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP</td><td></td><td>197</td><td>-0.28</td><td>-0.84</td><td>0.805</td><td>1.000</td><td>1.000</td><td>2059</td><td>tags=20%, list=16%, signal=24%</td></tr><tr><td class='lessen'>580</td><td>LY_AGING_PREMATURE_DN</td><td></td><td>28</td><td>-0.35</td><td>-0.84</td><td>0.691</td><td>1.000</td><td>1.000</td><td>1279</td><td>tags=18%, list=10%, signal=20%</td></tr><tr><td class='lessen'>581</td><td>BROWNE_HCMV_INFECTION_30MIN_UP</td><td></td><td>43</td><td>-0.33</td><td>-0.84</td><td>0.709</td><td>1.000</td><td>1.000</td><td>1613</td><td>tags=21%, list=12%, signal=24%</td></tr><tr><td class='lessen'>582</td><td>ZHAN_MULTIPLE_MYELOMA_MF_DN</td><td></td><td>29</td><td>-0.35</td><td>-0.84</td><td>0.719</td><td>1.000</td><td>1.000</td><td>3553</td><td>tags=41%, list=27%, signal=57%</td></tr><tr><td class='lessen'>583</td><td>VALK_AML_WITH_11Q23_REARRANGED</td><td></td><td>15</td><td>-0.38</td><td>-0.84</td><td>0.671</td><td>1.000</td><td>1.000</td><td>58</td><td>tags=7%, list=0%, signal=7%</td></tr><tr><td class='lessen'>584</td><td>VANTVEER_BREAST_CANCER_METASTASIS_UP</td><td></td><td>41</td><td>-0.33</td><td>-0.84</td><td>0.713</td><td>1.000</td><td>1.000</td><td>2882</td><td>tags=29%, list=22%, signal=38%</td></tr><tr><td class='lessen'>585</td><td>KORKOLA_TERATOMA_UP</td><td></td><td>14</td><td>-0.40</td><td>-0.84</td><td>0.678</td><td>1.000</td><td>1.000</td><td>1047</td><td>tags=14%, list=8%, signal=16%</td></tr><tr><td class='lessen'>586</td><td>CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP</td><td></td><td>90</td><td>-0.30</td><td>-0.84</td><td>0.760</td><td>1.000</td><td>1.000</td><td>3820</td><td>tags=56%, list=30%, signal=78%</td></tr><tr><td class='lessen'>587</td><td>LASTOWSKA_COAMPLIFIED_WITH_MYCN</td><td></td><td>33</td><td>-0.34</td><td>-0.84</td><td>0.705</td><td>1.000</td><td>1.000</td><td>3445</td><td>tags=42%, list=27%, signal=58%</td></tr><tr><td class='lessen'>588</td><td>SWEET_KRAS_TARGETS_DN</td><td></td><td>56</td><td>-0.32</td><td>-0.84</td><td>0.702</td><td>1.000</td><td>1.000</td><td>3096</td><td>tags=27%, list=24%, signal=35%</td></tr><tr><td class='lessen'>589</td><td>IVANOVA_HEMATOPOIESIS_STEM_CELL</td><td></td><td>203</td><td>-0.28</td><td>-0.84</td><td>0.819</td><td>1.000</td><td>1.000</td><td>2070</td><td>tags=13%, list=16%, signal=15%</td></tr><tr><td class='lessen'>590</td><td>LEE_CALORIE_RESTRICTION_NEOCORTEX_DN</td><td></td><td>82</td><td>-0.30</td><td>-0.84</td><td>0.753</td><td>1.000</td><td>1.000</td><td>1262</td><td>tags=9%, list=10%, signal=9%</td></tr><tr><td class='lessen'>591</td><td>RODWELL_AGING_KIDNEY_DN</td><td></td><td>114</td><td>-0.29</td><td>-0.84</td><td>0.775</td><td>1.000</td><td>1.000</td><td>3098</td><td>tags=28%, list=24%, signal=37%</td></tr><tr><td class='lessen'>592</td><td>GRADE_METASTASIS_DN</td><td></td><td>39</td><td>-0.33</td><td>-0.84</td><td>0.710</td><td>1.000</td><td>1.000</td><td>5740</td><td>tags=54%, list=44%, signal=97%</td></tr><tr><td class='lessen'>593</td><td>KIM_WT1_TARGETS_DN</td><td></td><td>376</td><td>-0.28</td><td>-0.84</td><td>0.881</td><td>1.000</td><td>1.000</td><td>3146</td><td>tags=23%, list=24%, signal=29%</td></tr><tr><td class='lessen'>594</td><td>STAMBOLSKY_BOUND_BY_MUTATED_TP53</td><td></td><td>14</td><td>-0.40</td><td>-0.84</td><td>0.680</td><td>1.000</td><td>1.000</td><td>1345</td><td>tags=21%, list=10%, signal=24%</td></tr><tr><td class='lessen'>595</td><td>SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1</td><td></td><td>336</td><td>-0.27</td><td>-0.84</td><td>0.871</td><td>1.000</td><td>1.000</td><td>2689</td><td>tags=26%, list=21%, signal=32%</td></tr><tr><td class='lessen'>596</td><td>BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D</td><td></td><td>212</td><td>-0.28</td><td>-0.84</td><td>0.845</td><td>1.000</td><td>1.000</td><td>1525</td><td>tags=13%, list=12%, signal=14%</td></tr><tr><td class='lessen'>597</td><td>HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_DN</td><td></td><td>10</td><td>-0.42</td><td>-0.84</td><td>0.692</td><td>1.000</td><td>1.000</td><td>651</td><td>tags=10%, list=5%, signal=11%</td></tr><tr><td class='lessen'>598</td><td>LABBE_WNT3A_TARGETS_UP</td><td></td><td>99</td><td>-0.30</td><td>-0.84</td><td>0.780</td><td>1.000</td><td>1.000</td><td>2866</td><td>tags=26%, list=22%, signal=33%</td></tr><tr><td class='lessen'>599</td><td>MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN</td><td></td><td>52</td><td>-0.32</td><td>-0.83</td><td>0.755</td><td>1.000</td><td>1.000</td><td>5722</td><td>tags=48%, list=44%, signal=86%</td></tr><tr><td class='lessen'>600</td><td>FIGUEROA_AML_METHYLATION_CLUSTER_2_UP</td><td></td><td>36</td><td>-0.33</td><td>-0.83</td><td>0.707</td><td>1.000</td><td>1.000</td><td>2031</td><td>tags=17%, list=16%, signal=20%</td></tr><tr><td class='lessen'>601</td><td>IRITANI_MAD1_TARGETS_DN</td><td></td><td>38</td><td>-0.33</td><td>-0.83</td><td>0.727</td><td>1.000</td><td>1.000</td><td>6293</td><td>tags=66%, list=49%, signal=128%</td></tr><tr><td class='lessen'>602</td><td>MURAKAMI_UV_RESPONSE_1HR_UP</td><td></td><td>15</td><td>-0.39</td><td>-0.83</td><td>0.693</td><td>1.000</td><td>1.000</td><td>2416</td><td>tags=27%, list=19%, signal=33%</td></tr><tr><td class='lessen'>603</td><td>KOYAMA_SEMA3B_TARGETS_DN</td><td></td><td>310</td><td>-0.27</td><td>-0.83</td><td>0.890</td><td>1.000</td><td>1.000</td><td>2105</td><td>tags=15%, list=16%, signal=18%</td></tr><tr><td class='lessen'>604</td><td>SMID_BREAST_CANCER_ERBB2_UP</td><td></td><td>111</td><td>-0.29</td><td>-0.83</td><td>0.800</td><td>1.000</td><td>1.000</td><td>3220</td><td>tags=41%, list=25%, signal=55%</td></tr><tr><td class='lessen'>605</td><td>WARTERS_RESPONSE_TO_IR_SKIN</td><td></td><td>55</td><td>-0.31</td><td>-0.83</td><td>0.749</td><td>1.000</td><td>1.000</td><td>2521</td><td>tags=27%, list=19%, signal=34%</td></tr><tr><td class='lessen'>606</td><td>CAIRO_HEPATOBLASTOMA_POOR_SURVIVAL</td><td></td><td>14</td><td>-0.39</td><td>-0.83</td><td>0.704</td><td>1.000</td><td>1.000</td><td>2365</td><td>tags=43%, list=18%, signal=52%</td></tr><tr><td class='lessen'>607</td><td>PENG_LEUCINE_DEPRIVATION_DN</td><td></td><td>165</td><td>-0.28</td><td>-0.82</td><td>0.832</td><td>1.000</td><td>1.000</td><td>4476</td><td>tags=32%, list=35%, signal=48%</td></tr><tr><td class='lessen'>608</td><td>RUIZ_TNC_TARGETS_DN</td><td></td><td>122</td><td>-0.28</td><td>-0.82</td><td>0.818</td><td>1.000</td><td>1.000</td><td>3883</td><td>tags=39%, list=30%, signal=56%</td></tr><tr><td class='lessen'>609</td><td>MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP</td><td></td><td>84</td><td>-0.29</td><td>-0.82</td><td>0.767</td><td>1.000</td><td>1.000</td><td>5273</td><td>tags=44%, list=41%, signal=74%</td></tr><tr><td class='lessen'>610</td><td>CHANDRAN_METASTASIS_TOP50_UP</td><td></td><td>28</td><td>-0.34</td><td>-0.82</td><td>0.718</td><td>1.000</td><td>1.000</td><td>4043</td><td>tags=32%, list=31%, signal=47%</td></tr><tr><td class='lessen'>611</td><td>WU_HBX_TARGETS_3_UP</td><td></td><td>17</td><td>-0.38</td><td>-0.82</td><td>0.718</td><td>1.000</td><td>1.000</td><td>654</td><td>tags=12%, list=5%, signal=12%</td></tr><tr><td class='lessen'>612</td><td>AKL_HTLV1_INFECTION_DN</td><td></td><td>55</td><td>-0.31</td><td>-0.82</td><td>0.750</td><td>1.000</td><td>1.000</td><td>925</td><td>tags=9%, list=7%, signal=10%</td></tr><tr><td class='lessen'>613</td><td>DARWICHE_PAPILLOMA_PROGRESSION_RISK</td><td></td><td>59</td><td>-0.31</td><td>-0.82</td><td>0.775</td><td>1.000</td><td>1.000</td><td>1904</td><td>tags=20%, list=15%, signal=24%</td></tr><tr><td class='lessen'>614</td><td>MIKKELSEN_ES_ICP_WITH_H3K27ME3</td><td></td><td>33</td><td>-0.33</td><td>-0.82</td><td>0.733</td><td>1.000</td><td>1.000</td><td>2668</td><td>tags=42%, list=21%, signal=53%</td></tr><tr><td class='lessen'>615</td><td>NIELSEN_SYNOVIAL_SARCOMA_UP</td><td></td><td>18</td><td>-0.37</td><td>-0.82</td><td>0.709</td><td>1.000</td><td>1.000</td><td>2474</td><td>tags=33%, list=19%, signal=41%</td></tr><tr><td class='lessen'>616</td><td>DOANE_BREAST_CANCER_ESR1_DN</td><td></td><td>43</td><td>-0.32</td><td>-0.82</td><td>0.769</td><td>1.000</td><td>1.000</td><td>3103</td><td>tags=44%, list=24%, signal=58%</td></tr><tr><td class='lessen'>617</td><td>OUILLETTE_CLL_13Q14_DELETION_UP</td><td></td><td>54</td><td>-0.31</td><td>-0.82</td><td>0.749</td><td>1.000</td><td>1.000</td><td>4046</td><td>tags=37%, list=31%, signal=54%</td></tr><tr><td class='lessen'>618</td><td>THEODOROU_MAMMARY_TUMORIGENESIS</td><td></td><td>27</td><td>-0.34</td><td>-0.82</td><td>0.723</td><td>1.000</td><td>1.000</td><td>1510</td><td>tags=19%, list=12%, signal=21%</td></tr><tr><td class='lessen'>619</td><td>LABBE_TARGETS_OF_TGFB1_AND_WNT3A_DN</td><td></td><td>91</td><td>-0.29</td><td>-0.82</td><td>0.804</td><td>1.000</td><td>1.000</td><td>3179</td><td>tags=33%, list=25%, signal=43%</td></tr><tr><td class='lessen'>620</td><td>BROWNE_HCMV_INFECTION_1HR_UP</td><td></td><td>55</td><td>-0.31</td><td>-0.82</td><td>0.758</td><td>1.000</td><td>1.000</td><td>1099</td><td>tags=11%, list=8%, signal=12%</td></tr><tr><td class='lessen'>621</td><td>PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP</td><td></td><td>68</td><td>-0.30</td><td>-0.81</td><td>0.778</td><td>1.000</td><td>1.000</td><td>2197</td><td>tags=16%, list=17%, signal=19%</td></tr><tr><td class='lessen'>622</td><td>ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_UP</td><td></td><td>13</td><td>-0.39</td><td>-0.81</td><td>0.736</td><td>1.000</td><td>1.000</td><td>852</td><td>tags=15%, list=7%, signal=16%</td></tr><tr><td class='lessen'>623</td><td>HELLER_SILENCED_BY_METHYLATION_DN</td><td></td><td>87</td><td>-0.29</td><td>-0.81</td><td>0.789</td><td>1.000</td><td>1.000</td><td>2562</td><td>tags=24%, list=20%, signal=30%</td></tr><tr><td class='lessen'>624</td><td>WU_HBX_TARGETS_1_DN</td><td></td><td>21</td><td>-0.36</td><td>-0.81</td><td>0.738</td><td>1.000</td><td>1.000</td><td>241</td><td>tags=5%, list=2%, signal=5%</td></tr><tr><td class='lessen'>625</td><td>SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN</td><td></td><td>265</td><td>-0.27</td><td>-0.81</td><td>0.901</td><td>1.000</td><td>1.000</td><td>2247</td><td>tags=20%, list=17%, signal=24%</td></tr><tr><td class='lessen'>626</td><td>ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP</td><td></td><td>24</td><td>-0.34</td><td>-0.81</td><td>0.735</td><td>1.000</td><td>1.000</td><td>2483</td><td>tags=21%, list=19%, signal=26%</td></tr><tr><td class='lessen'>627</td><td>VALK_AML_CLUSTER_13</td><td></td><td>24</td><td>-0.35</td><td>-0.81</td><td>0.743</td><td>1.000</td><td>1.000</td><td>1841</td><td>tags=21%, list=14%, signal=24%</td></tr><tr><td class='lessen'>628</td><td>GALE_APL_WITH_FLT3_MUTATED_UP</td><td></td><td>40</td><td>-0.32</td><td>-0.81</td><td>0.755</td><td>1.000</td><td>1.000</td><td>2496</td><td>tags=20%, list=19%, signal=25%</td></tr><tr><td class='lessen'>629</td><td>SASSON_RESPONSE_TO_GONADOTROPHINS_UP</td><td></td><td>77</td><td>-0.29</td><td>-0.81</td><td>0.785</td><td>1.000</td><td>1.000</td><td>1105</td><td>tags=8%, list=9%, signal=8%</td></tr><tr><td class='lessen'>630</td><td>RIZKI_TUMOR_INVASIVENESS_3D_UP</td><td></td><td>176</td><td>-0.27</td><td>-0.81</td><td>0.839</td><td>1.000</td><td>1.000</td><td>2762</td><td>tags=22%, list=21%, signal=28%</td></tr><tr><td class='lessen'>631</td><td>FIGUEROA_AML_METHYLATION_CLUSTER_4_UP</td><td></td><td>83</td><td>-0.29</td><td>-0.81</td><td>0.805</td><td>1.000</td><td>1.000</td><td>2079</td><td>tags=14%, list=16%, signal=17%</td></tr><tr><td class='lessen'>632</td><td>CROMER_TUMORIGENESIS_DN</td><td></td><td>41</td><td>-0.32</td><td>-0.81</td><td>0.745</td><td>1.000</td><td>1.000</td><td>2809</td><td>tags=37%, list=22%, signal=47%</td></tr><tr><td class='lessen'>633</td><td>VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN</td><td></td><td>12</td><td>-0.39</td><td>-0.81</td><td>0.732</td><td>1.000</td><td>1.000</td><td>3231</td><td>tags=50%, list=25%, signal=67%</td></tr><tr><td class='lessen'>634</td><td>DELACROIX_RAR_BOUND_ES</td><td></td><td>359</td><td>-0.26</td><td>-0.80</td><td>0.934</td><td>1.000</td><td>1.000</td><td>3094</td><td>tags=22%, list=24%, signal=28%</td></tr><tr><td class='lessen'>635</td><td>FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL</td><td></td><td>259</td><td>-0.26</td><td>-0.80</td><td>0.896</td><td>1.000</td><td>1.000</td><td>3391</td><td>tags=31%, list=26%, signal=42%</td></tr><tr><td class='lessen'>636</td><td>ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN</td><td></td><td>269</td><td>-0.27</td><td>-0.80</td><td>0.910</td><td>1.000</td><td>1.000</td><td>3529</td><td>tags=26%, list=27%, signal=35%</td></tr><tr><td class='lessen'>637</td><td>YIH_RESPONSE_TO_ARSENITE_C1</td><td></td><td>23</td><td>-0.34</td><td>-0.80</td><td>0.742</td><td>1.000</td><td>1.000</td><td>2993</td><td>tags=30%, list=23%, signal=40%</td></tr><tr><td class='lessen'>638</td><td>SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1B</td><td></td><td>15</td><td>-0.37</td><td>-0.80</td><td>0.742</td><td>1.000</td><td>1.000</td><td>2870</td><td>tags=33%, list=22%, signal=43%</td></tr><tr><td class='lessen'>639</td><td>PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP</td><td></td><td>59</td><td>-0.30</td><td>-0.80</td><td>0.801</td><td>1.000</td><td>1.000</td><td>5972</td><td>tags=58%, list=46%, signal=107%</td></tr><tr><td class='lessen'>640</td><td>ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP</td><td></td><td>129</td><td>-0.27</td><td>-0.80</td><td>0.841</td><td>1.000</td><td>1.000</td><td>2944</td><td>tags=16%, list=23%, signal=21%</td></tr><tr><td class='lessen'>641</td><td>DEN_INTERACT_WITH_LCA5</td><td></td><td>25</td><td>-0.34</td><td>-0.80</td><td>0.761</td><td>1.000</td><td>1.000</td><td>2782</td><td>tags=24%, list=22%, signal=31%</td></tr><tr><td class='lessen'>642</td><td>RHODES_CANCER_META_SIGNATURE</td><td></td><td>56</td><td>-0.30</td><td>-0.80</td><td>0.790</td><td>1.000</td><td>1.000</td><td>3845</td><td>tags=30%, list=30%, signal=43%</td></tr><tr><td class='lessen'>643</td><td>NIKOLSKY_BREAST_CANCER_16P13_AMPLICON</td><td></td><td>84</td><td>-0.29</td><td>-0.80</td><td>0.824</td><td>1.000</td><td>1.000</td><td>65</td><td>tags=2%, list=1%, signal=2%</td></tr><tr><td class='lessen'>644</td><td>CHANGOLKAR_H2AFY_TARGETS_DN</td><td></td><td>32</td><td>-0.33</td><td>-0.80</td><td>0.762</td><td>1.000</td><td>1.000</td><td>2612</td><td>tags=25%, list=20%, signal=31%</td></tr><tr><td class='lessen'>645</td><td>RODWELL_AGING_KIDNEY_NO_BLOOD_DN</td><td></td><td>122</td><td>-0.28</td><td>-0.80</td><td>0.842</td><td>1.000</td><td>1.000</td><td>3098</td><td>tags=24%, list=24%, signal=31%</td></tr><tr><td class='lessen'>646</td><td>AUNG_GASTRIC_CANCER</td><td></td><td>42</td><td>-0.31</td><td>-0.80</td><td>0.747</td><td>1.000</td><td>1.000</td><td>3215</td><td>tags=31%, list=25%, signal=41%</td></tr><tr><td class='lessen'>647</td><td>DARWICHE_PAPILLOMA_RISK_HIGH_VS_LOW_DN</td><td></td><td>28</td><td>-0.33</td><td>-0.80</td><td>0.760</td><td>1.000</td><td>1.000</td><td>1922</td><td>tags=21%, list=15%, signal=25%</td></tr><tr><td class='lessen'>648</td><td>MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP</td><td></td><td>326</td><td>-0.26</td><td>-0.80</td><td>0.931</td><td>1.000</td><td>1.000</td><td>2466</td><td>tags=21%, list=19%, signal=25%</td></tr><tr><td class='lessen'>649</td><td>GROSS_HYPOXIA_VIA_HIF1A_UP</td><td></td><td>65</td><td>-0.30</td><td>-0.80</td><td>0.798</td><td>1.000</td><td>1.000</td><td>2216</td><td>tags=12%, list=17%, signal=15%</td></tr><tr><td class='lessen'>650</td><td>SASSON_RESPONSE_TO_FORSKOLIN_UP</td><td></td><td>77</td><td>-0.29</td><td>-0.80</td><td>0.810</td><td>1.000</td><td>1.000</td><td>1105</td><td>tags=8%, list=9%, signal=8%</td></tr><tr><td class='lessen'>651</td><td>YANG_BCL3_TARGETS_UP</td><td></td><td>305</td><td>-0.26</td><td>-0.79</td><td>0.925</td><td>1.000</td><td>1.000</td><td>2189</td><td>tags=20%, list=17%, signal=24%</td></tr><tr><td class='lessen'>652</td><td>LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_DN</td><td></td><td>14</td><td>-0.37</td><td>-0.79</td><td>0.750</td><td>1.000</td><td>1.000</td><td>884</td><td>tags=14%, list=7%, signal=15%</td></tr><tr><td class='lessen'>653</td><td>BHATTACHARYA_EMBRYONIC_STEM_CELL</td><td></td><td>75</td><td>-0.29</td><td>-0.79</td><td>0.821</td><td>1.000</td><td>1.000</td><td>2388</td><td>tags=20%, list=18%, signal=24%</td></tr><tr><td class='lessen'>654</td><td>HWANG_PROSTATE_CANCER_MARKERS</td><td></td><td>25</td><td>-0.34</td><td>-0.79</td><td>0.773</td><td>1.000</td><td>1.000</td><td>3133</td><td>tags=40%, list=24%, signal=53%</td></tr><tr><td class='lessen'>655</td><td>MEISSNER_NPC_ICP_WITH_H3_UNMETHYLATED</td><td></td><td>16</td><td>-0.37</td><td>-0.79</td><td>0.739</td><td>1.000</td><td>1.000</td><td>2062</td><td>tags=38%, list=16%, signal=45%</td></tr><tr><td class='lessen'>656</td><td>LEE_LIVER_CANCER_MYC_DN</td><td></td><td>52</td><td>-0.30</td><td>-0.79</td><td>0.792</td><td>1.000</td><td>1.000</td><td>2782</td><td>tags=38%, list=22%, signal=49%</td></tr><tr><td class='lessen'>657</td><td>TERAO_AOX4_TARGETS_SKIN_UP</td><td></td><td>37</td><td>-0.32</td><td>-0.79</td><td>0.784</td><td>1.000</td><td>1.000</td><td>670</td><td>tags=5%, list=5%, signal=6%</td></tr><tr><td class='lessen'>658</td><td>WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP</td><td></td><td>205</td><td>-0.27</td><td>-0.79</td><td>0.881</td><td>1.000</td><td>1.000</td><td>4330</td><td>tags=38%, list=33%, signal=56%</td></tr><tr><td class='lessen'>659</td><td>LIM_MAMMARY_LUMINAL_PROGENITOR_UP</td><td></td><td>49</td><td>-0.30</td><td>-0.79</td><td>0.802</td><td>1.000</td><td>1.000</td><td>3396</td><td>tags=49%, list=26%, signal=66%</td></tr><tr><td class='lessen'>660</td><td>FIGUEROA_AML_METHYLATION_CLUSTER_6_DN</td><td></td><td>23</td><td>-0.34</td><td>-0.79</td><td>0.759</td><td>1.000</td><td>1.000</td><td>1654</td><td>tags=17%, list=13%, signal=20%</td></tr><tr><td class='lessen'>661</td><td>ZHAN_LATE_DIFFERENTIATION_GENES_DN</td><td></td><td>14</td><td>-0.37</td><td>-0.79</td><td>0.737</td><td>1.000</td><td>1.000</td><td>1160</td><td>tags=21%, list=9%, signal=24%</td></tr><tr><td class='lessen'>662</td><td>LEIN_MEDULLA_MARKERS</td><td></td><td>69</td><td>-0.29</td><td>-0.79</td><td>0.818</td><td>1.000</td><td>1.000</td><td>2245</td><td>tags=22%, list=17%, signal=26%</td></tr><tr><td class='lessen'>663</td><td>MATZUK_OVULATION</td><td></td><td>14</td><td>-0.37</td><td>-0.79</td><td>0.749</td><td>1.000</td><td>1.000</td><td>1325</td><td>tags=21%, list=10%, signal=24%</td></tr><tr><td class='lessen'>664</td><td>CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_UP</td><td></td><td>32</td><td>-0.32</td><td>-0.78</td><td>0.760</td><td>1.000</td><td>1.000</td><td>632</td><td>tags=13%, list=5%, signal=13%</td></tr><tr><td class='lessen'>665</td><td>IWANAGA_CARCINOGENESIS_BY_KRAS_DN</td><td></td><td>98</td><td>-0.28</td><td>-0.78</td><td>0.853</td><td>1.000</td><td>1.000</td><td>772</td><td>tags=7%, list=6%, signal=8%</td></tr><tr><td class='lessen'>666</td><td>SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN</td><td></td><td>50</td><td>-0.30</td><td>-0.78</td><td>0.797</td><td>1.000</td><td>1.000</td><td>1406</td><td>tags=14%, list=11%, signal=16%</td></tr><tr><td class='lessen'>667</td><td>YANG_MUC2_TARGETS_DUODENUM_3MO_DN</td><td></td><td>17</td><td>-0.35</td><td>-0.78</td><td>0.751</td><td>1.000</td><td>1.000</td><td>2275</td><td>tags=24%, list=18%, signal=29%</td></tr><tr><td class='lessen'>668</td><td>GENTILE_UV_RESPONSE_CLUSTER_D6</td><td></td><td>26</td><td>-0.33</td><td>-0.78</td><td>0.752</td><td>1.000</td><td>1.000</td><td>259</td><td>tags=4%, list=2%, signal=4%</td></tr><tr><td class='lessen'>669</td><td>LUI_THYROID_CANCER_CLUSTER_5</td><td></td><td>12</td><td>-0.39</td><td>-0.78</td><td>0.753</td><td>1.000</td><td>1.000</td><td>43</td><td>tags=8%, list=0%, signal=8%</td></tr><tr><td class='lessen'>670</td><td>MASSARWEH_TAMOXIFEN_RESISTANCE_DN</td><td></td><td>192</td><td>-0.26</td><td>-0.78</td><td>0.896</td><td>1.000</td><td>1.000</td><td>2088</td><td>tags=16%, list=16%, signal=18%</td></tr><tr><td class='lessen'>671</td><td>CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN</td><td></td><td>86</td><td>-0.28</td><td>-0.78</td><td>0.823</td><td>1.000</td><td>1.000</td><td>1969</td><td>tags=21%, list=15%, signal=25%</td></tr><tr><td class='lessen'>672</td><td>JI_CARCINOGENESIS_BY_KRAS_AND_STK11_UP</td><td></td><td>11</td><td>-0.38</td><td>-0.78</td><td>0.752</td><td>1.000</td><td>1.000</td><td>2988</td><td>tags=64%, list=23%, signal=83%</td></tr><tr><td class='lessen'>673</td><td>MIKKELSEN_ES_LCP_WITH_H3K4ME3</td><td></td><td>100</td><td>-0.27</td><td>-0.78</td><td>0.850</td><td>1.000</td><td>1.000</td><td>2505</td><td>tags=25%, list=19%, signal=31%</td></tr><tr><td class='lessen'>674</td><td>SHIPP_DLBCL_CURED_VS_FATAL_DN</td><td></td><td>35</td><td>-0.31</td><td>-0.78</td><td>0.801</td><td>1.000</td><td>1.000</td><td>2075</td><td>tags=17%, list=16%, signal=20%</td></tr><tr><td class='lessen'>675</td><td>MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3</td><td></td><td>905</td><td>-0.25</td><td>-0.78</td><td>0.996</td><td>1.000</td><td>1.000</td><td>2760</td><td>tags=27%, list=21%, signal=32%</td></tr><tr><td class='lessen'>676</td><td>CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP</td><td></td><td>138</td><td>-0.26</td><td>-0.78</td><td>0.884</td><td>1.000</td><td>1.000</td><td>1537</td><td>tags=17%, list=12%, signal=19%</td></tr><tr><td class='lessen'>677</td><td>MEISSNER_BRAIN_ICP_WITH_H3K4ME3</td><td></td><td>22</td><td>-0.34</td><td>-0.77</td><td>0.751</td><td>1.000</td><td>1.000</td><td>2312</td><td>tags=27%, list=18%, signal=33%</td></tr><tr><td class='lessen'>678</td><td>RAMASWAMY_METASTASIS_UP</td><td></td><td>52</td><td>-0.29</td><td>-0.77</td><td>0.814</td><td>1.000</td><td>1.000</td><td>4161</td><td>tags=33%, list=32%, signal=48%</td></tr><tr><td class='lessen'>679</td><td>ZHENG_IL22_SIGNALING_DN</td><td></td><td>34</td><td>-0.31</td><td>-0.77</td><td>0.793</td><td>1.000</td><td>1.000</td><td>1632</td><td>tags=24%, list=13%, signal=27%</td></tr><tr><td class='lessen'>680</td><td>DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP</td><td></td><td>296</td><td>-0.26</td><td>-0.77</td><td>0.943</td><td>1.000</td><td>1.000</td><td>3417</td><td>tags=26%, list=26%, signal=34%</td></tr><tr><td class='lessen'>681</td><td>CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP</td><td></td><td>32</td><td>-0.32</td><td>-0.77</td><td>0.794</td><td>1.000</td><td>1.000</td><td>4519</td><td>tags=44%, list=35%, signal=67%</td></tr><tr><td class='lessen'>682</td><td>CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS</td><td></td><td>43</td><td>-0.30</td><td>-0.77</td><td>0.806</td><td>1.000</td><td>1.000</td><td>4235</td><td>tags=40%, list=33%, signal=59%</td></tr><tr><td class='lessen'>683</td><td>CHANG_CORE_SERUM_RESPONSE_UP</td><td></td><td>170</td><td>-0.26</td><td>-0.77</td><td>0.911</td><td>1.000</td><td>1.000</td><td>3558</td><td>tags=24%, list=28%, signal=33%</td></tr><tr><td class='lessen'>684</td><td>MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN</td><td></td><td>132</td><td>-0.27</td><td>-0.77</td><td>0.873</td><td>1.000</td><td>1.000</td><td>6042</td><td>tags=47%, list=47%, signal=87%</td></tr><tr><td class='lessen'>685</td><td>SANSOM_APC_TARGETS_REQUIRE_MYC</td><td></td><td>163</td><td>-0.26</td><td>-0.77</td><td>0.907</td><td>1.000</td><td>1.000</td><td>4040</td><td>tags=33%, list=31%, signal=47%</td></tr><tr><td class='lessen'>686</td><td>OXFORD_RALA_OR_RALB_TARGETS_UP</td><td></td><td>42</td><td>-0.30</td><td>-0.77</td><td>0.821</td><td>1.000</td><td>1.000</td><td>4330</td><td>tags=38%, list=33%, signal=57%</td></tr><tr><td class='lessen'>687</td><td>LI_CYTIDINE_ANALOG_PATHWAY</td><td></td><td>16</td><td>-0.35</td><td>-0.77</td><td>0.780</td><td>1.000</td><td>1.000</td><td>3389</td><td>tags=38%, list=26%, signal=51%</td></tr><tr><td class='lessen'>688</td><td>BARRIER_COLON_CANCER_RECURRENCE_UP</td><td></td><td>37</td><td>-0.31</td><td>-0.77</td><td>0.802</td><td>1.000</td><td>1.000</td><td>3566</td><td>tags=30%, list=28%, signal=41%</td></tr><tr><td class='lessen'>689</td><td>SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP</td><td></td><td>42</td><td>-0.30</td><td>-0.77</td><td>0.809</td><td>1.000</td><td>1.000</td><td>4169</td><td>tags=36%, list=32%, signal=53%</td></tr><tr><td class='lessen'>690</td><td>KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN</td><td></td><td>38</td><td>-0.30</td><td>-0.77</td><td>0.819</td><td>1.000</td><td>1.000</td><td>3224</td><td>tags=24%, list=25%, signal=31%</td></tr><tr><td class='lessen'>691</td><td>GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN</td><td></td><td>53</td><td>-0.29</td><td>-0.77</td><td>0.849</td><td>1.000</td><td>1.000</td><td>2809</td><td>tags=17%, list=22%, signal=22%</td></tr><tr><td class='lessen'>692</td><td>GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP</td><td></td><td>73</td><td>-0.28</td><td>-0.76</td><td>0.839</td><td>1.000</td><td>1.000</td><td>3307</td><td>tags=38%, list=26%, signal=51%</td></tr><tr><td class='lessen'>693</td><td>VANTVEER_BREAST_CANCER_METASTASIS_DN</td><td></td><td>94</td><td>-0.27</td><td>-0.76</td><td>0.855</td><td>1.000</td><td>1.000</td><td>2763</td><td>tags=23%, list=21%, signal=30%</td></tr><tr><td class='lessen'>694</td><td>LIM_MAMMARY_LUMINAL_MATURE_UP</td><td></td><td>100</td><td>-0.27</td><td>-0.76</td><td>0.865</td><td>1.000</td><td>1.000</td><td>3351</td><td>tags=38%, list=26%, signal=51%</td></tr><tr><td class='lessen'>695</td><td>WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN</td><td></td><td>34</td><td>-0.31</td><td>-0.76</td><td>0.815</td><td>1.000</td><td>1.000</td><td>1500</td><td>tags=15%, list=12%, signal=17%</td></tr><tr><td class='lessen'>696</td><td>WENG_POR_TARGETS_LIVER_UP</td><td></td><td>31</td><td>-0.31</td><td>-0.76</td><td>0.835</td><td>1.000</td><td>1.000</td><td>3137</td><td>tags=45%, list=24%, signal=59%</td></tr><tr><td class='lessen'>697</td><td>CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN</td><td></td><td>141</td><td>-0.26</td><td>-0.76</td><td>0.899</td><td>1.000</td><td>1.000</td><td>3575</td><td>tags=34%, list=28%, signal=47%</td></tr><tr><td class='lessen'>698</td><td>NIKOLSKY_BREAST_CANCER_7Q21_Q22_AMPLICON</td><td></td><td>49</td><td>-0.29</td><td>-0.76</td><td>0.828</td><td>1.000</td><td>1.000</td><td>2237</td><td>tags=22%, list=17%, signal=27%</td></tr><tr><td class='lessen'>699</td><td>MURAKAMI_UV_RESPONSE_6HR_DN</td><td></td><td>19</td><td>-0.34</td><td>-0.76</td><td>0.808</td><td>1.000</td><td>1.000</td><td>2697</td><td>tags=37%, list=21%, signal=46%</td></tr><tr><td class='lessen'>700</td><td>BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP</td><td></td><td>38</td><td>-0.30</td><td>-0.76</td><td>0.820</td><td>1.000</td><td>1.000</td><td>2456</td><td>tags=24%, list=19%, signal=29%</td></tr><tr><td class='lessen'>701</td><td>BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP</td><td></td><td>152</td><td>-0.26</td><td>-0.76</td><td>0.899</td><td>1.000</td><td>1.000</td><td>3655</td><td>tags=21%, list=28%, signal=29%</td></tr><tr><td class='lessen'>702</td><td>HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP</td><td></td><td>24</td><td>-0.33</td><td>-0.76</td><td>0.777</td><td>1.000</td><td>1.000</td><td>938</td><td>tags=17%, list=7%, signal=18%</td></tr><tr><td class='lessen'>703</td><td>STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP</td><td></td><td>38</td><td>-0.30</td><td>-0.76</td><td>0.802</td><td>1.000</td><td>1.000</td><td>2204</td><td>tags=18%, list=17%, signal=22%</td></tr><tr><td class='lessen'>704</td><td>MARCHINI_TRABECTEDIN_RESISTANCE_UP</td><td></td><td>17</td><td>-0.35</td><td>-0.76</td><td>0.779</td><td>1.000</td><td>1.000</td><td>4152</td><td>tags=41%, list=32%, signal=61%</td></tr><tr><td class='lessen'>705</td><td>HEIDENBLAD_AMPLICON_8Q24_UP</td><td></td><td>28</td><td>-0.32</td><td>-0.76</td><td>0.797</td><td>1.000</td><td>1.000</td><td>1825</td><td>tags=18%, list=14%, signal=21%</td></tr><tr><td class='lessen'>706</td><td>ZUCCHI_METASTASIS_UP</td><td></td><td>37</td><td>-0.30</td><td>-0.76</td><td>0.818</td><td>1.000</td><td>1.000</td><td>1597</td><td>tags=11%, list=12%, signal=12%</td></tr><tr><td class='lessen'>707</td><td>CERVERA_SDHB_TARGETS_2</td><td></td><td>91</td><td>-0.27</td><td>-0.76</td><td>0.864</td><td>1.000</td><td>1.000</td><td>2272</td><td>tags=25%, list=18%, signal=30%</td></tr><tr><td class='lessen'>708</td><td>WEI_MYCN_TARGETS_WITH_E_BOX</td><td></td><td>609</td><td>-0.25</td><td>-0.76</td><td>0.982</td><td>1.000</td><td>1.000</td><td>4810</td><td>tags=33%, list=37%, signal=51%</td></tr><tr><td class='lessen'>709</td><td>HENDRICKS_SMARCA4_TARGETS_UP</td><td></td><td>47</td><td>-0.29</td><td>-0.76</td><td>0.831</td><td>1.000</td><td>1.000</td><td>7</td><td>tags=2%, list=0%, signal=2%</td></tr><tr><td class='lessen'>710</td><td>LEE_LIVER_CANCER_MYC_E2F1_DN</td><td></td><td>57</td><td>-0.28</td><td>-0.76</td><td>0.860</td><td>1.000</td><td>1.000</td><td>2530</td><td>tags=40%, list=20%, signal=50%</td></tr><tr><td class='lessen'>711</td><td>HU_ANGIOGENESIS_UP</td><td></td><td>19</td><td>-0.34</td><td>-0.76</td><td>0.815</td><td>1.000</td><td>1.000</td><td>1740</td><td>tags=16%, list=13%, signal=18%</td></tr><tr><td class='lessen'>712</td><td>WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN</td><td></td><td>291</td><td>-0.25</td><td>-0.76</td><td>0.959</td><td>1.000</td><td>1.000</td><td>3706</td><td>tags=32%, list=29%, signal=44%</td></tr><tr><td class='lessen'>713</td><td>SPIRA_SMOKERS_LUNG_CANCER_DN</td><td></td><td>14</td><td>-0.35</td><td>-0.75</td><td>0.787</td><td>1.000</td><td>1.000</td><td>1212</td><td>tags=14%, list=9%, signal=16%</td></tr><tr><td class='lessen'>714</td><td>TERAMOTO_OPN_TARGETS_CLUSTER_1</td><td></td><td>10</td><td>-0.38</td><td>-0.75</td><td>0.788</td><td>1.000</td><td>1.000</td><td>4870</td><td>tags=60%, list=38%, signal=96%</td></tr><tr><td class='lessen'>715</td><td>WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP</td><td></td><td>38</td><td>-0.30</td><td>-0.75</td><td>0.841</td><td>1.000</td><td>1.000</td><td>1452</td><td>tags=13%, list=11%, signal=15%</td></tr><tr><td class='lessen'>716</td><td>LIN_NPAS4_TARGETS_DN</td><td></td><td>55</td><td>-0.29</td><td>-0.75</td><td>0.839</td><td>1.000</td><td>1.000</td><td>1395</td><td>tags=16%, list=11%, signal=18%</td></tr><tr><td class='lessen'>717</td><td>ABDELMOHSEN_ELAVL4_TARGETS</td><td></td><td>16</td><td>-0.34</td><td>-0.75</td><td>0.789</td><td>1.000</td><td>1.000</td><td>2241</td><td>tags=19%, list=17%, signal=23%</td></tr><tr><td class='lessen'>718</td><td>SEIDEN_MET_SIGNALING</td><td></td><td>18</td><td>-0.34</td><td>-0.75</td><td>0.805</td><td>1.000</td><td>1.000</td><td>6541</td><td>tags=56%, list=51%, signal=112%</td></tr><tr><td class='lessen'>719</td><td>GYORFFY_MITOXANTRONE_RESISTANCE</td><td></td><td>43</td><td>-0.29</td><td>-0.75</td><td>0.820</td><td>1.000</td><td>1.000</td><td>1902</td><td>tags=16%, list=15%, signal=19%</td></tr><tr><td class='lessen'>720</td><td>CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN</td><td></td><td>159</td><td>-0.26</td><td>-0.75</td><td>0.942</td><td>1.000</td><td>1.000</td><td>4429</td><td>tags=33%, list=34%, signal=50%</td></tr><tr><td class='lessen'>721</td><td>IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR</td><td></td><td>518</td><td>-0.24</td><td>-0.75</td><td>0.981</td><td>1.000</td><td>1.000</td><td>2854</td><td>tags=18%, list=22%, signal=23%</td></tr><tr><td class='lessen'>722</td><td>PATIL_LIVER_CANCER</td><td></td><td>583</td><td>-0.25</td><td>-0.75</td><td>0.984</td><td>1.000</td><td>1.000</td><td>3489</td><td>tags=25%, list=27%, signal=33%</td></tr><tr><td class='lessen'>723</td><td>SMID_BREAST_CANCER_RELAPSE_IN_LIVER_DN</td><td></td><td>10</td><td>-0.37</td><td>-0.75</td><td>0.799</td><td>1.000</td><td>1.000</td><td>2981</td><td>tags=40%, list=23%, signal=52%</td></tr><tr><td class='lessen'>724</td><td>IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR</td><td></td><td>413</td><td>-0.24</td><td>-0.75</td><td>0.971</td><td>1.000</td><td>1.000</td><td>773</td><td>tags=4%, list=6%, signal=4%</td></tr><tr><td class='lessen'>725</td><td>FARMER_BREAST_CANCER_APOCRINE_VS_BASAL</td><td></td><td>267</td><td>-0.25</td><td>-0.75</td><td>0.946</td><td>1.000</td><td>1.000</td><td>3869</td><td>tags=35%, list=30%, signal=49%</td></tr><tr><td class='lessen'>726</td><td>SAFFORD_T_LYMPHOCYTE_ANERGY</td><td></td><td>79</td><td>-0.27</td><td>-0.75</td><td>0.879</td><td>1.000</td><td>1.000</td><td>1199</td><td>tags=10%, list=9%, signal=11%</td></tr><tr><td class='lessen'>727</td><td>MOREIRA_RESPONSE_TO_TSA_DN</td><td></td><td>18</td><td>-0.34</td><td>-0.75</td><td>0.803</td><td>1.000</td><td>1.000</td><td>222</td><td>tags=6%, list=2%, signal=6%</td></tr><tr><td class='lessen'>728</td><td>DORN_ADENOVIRUS_INFECTION_12HR_DN</td><td></td><td>30</td><td>-0.31</td><td>-0.75</td><td>0.815</td><td>1.000</td><td>1.000</td><td>3265</td><td>tags=27%, list=25%, signal=36%</td></tr><tr><td class='lessen'>729</td><td>MCCLUNG_COCAIN_REWARD_4WK</td><td></td><td>66</td><td>-0.28</td><td>-0.75</td><td>0.869</td><td>1.000</td><td>1.000</td><td>1291</td><td>tags=12%, list=10%, signal=13%</td></tr><tr><td class='lessen'>730</td><td>DEMAGALHAES_AGING_DN</td><td></td><td>14</td><td>-0.36</td><td>-0.75</td><td>0.793</td><td>1.000</td><td>1.000</td><td>390</td><td>tags=7%, list=3%, signal=7%</td></tr><tr><td class='lessen'>731</td><td>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP</td><td></td><td>20</td><td>-0.33</td><td>-0.75</td><td>0.811</td><td>1.000</td><td>1.000</td><td>2997</td><td>tags=35%, list=23%, signal=45%</td></tr><tr><td class='lessen'>732</td><td>ZHAN_MULTIPLE_MYELOMA_MS_UP</td><td></td><td>38</td><td>-0.30</td><td>-0.74</td><td>0.842</td><td>1.000</td><td>1.000</td><td>574</td><td>tags=5%, list=4%, signal=5%</td></tr><tr><td class='lessen'>733</td><td>TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP</td><td></td><td>48</td><td>-0.28</td><td>-0.74</td><td>0.840</td><td>1.000</td><td>1.000</td><td>1268</td><td>tags=13%, list=10%, signal=14%</td></tr><tr><td class='lessen'>734</td><td>BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE</td><td></td><td>49</td><td>-0.28</td><td>-0.74</td><td>0.851</td><td>1.000</td><td>1.000</td><td>3910</td><td>tags=51%, list=30%, signal=73%</td></tr><tr><td class='lessen'>735</td><td>GEORGES_CELL_CYCLE_MIR192_TARGETS</td><td></td><td>58</td><td>-0.28</td><td>-0.74</td><td>0.859</td><td>1.000</td><td>1.000</td><td>4591</td><td>tags=41%, list=35%, signal=64%</td></tr><tr><td class='lessen'>736</td><td>SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN</td><td></td><td>74</td><td>-0.27</td><td>-0.74</td><td>0.881</td><td>1.000</td><td>1.000</td><td>3951</td><td>tags=43%, list=31%, signal=62%</td></tr><tr><td class='lessen'>737</td><td>GRADE_COLON_VS_RECTAL_CANCER_DN</td><td></td><td>42</td><td>-0.29</td><td>-0.74</td><td>0.847</td><td>1.000</td><td>1.000</td><td>3740</td><td>tags=36%, list=29%, signal=50%</td></tr><tr><td class='lessen'>738</td><td>STONER_ESOPHAGEAL_CARCINOGENESIS_UP</td><td></td><td>29</td><td>-0.30</td><td>-0.74</td><td>0.832</td><td>1.000</td><td>1.000</td><td>3550</td><td>tags=24%, list=27%, signal=33%</td></tr><tr><td class='lessen'>739</td><td>GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP</td><td></td><td>178</td><td>-0.25</td><td>-0.74</td><td>0.933</td><td>1.000</td><td>1.000</td><td>2434</td><td>tags=21%, list=19%, signal=26%</td></tr><tr><td class='lessen'>740</td><td>RICKMAN_METASTASIS_UP</td><td></td><td>235</td><td>-0.25</td><td>-0.74</td><td>0.953</td><td>1.000</td><td>1.000</td><td>3201</td><td>tags=19%, list=25%, signal=25%</td></tr><tr><td class='lessen'>741</td><td>ZHAN_MULTIPLE_MYELOMA_CD1_DN</td><td></td><td>35</td><td>-0.30</td><td>-0.74</td><td>0.841</td><td>1.000</td><td>1.000</td><td>4148</td><td>tags=37%, list=32%, signal=55%</td></tr><tr><td class='lessen'>742</td><td>BILANGES_RAPAMYCIN_SENSITIVE_GENES</td><td></td><td>32</td><td>-0.30</td><td>-0.74</td><td>0.844</td><td>1.000</td><td>1.000</td><td>4141</td><td>tags=38%, list=32%, signal=55%</td></tr><tr><td class='lessen'>743</td><td>MIKKELSEN_IPS_LCP_WITH_H3K4ME3</td><td></td><td>127</td><td>-0.25</td><td>-0.74</td><td>0.916</td><td>1.000</td><td>1.000</td><td>3251</td><td>tags=31%, list=25%, signal=42%</td></tr><tr><td class='lessen'>744</td><td>CLIMENT_BREAST_CANCER_COPY_NUMBER_UP</td><td></td><td>22</td><td>-0.32</td><td>-0.73</td><td>0.811</td><td>1.000</td><td>1.000</td><td>1911</td><td>tags=18%, list=15%, signal=21%</td></tr><tr><td class='lessen'>745</td><td>FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP</td><td></td><td>55</td><td>-0.28</td><td>-0.73</td><td>0.866</td><td>1.000</td><td>1.000</td><td>2413</td><td>tags=24%, list=19%, signal=29%</td></tr><tr><td class='lessen'>746</td><td>TARTE_PLASMA_CELL_VS_PLASMABLAST_DN</td><td></td><td>273</td><td>-0.24</td><td>-0.73</td><td>0.972</td><td>1.000</td><td>1.000</td><td>3082</td><td>tags=18%, list=24%, signal=23%</td></tr><tr><td class='lessen'>747</td><td>IVANOV_MUTATED_IN_COLON_CANCER</td><td></td><td>10</td><td>-0.38</td><td>-0.73</td><td>0.811</td><td>1.000</td><td>1.000</td><td>3855</td><td>tags=40%, list=30%, signal=57%</td></tr><tr><td class='lessen'>748</td><td>LI_DCP2_BOUND_MRNA</td><td></td><td>77</td><td>-0.27</td><td>-0.73</td><td>0.894</td><td>1.000</td><td>1.000</td><td>6331</td><td>tags=55%, list=49%, signal=106%</td></tr><tr><td class='lessen'>749</td><td>RIZ_ERYTHROID_DIFFERENTIATION_6HR</td><td></td><td>34</td><td>-0.29</td><td>-0.73</td><td>0.831</td><td>1.000</td><td>1.000</td><td>2448</td><td>tags=26%, list=19%, signal=33%</td></tr><tr><td class='lessen'>750</td><td>COLDREN_GEFITINIB_RESISTANCE_UP</td><td></td><td>64</td><td>-0.27</td><td>-0.73</td><td>0.874</td><td>1.000</td><td>1.000</td><td>2036</td><td>tags=19%, list=16%, signal=22%</td></tr><tr><td class='lessen'>751</td><td>HEIDENBLAD_AMPLICON_12P11_12_DN</td><td></td><td>16</td><td>-0.34</td><td>-0.73</td><td>0.799</td><td>1.000</td><td>1.000</td><td>3241</td><td>tags=25%, list=25%, signal=33%</td></tr><tr><td class='lessen'>752</td><td>AMIT_EGF_RESPONSE_40_HELA</td><td></td><td>38</td><td>-0.29</td><td>-0.73</td><td>0.847</td><td>1.000</td><td>1.000</td><td>1047</td><td>tags=11%, list=8%, signal=11%</td></tr><tr><td class='lessen'>753</td><td>MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY</td><td></td><td>10</td><td>-0.37</td><td>-0.73</td><td>0.797</td><td>1.000</td><td>1.000</td><td>2272</td><td>tags=40%, list=18%, signal=48%</td></tr><tr><td class='lessen'>754</td><td>PEART_HDAC_PROLIFERATION_CLUSTER_DN</td><td></td><td>69</td><td>-0.27</td><td>-0.73</td><td>0.891</td><td>1.000</td><td>1.000</td><td>1213</td><td>tags=7%, list=9%, signal=8%</td></tr><tr><td class='lessen'>755</td><td>ASTON_MAJOR_DEPRESSIVE_DISORDER_UP</td><td></td><td>37</td><td>-0.30</td><td>-0.73</td><td>0.863</td><td>1.000</td><td>1.000</td><td>3720</td><td>tags=30%, list=29%, signal=42%</td></tr><tr><td class='lessen'>756</td><td>MIKKELSEN_ES_LCP_WITH_H3K27ME3</td><td></td><td>13</td><td>-0.34</td><td>-0.73</td><td>0.818</td><td>1.000</td><td>1.000</td><td>1113</td><td>tags=15%, list=9%, signal=17%</td></tr><tr><td class='lessen'>757</td><td>TRAYNOR_RETT_SYNDROM_DN</td><td></td><td>13</td><td>-0.35</td><td>-0.73</td><td>0.814</td><td>1.000</td><td>1.000</td><td>707</td><td>tags=15%, list=5%, signal=16%</td></tr><tr><td class='lessen'>758</td><td>HOEGERKORP_CD44_TARGETS_DIRECT_UP</td><td></td><td>24</td><td>-0.31</td><td>-0.73</td><td>0.837</td><td>1.000</td><td>1.000</td><td>1831</td><td>tags=33%, list=14%, signal=39%</td></tr><tr><td class='lessen'>759</td><td>RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_DN</td><td></td><td>10</td><td>-0.37</td><td>-0.73</td><td>0.835</td><td>1.000</td><td>1.000</td><td>1740</td><td>tags=20%, list=13%, signal=23%</td></tr><tr><td class='lessen'>760</td><td>GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN</td><td></td><td>234</td><td>-0.24</td><td>-0.73</td><td>0.971</td><td>1.000</td><td>1.000</td><td>5542</td><td>tags=44%, list=43%, signal=76%</td></tr><tr><td class='lessen'>761</td><td>BRUECKNER_TARGETS_OF_MIRLET7A3_UP</td><td></td><td>96</td><td>-0.26</td><td>-0.73</td><td>0.908</td><td>1.000</td><td>1.000</td><td>3815</td><td>tags=31%, list=29%, signal=44%</td></tr><tr><td class='lessen'>762</td><td>BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP</td><td></td><td>22</td><td>-0.32</td><td>-0.73</td><td>0.822</td><td>1.000</td><td>1.000</td><td>3220</td><td>tags=36%, list=25%, signal=48%</td></tr><tr><td class='lessen'>763</td><td>MODY_HIPPOCAMPUS_NEONATAL</td><td></td><td>30</td><td>-0.30</td><td>-0.73</td><td>0.841</td><td>1.000</td><td>1.000</td><td>666</td><td>tags=10%, list=5%, signal=11%</td></tr><tr><td class='lessen'>764</td><td>XU_GH1_EXOGENOUS_TARGETS_DN</td><td></td><td>87</td><td>-0.26</td><td>-0.73</td><td>0.902</td><td>1.000</td><td>1.000</td><td>3140</td><td>tags=30%, list=24%, signal=39%</td></tr><tr><td class='lessen'>765</td><td>LIU_VAV3_PROSTATE_CARCINOGENESIS_DN</td><td></td><td>14</td><td>-0.35</td><td>-0.73</td><td>0.817</td><td>1.000</td><td>1.000</td><td>2927</td><td>tags=36%, list=23%, signal=46%</td></tr><tr><td class='lessen'>766</td><td>GOLDRATH_ANTIGEN_RESPONSE</td><td></td><td>297</td><td>-0.24</td><td>-0.73</td><td>0.971</td><td>1.000</td><td>1.000</td><td>1921</td><td>tags=17%, list=15%, signal=19%</td></tr><tr><td class='lessen'>767</td><td>SMID_BREAST_CANCER_BASAL_DN</td><td></td><td>536</td><td>-0.24</td><td>-0.73</td><td>0.994</td><td>1.000</td><td>1.000</td><td>2637</td><td>tags=25%, list=20%, signal=30%</td></tr><tr><td class='lessen'>768</td><td>HUANG_FOXA2_TARGETS_UP</td><td></td><td>37</td><td>-0.29</td><td>-0.73</td><td>0.849</td><td>1.000</td><td>1.000</td><td>2407</td><td>tags=22%, list=19%, signal=26%</td></tr><tr><td class='lessen'>769</td><td>LEE_AGING_MUSCLE_UP</td><td></td><td>40</td><td>-0.29</td><td>-0.73</td><td>0.883</td><td>1.000</td><td>1.000</td><td>44</td><td>tags=3%, list=0%, signal=3%</td></tr><tr><td class='lessen'>770</td><td>BROWNE_HCMV_INFECTION_16HR_UP</td><td></td><td>188</td><td>-0.24</td><td>-0.73</td><td>0.955</td><td>1.000</td><td>1.000</td><td>2999</td><td>tags=21%, list=23%, signal=27%</td></tr><tr><td class='lessen'>771</td><td>BROWNE_HCMV_INFECTION_24HR_UP</td><td></td><td>128</td><td>-0.25</td><td>-0.73</td><td>0.914</td><td>1.000</td><td>1.000</td><td>2205</td><td>tags=17%, list=17%, signal=21%</td></tr><tr><td class='lessen'>772</td><td>FIGUEROA_AML_METHYLATION_CLUSTER_1_UP</td><td></td><td>83</td><td>-0.26</td><td>-0.73</td><td>0.903</td><td>1.000</td><td>1.000</td><td>1156</td><td>tags=10%, list=9%, signal=11%</td></tr><tr><td class='lessen'>773</td><td>VALK_AML_CLUSTER_16</td><td></td><td>20</td><td>-0.32</td><td>-0.73</td><td>0.834</td><td>1.000</td><td>1.000</td><td>58</td><td>tags=5%, list=0%, signal=5%</td></tr><tr><td class='lessen'>774</td><td>CHEN_PDGF_TARGETS</td><td></td><td>16</td><td>-0.34</td><td>-0.73</td><td>0.829</td><td>1.000</td><td>1.000</td><td>2281</td><td>tags=25%, list=18%, signal=30%</td></tr><tr><td class='lessen'>775</td><td>CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1</td><td></td><td>399</td><td>-0.24</td><td>-0.72</td><td>0.987</td><td>1.000</td><td>1.000</td><td>3175</td><td>tags=22%, list=25%, signal=28%</td></tr><tr><td class='lessen'>776</td><td>BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_UP</td><td></td><td>15</td><td>-0.34</td><td>-0.72</td><td>0.840</td><td>1.000</td><td>1.000</td><td>2289</td><td>tags=20%, list=18%, signal=24%</td></tr><tr><td class='lessen'>777</td><td>RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_DN</td><td></td><td>10</td><td>-0.38</td><td>-0.72</td><td>0.808</td><td>1.000</td><td>1.000</td><td>4779</td><td>tags=60%, list=37%, signal=95%</td></tr><tr><td class='lessen'>778</td><td>LUI_TARGETS_OF_PAX8_PPARG_FUSION</td><td></td><td>27</td><td>-0.30</td><td>-0.72</td><td>0.844</td><td>1.000</td><td>1.000</td><td>6696</td><td>tags=78%, list=52%, signal=161%</td></tr><tr><td class='lessen'>779</td><td>SHIN_B_CELL_LYMPHOMA_CLUSTER_9</td><td></td><td>16</td><td>-0.33</td><td>-0.72</td><td>0.834</td><td>1.000</td><td>1.000</td><td>1998</td><td>tags=31%, list=15%, signal=37%</td></tr><tr><td class='lessen'>780</td><td>HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_4HR</td><td></td><td>32</td><td>-0.29</td><td>-0.72</td><td>0.859</td><td>1.000</td><td>1.000</td><td>1109</td><td>tags=9%, list=9%, signal=10%</td></tr><tr><td class='lessen'>781</td><td>MAYBURD_RESPONSE_TO_L663536_DN</td><td></td><td>43</td><td>-0.28</td><td>-0.72</td><td>0.865</td><td>1.000</td><td>1.000</td><td>4229</td><td>tags=28%, list=33%, signal=41%</td></tr><tr><td class='lessen'>782</td><td>BOYAULT_LIVER_CANCER_SUBCLASS_G56_UP</td><td></td><td>10</td><td>-0.36</td><td>-0.72</td><td>0.820</td><td>1.000</td><td>1.000</td><td>4287</td><td>tags=60%, list=33%, signal=90%</td></tr><tr><td class='lessen'>783</td><td>SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2</td><td></td><td>39</td><td>-0.29</td><td>-0.72</td><td>0.869</td><td>1.000</td><td>1.000</td><td>3477</td><td>tags=44%, list=27%, signal=59%</td></tr><tr><td class='lessen'>784</td><td>IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM</td><td></td><td>24</td><td>-0.31</td><td>-0.72</td><td>0.843</td><td>1.000</td><td>1.000</td><td>4842</td><td>tags=42%, list=37%, signal=66%</td></tr><tr><td class='lessen'>785</td><td>SCHUHMACHER_MYC_TARGETS_UP</td><td></td><td>70</td><td>-0.26</td><td>-0.72</td><td>0.904</td><td>1.000</td><td>1.000</td><td>4713</td><td>tags=44%, list=36%, signal=69%</td></tr><tr><td class='lessen'>786</td><td>CADWELL_ATG16L1_TARGETS_DN</td><td></td><td>54</td><td>-0.27</td><td>-0.72</td><td>0.897</td><td>1.000</td><td>1.000</td><td>3578</td><td>tags=33%, list=28%, signal=46%</td></tr><tr><td class='lessen'>787</td><td>VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP</td><td></td><td>14</td><td>-0.34</td><td>-0.72</td><td>0.826</td><td>1.000</td><td>1.000</td><td>4431</td><td>tags=43%, list=34%, signal=65%</td></tr><tr><td class='lessen'>788</td><td>HUANG_DASATINIB_RESISTANCE_DN</td><td></td><td>55</td><td>-0.27</td><td>-0.72</td><td>0.900</td><td>1.000</td><td>1.000</td><td>3704</td><td>tags=35%, list=29%, signal=48%</td></tr><tr><td class='lessen'>789</td><td>UEDA_PERIFERAL_CLOCK</td><td></td><td>138</td><td>-0.25</td><td>-0.71</td><td>0.946</td><td>1.000</td><td>1.000</td><td>4426</td><td>tags=41%, list=34%, signal=62%</td></tr><tr><td class='lessen'>790</td><td>JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP</td><td></td><td>91</td><td>-0.26</td><td>-0.71</td><td>0.909</td><td>1.000</td><td>1.000</td><td>2586</td><td>tags=18%, list=20%, signal=22%</td></tr><tr><td class='lessen'>791</td><td>CHEBOTAEV_GR_TARGETS_DN</td><td></td><td>100</td><td>-0.25</td><td>-0.71</td><td>0.914</td><td>1.000</td><td>1.000</td><td>2189</td><td>tags=22%, list=17%, signal=26%</td></tr><tr><td class='lessen'>792</td><td>MARTINEZ_RB1_AND_TP53_TARGETS_DN</td><td></td><td>473</td><td>-0.23</td><td>-0.71</td><td>0.988</td><td>1.000</td><td>1.000</td><td>3886</td><td>tags=27%, list=30%, signal=38%</td></tr><tr><td class='lessen'>793</td><td>BROWNE_HCMV_INFECTION_20HR_UP</td><td></td><td>193</td><td>-0.24</td><td>-0.71</td><td>0.958</td><td>1.000</td><td>1.000</td><td>2231</td><td>tags=13%, list=17%, signal=16%</td></tr><tr><td class='lessen'>794</td><td>MAHADEVAN_RESPONSE_TO_MP470_UP</td><td></td><td>13</td><td>-0.34</td><td>-0.71</td><td>0.841</td><td>1.000</td><td>1.000</td><td>1561</td><td>tags=23%, list=12%, signal=26%</td></tr><tr><td class='lessen'>795</td><td>MIKKELSEN_NPC_LCP_WITH_H3K4ME3</td><td></td><td>44</td><td>-0.28</td><td>-0.71</td><td>0.890</td><td>1.000</td><td>1.000</td><td>2276</td><td>tags=23%, list=18%, signal=27%</td></tr><tr><td class='lessen'>796</td><td>DOANE_RESPONSE_TO_ANDROGEN_UP</td><td></td><td>141</td><td>-0.25</td><td>-0.71</td><td>0.950</td><td>1.000</td><td>1.000</td><td>3091</td><td>tags=28%, list=24%, signal=36%</td></tr><tr><td class='lessen'>797</td><td>ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN</td><td></td><td>49</td><td>-0.27</td><td>-0.71</td><td>0.896</td><td>1.000</td><td>1.000</td><td>4779</td><td>tags=29%, list=37%, signal=45%</td></tr><tr><td class='lessen'>798</td><td>RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP</td><td></td><td>561</td><td>-0.23</td><td>-0.71</td><td>0.991</td><td>1.000</td><td>1.000</td><td>2921</td><td>tags=18%, list=23%, signal=22%</td></tr><tr><td class='lessen'>799</td><td>AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53</td><td></td><td>87</td><td>-0.25</td><td>-0.71</td><td>0.924</td><td>1.000</td><td>1.000</td><td>2390</td><td>tags=20%, list=18%, signal=24%</td></tr><tr><td class='lessen'>800</td><td>MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP</td><td></td><td>176</td><td>-0.24</td><td>-0.71</td><td>0.960</td><td>1.000</td><td>1.000</td><td>1331</td><td>tags=9%, list=10%, signal=10%</td></tr><tr><td class='lessen'>801</td><td>MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN</td><td></td><td>130</td><td>-0.24</td><td>-0.71</td><td>0.946</td><td>1.000</td><td>1.000</td><td>2209</td><td>tags=19%, list=17%, signal=23%</td></tr><tr><td class='lessen'>802</td><td>SANSOM_APC_TARGETS</td><td></td><td>157</td><td>-0.24</td><td>-0.71</td><td>0.965</td><td>1.000</td><td>1.000</td><td>3660</td><td>tags=31%, list=28%, signal=42%</td></tr><tr><td class='lessen'>803</td><td>TIEN_INTESTINE_PROBIOTICS_24HR_DN</td><td></td><td>183</td><td>-0.24</td><td>-0.71</td><td>0.967</td><td>1.000</td><td>1.000</td><td>4967</td><td>tags=42%, list=38%, signal=66%</td></tr><tr><td class='lessen'>804</td><td>WIERENGA_PML_INTERACTOME</td><td></td><td>36</td><td>-0.28</td><td>-0.70</td><td>0.874</td><td>1.000</td><td>1.000</td><td>1363</td><td>tags=8%, list=11%, signal=9%</td></tr><tr><td class='lessen'>805</td><td>NIKOLSKY_BREAST_CANCER_6P24_P22_AMPLICON</td><td></td><td>17</td><td>-0.32</td><td>-0.70</td><td>0.853</td><td>1.000</td><td>1.000</td><td>2729</td><td>tags=35%, list=21%, signal=45%</td></tr><tr><td class='lessen'>806</td><td>SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER</td><td></td><td>34</td><td>-0.28</td><td>-0.70</td><td>0.886</td><td>1.000</td><td>1.000</td><td>2784</td><td>tags=32%, list=22%, signal=41%</td></tr><tr><td class='lessen'>807</td><td>TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN</td><td></td><td>150</td><td>-0.24</td><td>-0.70</td><td>0.962</td><td>1.000</td><td>1.000</td><td>3566</td><td>tags=35%, list=28%, signal=48%</td></tr><tr><td class='lessen'>808</td><td>FURUKAWA_DUSP6_TARGETS_PCI35_UP</td><td></td><td>51</td><td>-0.27</td><td>-0.70</td><td>0.914</td><td>1.000</td><td>1.000</td><td>2519</td><td>tags=22%, list=19%, signal=27%</td></tr><tr><td class='lessen'>809</td><td>CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN</td><td></td><td>274</td><td>-0.23</td><td>-0.70</td><td>0.986</td><td>1.000</td><td>1.000</td><td>4145</td><td>tags=37%, list=32%, signal=54%</td></tr><tr><td class='lessen'>810</td><td>DURCHDEWALD_SKIN_CARCINOGENESIS_UP</td><td></td><td>68</td><td>-0.25</td><td>-0.70</td><td>0.923</td><td>1.000</td><td>1.000</td><td>1519</td><td>tags=12%, list=12%, signal=13%</td></tr><tr><td class='lessen'>811</td><td>MIKKELSEN_NPC_ICP_WITH_H3K4ME3</td><td></td><td>344</td><td>-0.23</td><td>-0.70</td><td>0.982</td><td>1.000</td><td>1.000</td><td>2999</td><td>tags=22%, list=23%, signal=28%</td></tr><tr><td class='lessen'>812</td><td>NAGASHIMA_NRG1_SIGNALING_DN</td><td></td><td>41</td><td>-0.28</td><td>-0.70</td><td>0.891</td><td>1.000</td><td>1.000</td><td>2885</td><td>tags=29%, list=22%, signal=38%</td></tr><tr><td class='lessen'>813</td><td>LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_UP</td><td></td><td>12</td><td>-0.35</td><td>-0.70</td><td>0.841</td><td>1.000</td><td>1.000</td><td>4330</td><td>tags=58%, list=33%, signal=88%</td></tr><tr><td class='lessen'>814</td><td>GEORGES_TARGETS_OF_MIR192_AND_MIR215</td><td></td><td>679</td><td>-0.23</td><td>-0.70</td><td>0.999</td><td>1.000</td><td>1.000</td><td>2609</td><td>tags=17%, list=20%, signal=21%</td></tr><tr><td class='lessen'>815</td><td>RATTENBACHER_BOUND_BY_CELF1</td><td></td><td>313</td><td>-0.23</td><td>-0.70</td><td>0.985</td><td>1.000</td><td>1.000</td><td>2585</td><td>tags=16%, list=20%, signal=19%</td></tr><tr><td class='lessen'>816</td><td>PEART_HDAC_PROLIFERATION_CLUSTER_UP</td><td></td><td>54</td><td>-0.27</td><td>-0.70</td><td>0.913</td><td>1.000</td><td>1.000</td><td>1780</td><td>tags=13%, list=14%, signal=15%</td></tr><tr><td class='lessen'>817</td><td>LEIN_LOCALIZED_TO_PROXIMAL_DENDRITES</td><td></td><td>33</td><td>-0.28</td><td>-0.70</td><td>0.875</td><td>1.000</td><td>1.000</td><td>2978</td><td>tags=36%, list=23%, signal=47%</td></tr><tr><td class='lessen'>818</td><td>RIZ_ERYTHROID_DIFFERENTIATION_HEMGN</td><td></td><td>28</td><td>-0.29</td><td>-0.70</td><td>0.851</td><td>1.000</td><td>1.000</td><td>1203</td><td>tags=18%, list=9%, signal=20%</td></tr><tr><td class='lessen'>819</td><td>THILLAINADESAN_ZNF217_TARGETS_UP</td><td></td><td>34</td><td>-0.28</td><td>-0.70</td><td>0.879</td><td>1.000</td><td>1.000</td><td>4600</td><td>tags=50%, list=36%, signal=77%</td></tr><tr><td class='lessen'>820</td><td>BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS</td><td></td><td>759</td><td>-0.23</td><td>-0.70</td><td>1.000</td><td>1.000</td><td>1.000</td><td>2396</td><td>tags=15%, list=19%, signal=17%</td></tr><tr><td class='lessen'>821</td><td>HELLER_HDAC_TARGETS_UP</td><td></td><td>252</td><td>-0.23</td><td>-0.70</td><td>0.990</td><td>1.000</td><td>1.000</td><td>2800</td><td>tags=21%, list=22%, signal=26%</td></tr><tr><td class='lessen'>822</td><td>DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP</td><td></td><td>26</td><td>-0.29</td><td>-0.70</td><td>0.871</td><td>1.000</td><td>1.000</td><td>2494</td><td>tags=31%, list=19%, signal=38%</td></tr><tr><td class='lessen'>823</td><td>WANG_RESPONSE_TO_ANDROGEN_UP</td><td></td><td>24</td><td>-0.30</td><td>-0.69</td><td>0.864</td><td>1.000</td><td>1.000</td><td>4741</td><td>tags=46%, list=37%, signal=72%</td></tr><tr><td class='lessen'>824</td><td>LEE_BMP2_TARGETS_DN</td><td></td><td>714</td><td>-0.22</td><td>-0.69</td><td>1.000</td><td>1.000</td><td>1.000</td><td>3507</td><td>tags=22%, list=27%, signal=29%</td></tr><tr><td class='lessen'>825</td><td>RASHI_RESPONSE_TO_IONIZING_RADIATION_5</td><td></td><td>126</td><td>-0.24</td><td>-0.69</td><td>0.961</td><td>1.000</td><td>1.000</td><td>2765</td><td>tags=20%, list=21%, signal=25%</td></tr><tr><td class='lessen'>826</td><td>KIM_PTEN_TARGETS_UP</td><td></td><td>15</td><td>-0.32</td><td>-0.69</td><td>0.850</td><td>1.000</td><td>1.000</td><td>2407</td><td>tags=27%, list=19%, signal=33%</td></tr><tr><td class='lessen'>827</td><td>DAZARD_UV_RESPONSE_CLUSTER_G6</td><td></td><td>118</td><td>-0.24</td><td>-0.69</td><td>0.955</td><td>1.000</td><td>1.000</td><td>4720</td><td>tags=32%, list=36%, signal=50%</td></tr><tr><td class='lessen'>828</td><td>MCCLUNG_DELTA_FOSB_TARGETS_2WK</td><td></td><td>39</td><td>-0.27</td><td>-0.69</td><td>0.890</td><td>1.000</td><td>1.000</td><td>3093</td><td>tags=33%, list=24%, signal=44%</td></tr><tr><td class='lessen'>829</td><td>YAGI_AML_WITH_INV_16_TRANSLOCATION</td><td></td><td>355</td><td>-0.23</td><td>-0.69</td><td>0.990</td><td>1.000</td><td>1.000</td><td>1945</td><td>tags=12%, list=15%, signal=13%</td></tr><tr><td class='lessen'>830</td><td>SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN</td><td></td><td>69</td><td>-0.26</td><td>-0.69</td><td>0.920</td><td>1.000</td><td>1.000</td><td>2782</td><td>tags=17%, list=22%, signal=22%</td></tr><tr><td class='lessen'>831</td><td>GU_PDEF_TARGETS_DN</td><td></td><td>28</td><td>-0.28</td><td>-0.69</td><td>0.887</td><td>1.000</td><td>1.000</td><td>3250</td><td>tags=46%, list=25%, signal=62%</td></tr><tr><td class='lessen'>832</td><td>HOEGERKORP_CD44_TARGETS_TEMPORAL_UP</td><td></td><td>10</td><td>-0.35</td><td>-0.69</td><td>0.840</td><td>1.000</td><td>1.000</td><td>3879</td><td>tags=40%, list=30%, signal=57%</td></tr><tr><td class='lessen'>833</td><td>DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP</td><td></td><td>265</td><td>-0.23</td><td>-0.69</td><td>0.990</td><td>1.000</td><td>1.000</td><td>3210</td><td>tags=24%, list=25%, signal=31%</td></tr><tr><td class='lessen'>834</td><td>GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP</td><td></td><td>28</td><td>-0.29</td><td>-0.69</td><td>0.877</td><td>1.000</td><td>1.000</td><td>1873</td><td>tags=14%, list=14%, signal=17%</td></tr><tr><td class='lessen'>835</td><td>ZWANG_DOWN_BY_2ND_EGF_PULSE</td><td></td><td>117</td><td>-0.24</td><td>-0.69</td><td>0.961</td><td>1.000</td><td>1.000</td><td>1869</td><td>tags=15%, list=14%, signal=18%</td></tr><tr><td class='lessen'>836</td><td>PUJANA_BRCA1_PCC_NETWORK</td><td></td><td>1365</td><td>-0.22</td><td>-0.69</td><td>1.000</td><td>1.000</td><td>1.000</td><td>3285</td><td>tags=17%, list=25%, signal=21%</td></tr><tr><td class='lessen'>837</td><td>LEIN_CHOROID_PLEXUS_MARKERS</td><td></td><td>86</td><td>-0.25</td><td>-0.69</td><td>0.944</td><td>1.000</td><td>1.000</td><td>3596</td><td>tags=36%, list=28%, signal=50%</td></tr><tr><td class='lessen'>838</td><td>RAO_BOUND_BY_SALL4_ISOFORM_A</td><td></td><td>132</td><td>-0.23</td><td>-0.68</td><td>0.964</td><td>1.000</td><td>1.000</td><td>1188</td><td>tags=8%, list=9%, signal=9%</td></tr><tr><td class='lessen'>839</td><td>RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP</td><td></td><td>22</td><td>-0.30</td><td>-0.68</td><td>0.877</td><td>1.000</td><td>1.000</td><td>1404</td><td>tags=9%, list=11%, signal=10%</td></tr><tr><td class='lessen'>840</td><td>BURTON_ADIPOGENESIS_12</td><td></td><td>21</td><td>-0.30</td><td>-0.68</td><td>0.885</td><td>1.000</td><td>1.000</td><td>664</td><td>tags=5%, list=5%, signal=5%</td></tr><tr><td class='lessen'>841</td><td>GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN</td><td></td><td>18</td><td>-0.31</td><td>-0.68</td><td>0.863</td><td>1.000</td><td>1.000</td><td>2997</td><td>tags=33%, list=23%, signal=43%</td></tr><tr><td class='lessen'>842</td><td>PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1</td><td></td><td>39</td><td>-0.27</td><td>-0.68</td><td>0.904</td><td>1.000</td><td>1.000</td><td>4183</td><td>tags=46%, list=32%, signal=68%</td></tr><tr><td class='lessen'>843</td><td>ELLWOOD_MYC_TARGETS_DN</td><td></td><td>29</td><td>-0.28</td><td>-0.68</td><td>0.901</td><td>1.000</td><td>1.000</td><td>4724</td><td>tags=45%, list=37%, signal=70%</td></tr><tr><td class='lessen'>844</td><td>RIZKI_TUMOR_INVASIVENESS_2D_DN</td><td></td><td>59</td><td>-0.25</td><td>-0.68</td><td>0.936</td><td>1.000</td><td>1.000</td><td>4291</td><td>tags=36%, list=33%, signal=53%</td></tr><tr><td class='lessen'>845</td><td>ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN</td><td></td><td>199</td><td>-0.23</td><td>-0.68</td><td>0.983</td><td>1.000</td><td>1.000</td><td>1384</td><td>tags=10%, list=11%, signal=11%</td></tr><tr><td class='lessen'>846</td><td>DORSAM_HOXA9_TARGETS_UP</td><td></td><td>32</td><td>-0.27</td><td>-0.68</td><td>0.907</td><td>1.000</td><td>1.000</td><td>3347</td><td>tags=28%, list=26%, signal=38%</td></tr><tr><td class='lessen'>847</td><td>PETROVA_PROX1_TARGETS_UP</td><td></td><td>24</td><td>-0.29</td><td>-0.68</td><td>0.895</td><td>1.000</td><td>1.000</td><td>2976</td><td>tags=33%, list=23%, signal=43%</td></tr><tr><td class='lessen'>848</td><td>MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP</td><td></td><td>18</td><td>-0.30</td><td>-0.68</td><td>0.871</td><td>1.000</td><td>1.000</td><td>3630</td><td>tags=44%, list=28%, signal=62%</td></tr><tr><td class='lessen'>849</td><td>GOZGIT_ESR1_TARGETS_DN</td><td></td><td>569</td><td>-0.22</td><td>-0.68</td><td>1.000</td><td>1.000</td><td>1.000</td><td>3171</td><td>tags=25%, list=25%, signal=31%</td></tr><tr><td class='lessen'>850</td><td>CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN</td><td></td><td>550</td><td>-0.22</td><td>-0.68</td><td>0.998</td><td>1.000</td><td>1.000</td><td>3503</td><td>tags=25%, list=27%, signal=32%</td></tr><tr><td class='lessen'>851</td><td>ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN</td><td></td><td>38</td><td>-0.27</td><td>-0.68</td><td>0.916</td><td>1.000</td><td>1.000</td><td>3068</td><td>tags=26%, list=24%, signal=34%</td></tr><tr><td class='lessen'>852</td><td>JOHNSTONE_PARVB_TARGETS_3_DN</td><td></td><td>692</td><td>-0.22</td><td>-0.67</td><td>1.000</td><td>1.000</td><td>1.000</td><td>3487</td><td>tags=20%, list=27%, signal=26%</td></tr><tr><td class='lessen'>853</td><td>SPIRA_SMOKERS_LUNG_CANCER_UP</td><td></td><td>31</td><td>-0.28</td><td>-0.67</td><td>0.894</td><td>1.000</td><td>1.000</td><td>2849</td><td>tags=23%, list=22%, signal=29%</td></tr><tr><td class='lessen'>854</td><td>MARTINEZ_TP53_TARGETS_DN</td><td></td><td>474</td><td>-0.22</td><td>-0.67</td><td>0.997</td><td>1.000</td><td>1.000</td><td>3849</td><td>tags=28%, list=30%, signal=38%</td></tr><tr><td class='lessen'>855</td><td>IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP</td><td></td><td>24</td><td>-0.29</td><td>-0.67</td><td>0.880</td><td>1.000</td><td>1.000</td><td>3605</td><td>tags=38%, list=28%, signal=52%</td></tr><tr><td class='lessen'>856</td><td>JIANG_HYPOXIA_CANCER</td><td></td><td>68</td><td>-0.25</td><td>-0.67</td><td>0.943</td><td>1.000</td><td>1.000</td><td>3090</td><td>tags=21%, list=24%, signal=27%</td></tr><tr><td class='lessen'>857</td><td>NUTT_GBM_VS_AO_GLIOMA_DN</td><td></td><td>37</td><td>-0.27</td><td>-0.67</td><td>0.920</td><td>1.000</td><td>1.000</td><td>2320</td><td>tags=19%, list=18%, signal=23%</td></tr><tr><td class='lessen'>858</td><td>NIELSEN_SCHWANNOMA_DN</td><td></td><td>14</td><td>-0.31</td><td>-0.67</td><td>0.884</td><td>1.000</td><td>1.000</td><td>3199</td><td>tags=36%, list=25%, signal=47%</td></tr><tr><td class='lessen'>859</td><td>MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP</td><td></td><td>222</td><td>-0.22</td><td>-0.67</td><td>0.990</td><td>1.000</td><td>1.000</td><td>1998</td><td>tags=14%, list=15%, signal=17%</td></tr><tr><td class='lessen'>860</td><td>BERENJENO_TRANSFORMED_BY_RHOA_UP</td><td></td><td>456</td><td>-0.22</td><td>-0.67</td><td>0.997</td><td>1.000</td><td>1.000</td><td>3263</td><td>tags=23%, list=25%, signal=30%</td></tr><tr><td class='lessen'>861</td><td>RIZKI_TUMOR_INVASIVENESS_3D_DN</td><td></td><td>225</td><td>-0.22</td><td>-0.67</td><td>0.993</td><td>1.000</td><td>1.000</td><td>1709</td><td>tags=10%, list=13%, signal=11%</td></tr><tr><td class='lessen'>862</td><td>BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS</td><td></td><td>46</td><td>-0.25</td><td>-0.66</td><td>0.933</td><td>1.000</td><td>1.000</td><td>202</td><td>tags=2%, list=2%, signal=2%</td></tr><tr><td class='lessen'>863</td><td>ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN</td><td></td><td>281</td><td>-0.22</td><td>-0.66</td><td>0.992</td><td>1.000</td><td>1.000</td><td>4647</td><td>tags=36%, list=36%, signal=54%</td></tr><tr><td class='lessen'>864</td><td>WONG_PROTEASOME_GENE_MODULE</td><td></td><td>44</td><td>-0.25</td><td>-0.66</td><td>0.940</td><td>1.000</td><td>1.000</td><td>4772</td><td>tags=32%, list=37%, signal=50%</td></tr><tr><td class='lessen'>865</td><td>BENPORATH_NOS_TARGETS</td><td></td><td>145</td><td>-0.22</td><td>-0.66</td><td>0.989</td><td>1.000</td><td>1.000</td><td>1928</td><td>tags=12%, list=15%, signal=14%</td></tr><tr><td class='lessen'>866</td><td>KALMA_E2F1_TARGETS</td><td></td><td>11</td><td>-0.33</td><td>-0.66</td><td>0.887</td><td>1.000</td><td>1.000</td><td>2584</td><td>tags=18%, list=20%, signal=23%</td></tr><tr><td class='lessen'>867</td><td>WENG_POR_DOSAGE</td><td></td><td>16</td><td>-0.30</td><td>-0.66</td><td>0.897</td><td>1.000</td><td>1.000</td><td>1122</td><td>tags=19%, list=9%, signal=21%</td></tr><tr><td class='lessen'>868</td><td>TOMLINS_METASTASIS_DN</td><td></td><td>18</td><td>-0.29</td><td>-0.66</td><td>0.904</td><td>1.000</td><td>1.000</td><td>1341</td><td>tags=11%, list=10%, signal=12%</td></tr><tr><td class='lessen'>869</td><td>LEI_HOXC8_TARGETS_DN</td><td></td><td>17</td><td>-0.30</td><td>-0.66</td><td>0.892</td><td>1.000</td><td>1.000</td><td>3179</td><td>tags=47%, list=25%, signal=62%</td></tr><tr><td class='lessen'>870</td><td>GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP</td><td></td><td>20</td><td>-0.29</td><td>-0.66</td><td>0.896</td><td>1.000</td><td>1.000</td><td>3522</td><td>tags=30%, list=27%, signal=41%</td></tr><tr><td class='lessen'>871</td><td>SESTO_RESPONSE_TO_UV_C3</td><td></td><td>19</td><td>-0.29</td><td>-0.66</td><td>0.910</td><td>1.000</td><td>1.000</td><td>3493</td><td>tags=32%, list=27%, signal=43%</td></tr><tr><td class='lessen'>872</td><td>MEISSNER_ES_ICP_WITH_H3K4ME3</td><td></td><td>22</td><td>-0.28</td><td>-0.66</td><td>0.916</td><td>1.000</td><td>1.000</td><td>2312</td><td>tags=23%, list=18%, signal=28%</td></tr><tr><td class='lessen'>873</td><td>ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_UP</td><td></td><td>241</td><td>-0.22</td><td>-0.65</td><td>0.993</td><td>1.000</td><td>1.000</td><td>3270</td><td>tags=27%, list=25%, signal=35%</td></tr><tr><td class='lessen'>874</td><td>HILLION_HMGA1_TARGETS</td><td></td><td>86</td><td>-0.24</td><td>-0.65</td><td>0.963</td><td>1.000</td><td>1.000</td><td>1921</td><td>tags=12%, list=15%, signal=14%</td></tr><tr><td class='lessen'>875</td><td>SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12</td><td></td><td>223</td><td>-0.22</td><td>-0.65</td><td>0.995</td><td>1.000</td><td>1.000</td><td>2786</td><td>tags=22%, list=22%, signal=28%</td></tr><tr><td class='lessen'>876</td><td>ZHAN_V2_LATE_DIFFERENTIATION_GENES</td><td></td><td>40</td><td>-0.26</td><td>-0.65</td><td>0.938</td><td>1.000</td><td>1.000</td><td>2305</td><td>tags=18%, list=18%, signal=21%</td></tr><tr><td class='lessen'>877</td><td>WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP</td><td></td><td>23</td><td>-0.28</td><td>-0.65</td><td>0.922</td><td>1.000</td><td>1.000</td><td>2388</td><td>tags=35%, list=18%, signal=43%</td></tr><tr><td class='lessen'>878</td><td>FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN</td><td></td><td>19</td><td>-0.30</td><td>-0.65</td><td>0.899</td><td>1.000</td><td>1.000</td><td>1624</td><td>tags=16%, list=13%, signal=18%</td></tr><tr><td class='lessen'>879</td><td>VALK_AML_CLUSTER_1</td><td></td><td>25</td><td>-0.28</td><td>-0.65</td><td>0.919</td><td>1.000</td><td>1.000</td><td>1444</td><td>tags=16%, list=11%, signal=18%</td></tr><tr><td class='lessen'>880</td><td>AIYAR_COBRA1_TARGETS_DN</td><td></td><td>20</td><td>-0.29</td><td>-0.65</td><td>0.908</td><td>1.000</td><td>1.000</td><td>2334</td><td>tags=20%, list=18%, signal=24%</td></tr><tr><td class='lessen'>881</td><td>BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP</td><td></td><td>34</td><td>-0.26</td><td>-0.65</td><td>0.945</td><td>1.000</td><td>1.000</td><td>1299</td><td>tags=12%, list=10%, signal=13%</td></tr><tr><td class='lessen'>882</td><td>MURAKAMI_UV_RESPONSE_24HR</td><td></td><td>18</td><td>-0.29</td><td>-0.65</td><td>0.912</td><td>1.000</td><td>1.000</td><td>2697</td><td>tags=33%, list=21%, signal=42%</td></tr><tr><td class='lessen'>883</td><td>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_17</td><td></td><td>16</td><td>-0.29</td><td>-0.65</td><td>0.902</td><td>1.000</td><td>1.000</td><td>1274</td><td>tags=13%, list=10%, signal=14%</td></tr><tr><td class='lessen'>884</td><td>GRUETZMANN_PANCREATIC_CANCER_DN</td><td></td><td>175</td><td>-0.22</td><td>-0.65</td><td>0.986</td><td>1.000</td><td>1.000</td><td>1377</td><td>tags=9%, list=11%, signal=10%</td></tr><tr><td class='lessen'>885</td><td>HALMOS_CEBPA_TARGETS_UP</td><td></td><td>42</td><td>-0.25</td><td>-0.65</td><td>0.943</td><td>1.000</td><td>1.000</td><td>2365</td><td>tags=19%, list=18%, signal=23%</td></tr><tr><td class='lessen'>886</td><td>BILANGES_SERUM_SENSITIVE_VIA_TSC2</td><td></td><td>32</td><td>-0.26</td><td>-0.65</td><td>0.924</td><td>1.000</td><td>1.000</td><td>554</td><td>tags=6%, list=4%, signal=7%</td></tr><tr><td class='lessen'>887</td><td>TONG_INTERACT_WITH_PTTG1</td><td></td><td>39</td><td>-0.26</td><td>-0.65</td><td>0.933</td><td>1.000</td><td>1.000</td><td>1304</td><td>tags=8%, list=10%, signal=9%</td></tr><tr><td class='lessen'>888</td><td>LUI_THYROID_CANCER_CLUSTER_3</td><td></td><td>23</td><td>-0.28</td><td>-0.65</td><td>0.907</td><td>1.000</td><td>1.000</td><td>6398</td><td>tags=74%, list=49%, signal=146%</td></tr><tr><td class='lessen'>889</td><td>SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5</td><td></td><td>45</td><td>-0.25</td><td>-0.65</td><td>0.953</td><td>1.000</td><td>1.000</td><td>3626</td><td>tags=36%, list=28%, signal=49%</td></tr><tr><td class='lessen'>890</td><td>ROSS_AML_OF_FAB_M7_TYPE</td><td></td><td>65</td><td>-0.24</td><td>-0.65</td><td>0.961</td><td>1.000</td><td>1.000</td><td>2927</td><td>tags=25%, list=23%, signal=32%</td></tr><tr><td class='lessen'>891</td><td>VARELA_ZMPSTE24_TARGETS_DN</td><td></td><td>31</td><td>-0.26</td><td>-0.65</td><td>0.928</td><td>1.000</td><td>1.000</td><td>3022</td><td>tags=39%, list=23%, signal=50%</td></tr><tr><td class='lessen'>892</td><td>DE_YY1_TARGETS_DN</td><td></td><td>85</td><td>-0.23</td><td>-0.65</td><td>0.965</td><td>1.000</td><td>1.000</td><td>634</td><td>tags=2%, list=5%, signal=2%</td></tr><tr><td class='lessen'>893</td><td>DING_LUNG_CANCER_BY_MUTATION_RATE</td><td></td><td>19</td><td>-0.29</td><td>-0.65</td><td>0.898</td><td>1.000</td><td>1.000</td><td>2432</td><td>tags=26%, list=19%, signal=32%</td></tr><tr><td class='lessen'>894</td><td>ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN</td><td></td><td>35</td><td>-0.26</td><td>-0.65</td><td>0.949</td><td>1.000</td><td>1.000</td><td>1234</td><td>tags=9%, list=10%, signal=9%</td></tr><tr><td class='lessen'>895</td><td>LEE_LIVER_CANCER_MYC_UP</td><td></td><td>52</td><td>-0.24</td><td>-0.64</td><td>0.961</td><td>1.000</td><td>1.000</td><td>1554</td><td>tags=13%, list=12%, signal=15%</td></tr><tr><td class='lessen'>896</td><td>WANG_LMO4_TARGETS_DN</td><td></td><td>265</td><td>-0.21</td><td>-0.64</td><td>0.997</td><td>1.000</td><td>1.000</td><td>3199</td><td>tags=14%, list=25%, signal=19%</td></tr><tr><td class='lessen'>897</td><td>MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN</td><td></td><td>63</td><td>-0.24</td><td>-0.64</td><td>0.965</td><td>1.000</td><td>1.000</td><td>3596</td><td>tags=33%, list=28%, signal=46%</td></tr><tr><td class='lessen'>898</td><td>MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN</td><td></td><td>221</td><td>-0.21</td><td>-0.64</td><td>0.997</td><td>1.000</td><td>1.000</td><td>5114</td><td>tags=32%, list=40%, signal=51%</td></tr><tr><td class='lessen'>899</td><td>LIAO_METASTASIS</td><td></td><td>425</td><td>-0.21</td><td>-0.64</td><td>1.000</td><td>1.000</td><td>1.000</td><td>3507</td><td>tags=25%, list=27%, signal=33%</td></tr><tr><td class='lessen'>900</td><td>HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN</td><td></td><td>66</td><td>-0.23</td><td>-0.64</td><td>0.962</td><td>1.000</td><td>1.000</td><td>1165</td><td>tags=8%, list=9%, signal=8%</td></tr><tr><td class='lessen'>901</td><td>CUI_TCF21_TARGETS_2_UP</td><td></td><td>351</td><td>-0.21</td><td>-0.64</td><td>0.999</td><td>1.000</td><td>1.000</td><td>2839</td><td>tags=23%, list=22%, signal=28%</td></tr><tr><td class='lessen'>902</td><td>KIM_ALL_DISORDERS_DURATION_CORR_DN</td><td></td><td>125</td><td>-0.22</td><td>-0.63</td><td>0.988</td><td>1.000</td><td>1.000</td><td>5272</td><td>tags=35%, list=41%, signal=59%</td></tr><tr><td class='lessen'>903</td><td>IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP</td><td></td><td>13</td><td>-0.30</td><td>-0.63</td><td>0.899</td><td>1.000</td><td>1.000</td><td>3360</td><td>tags=31%, list=26%, signal=42%</td></tr><tr><td class='lessen'>904</td><td>WANG_LMO4_TARGETS_UP</td><td></td><td>271</td><td>-0.21</td><td>-0.63</td><td>0.999</td><td>1.000</td><td>1.000</td><td>3355</td><td>tags=19%, list=26%, signal=25%</td></tr><tr><td class='lessen'>905</td><td>NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_DN</td><td></td><td>15</td><td>-0.29</td><td>-0.63</td><td>0.910</td><td>1.000</td><td>1.000</td><td>3125</td><td>tags=27%, list=24%, signal=35%</td></tr><tr><td class='lessen'>906</td><td>RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN</td><td></td><td>322</td><td>-0.21</td><td>-0.63</td><td>0.998</td><td>1.000</td><td>1.000</td><td>2943</td><td>tags=17%, list=23%, signal=22%</td></tr><tr><td class='lessen'>907</td><td>LINDGREN_BLADDER_CANCER_CLUSTER_1_UP</td><td></td><td>91</td><td>-0.23</td><td>-0.63</td><td>0.974</td><td>1.000</td><td>1.000</td><td>2288</td><td>tags=12%, list=18%, signal=15%</td></tr><tr><td class='lessen'>908</td><td>MAYBURD_RESPONSE_TO_L663536_UP</td><td></td><td>23</td><td>-0.28</td><td>-0.63</td><td>0.929</td><td>1.000</td><td>1.000</td><td>4829</td><td>tags=43%, list=37%, signal=69%</td></tr><tr><td class='lessen'>909</td><td>VIETOR_IFRD1_TARGETS</td><td></td><td>20</td><td>-0.28</td><td>-0.63</td><td>0.911</td><td>1.000</td><td>1.000</td><td>1921</td><td>tags=20%, list=15%, signal=23%</td></tr><tr><td class='lessen'>910</td><td>PEREZ_TP53_TARGETS</td><td></td><td>800</td><td>-0.20</td><td>-0.63</td><td>1.000</td><td>1.000</td><td>1.000</td><td>3240</td><td>tags=25%, list=25%, signal=31%</td></tr><tr><td class='lessen'>911</td><td>LEIN_NEURON_MARKERS</td><td></td><td>60</td><td>-0.23</td><td>-0.63</td><td>0.969</td><td>1.000</td><td>1.000</td><td>4566</td><td>tags=53%, list=35%, signal=82%</td></tr><tr><td class='lessen'>912</td><td>BERNARD_PPAPDC1B_TARGETS_DN</td><td></td><td>45</td><td>-0.24</td><td>-0.63</td><td>0.966</td><td>1.000</td><td>1.000</td><td>43</td><td>tags=2%, list=0%, signal=2%</td></tr><tr><td class='lessen'>913</td><td>TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP</td><td></td><td>56</td><td>-0.24</td><td>-0.63</td><td>0.974</td><td>1.000</td><td>1.000</td><td>2585</td><td>tags=23%, list=20%, signal=29%</td></tr><tr><td class='lessen'>914</td><td>WALLACE_PROSTATE_CANCER_RACE_DN</td><td></td><td>55</td><td>-0.24</td><td>-0.63</td><td>0.954</td><td>1.000</td><td>1.000</td><td>3746</td><td>tags=35%, list=29%, signal=48%</td></tr><tr><td class='lessen'>915</td><td>PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN</td><td></td><td>126</td><td>-0.22</td><td>-0.63</td><td>0.985</td><td>1.000</td><td>1.000</td><td>3300</td><td>tags=25%, list=26%, signal=33%</td></tr><tr><td class='lessen'>916</td><td>TIEN_INTESTINE_PROBIOTICS_2HR_UP</td><td></td><td>24</td><td>-0.27</td><td>-0.63</td><td>0.934</td><td>1.000</td><td>1.000</td><td>1621</td><td>tags=8%, list=13%, signal=10%</td></tr><tr><td class='lessen'>917</td><td>STARK_HYPPOCAMPUS_22Q11_DELETION_UP</td><td></td><td>43</td><td>-0.24</td><td>-0.63</td><td>0.952</td><td>1.000</td><td>1.000</td><td>3576</td><td>tags=26%, list=28%, signal=35%</td></tr><tr><td class='lessen'>918</td><td>GARY_CD5_TARGETS_DN</td><td></td><td>348</td><td>-0.21</td><td>-0.63</td><td>0.998</td><td>1.000</td><td>1.000</td><td>4500</td><td>tags=27%, list=35%, signal=40%</td></tr><tr><td class='lessen'>919</td><td>MARTIN_INTERACT_WITH_HDAC</td><td></td><td>41</td><td>-0.24</td><td>-0.63</td><td>0.962</td><td>1.000</td><td>1.000</td><td>1525</td><td>tags=7%, list=12%, signal=8%</td></tr><tr><td class='lessen'>920</td><td>BENPORATH_OCT4_TARGETS</td><td></td><td>242</td><td>-0.21</td><td>-0.63</td><td>0.996</td><td>1.000</td><td>1.000</td><td>2032</td><td>tags=12%, list=16%, signal=14%</td></tr><tr><td class='lessen'>921</td><td>MULLIGHAN_NPM1_SIGNATURE_3_UP</td><td></td><td>278</td><td>-0.21</td><td>-0.63</td><td>1.000</td><td>1.000</td><td>1.000</td><td>3340</td><td>tags=23%, list=26%, signal=30%</td></tr><tr><td class='lessen'>922</td><td>MOOTHA_HUMAN_MITODB_6_2002</td><td></td><td>392</td><td>-0.20</td><td>-0.62</td><td>0.999</td><td>1.000</td><td>1.000</td><td>2483</td><td>tags=11%, list=19%, signal=13%</td></tr><tr><td class='lessen'>923</td><td>CASTELLANO_NRAS_TARGETS_DN</td><td></td><td>14</td><td>-0.30</td><td>-0.62</td><td>0.916</td><td>1.000</td><td>1.000</td><td>2241</td><td>tags=29%, list=17%, signal=35%</td></tr><tr><td class='lessen'>924</td><td>SESTO_RESPONSE_TO_UV_C7</td><td></td><td>59</td><td>-0.23</td><td>-0.62</td><td>0.965</td><td>1.000</td><td>1.000</td><td>1228</td><td>tags=8%, list=9%, signal=9%</td></tr><tr><td class='lessen'>925</td><td>NEBEN_AML_WITH_FLT3_OR_NRAS_DN</td><td></td><td>11</td><td>-0.31</td><td>-0.62</td><td>0.900</td><td>1.000</td><td>1.000</td><td>2782</td><td>tags=36%, list=22%, signal=46%</td></tr><tr><td class='lessen'>926</td><td>TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_UP</td><td></td><td>11</td><td>-0.31</td><td>-0.62</td><td>0.912</td><td>1.000</td><td>1.000</td><td>2053</td><td>tags=27%, list=16%, signal=32%</td></tr><tr><td class='lessen'>927</td><td>GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP</td><td></td><td>42</td><td>-0.24</td><td>-0.62</td><td>0.958</td><td>1.000</td><td>1.000</td><td>2645</td><td>tags=19%, list=20%, signal=24%</td></tr><tr><td class='lessen'>928</td><td>LUI_THYROID_CANCER_CLUSTER_2</td><td></td><td>33</td><td>-0.25</td><td>-0.62</td><td>0.950</td><td>1.000</td><td>1.000</td><td>3284</td><td>tags=36%, list=25%, signal=49%</td></tr><tr><td class='lessen'>929</td><td>MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_7</td><td></td><td>11</td><td>-0.30</td><td>-0.62</td><td>0.902</td><td>1.000</td><td>1.000</td><td>2276</td><td>tags=18%, list=18%, signal=22%</td></tr><tr><td class='lessen'>930</td><td>MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP</td><td></td><td>21</td><td>-0.27</td><td>-0.62</td><td>0.936</td><td>1.000</td><td>1.000</td><td>4357</td><td>tags=29%, list=34%, signal=43%</td></tr><tr><td class='lessen'>931</td><td>MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN</td><td></td><td>26</td><td>-0.26</td><td>-0.62</td><td>0.930</td><td>1.000</td><td>1.000</td><td>3140</td><td>tags=31%, list=24%, signal=41%</td></tr><tr><td class='lessen'>932</td><td>THUM_SYSTOLIC_HEART_FAILURE_DN</td><td></td><td>176</td><td>-0.21</td><td>-0.62</td><td>0.995</td><td>1.000</td><td>1.000</td><td>3554</td><td>tags=22%, list=27%, signal=30%</td></tr><tr><td class='lessen'>933</td><td>MAHAJAN_RESPONSE_TO_IL1A_DN</td><td></td><td>64</td><td>-0.23</td><td>-0.62</td><td>0.976</td><td>1.000</td><td>1.000</td><td>1396</td><td>tags=11%, list=11%, signal=12%</td></tr><tr><td class='lessen'>934</td><td>TIEN_INTESTINE_PROBIOTICS_24HR_UP</td><td></td><td>465</td><td>-0.20</td><td>-0.62</td><td>0.999</td><td>1.000</td><td>1.000</td><td>4386</td><td>tags=26%, list=34%, signal=38%</td></tr><tr><td class='lessen'>935</td><td>SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP</td><td></td><td>302</td><td>-0.20</td><td>-0.61</td><td>0.999</td><td>1.000</td><td>1.000</td><td>1459</td><td>tags=9%, list=11%, signal=10%</td></tr><tr><td class='lessen'>936</td><td>KYNG_NORMAL_AGING_DN</td><td></td><td>22</td><td>-0.27</td><td>-0.61</td><td>0.946</td><td>1.000</td><td>1.000</td><td>3803</td><td>tags=27%, list=29%, signal=39%</td></tr><tr><td class='lessen'>937</td><td>FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_UP</td><td></td><td>10</td><td>-0.31</td><td>-0.61</td><td>0.916</td><td>1.000</td><td>1.000</td><td>2483</td><td>tags=40%, list=19%, signal=49%</td></tr><tr><td class='lessen'>938</td><td>NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON</td><td></td><td>36</td><td>-0.24</td><td>-0.61</td><td>0.972</td><td>1.000</td><td>1.000</td><td>4429</td><td>tags=36%, list=34%, signal=55%</td></tr><tr><td class='lessen'>939</td><td>BLALOCK_ALZHEIMERS_DISEASE_DN</td><td></td><td>1067</td><td>-0.20</td><td>-0.61</td><td>1.000</td><td>1.000</td><td>1.000</td><td>3059</td><td>tags=17%, list=24%, signal=20%</td></tr><tr><td class='lessen'>940</td><td>SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP</td><td></td><td>36</td><td>-0.24</td><td>-0.61</td><td>0.965</td><td>1.000</td><td>1.000</td><td>3243</td><td>tags=33%, list=25%, signal=44%</td></tr><tr><td class='lessen'>941</td><td>PODAR_RESPONSE_TO_ADAPHOSTIN_DN</td><td></td><td>14</td><td>-0.29</td><td>-0.61</td><td>0.926</td><td>1.000</td><td>1.000</td><td>4870</td><td>tags=36%, list=38%, signal=57%</td></tr><tr><td class='lessen'>942</td><td>KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN</td><td></td><td>72</td><td>-0.22</td><td>-0.60</td><td>0.992</td><td>1.000</td><td>1.000</td><td>3263</td><td>tags=24%, list=25%, signal=31%</td></tr><tr><td class='lessen'>943</td><td>BILD_CTNNB1_ONCOGENIC_SIGNATURE</td><td></td><td>59</td><td>-0.23</td><td>-0.60</td><td>0.975</td><td>1.000</td><td>1.000</td><td>721</td><td>tags=3%, list=6%, signal=4%</td></tr><tr><td class='lessen'>944</td><td>MCBRYAN_TERMINAL_END_BUD_UP</td><td></td><td>11</td><td>-0.30</td><td>-0.60</td><td>0.934</td><td>1.000</td><td>1.000</td><td>4034</td><td>tags=64%, list=31%, signal=92%</td></tr><tr><td class='lessen'>945</td><td>JI_METASTASIS_REPRESSED_BY_STK11</td><td></td><td>23</td><td>-0.25</td><td>-0.60</td><td>0.952</td><td>1.000</td><td>1.000</td><td>2678</td><td>tags=30%, list=21%, signal=38%</td></tr><tr><td class='lessen'>946</td><td>OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP</td><td></td><td>104</td><td>-0.21</td><td>-0.60</td><td>0.989</td><td>1.000</td><td>1.000</td><td>5228</td><td>tags=35%, list=40%, signal=58%</td></tr><tr><td class='lessen'>947</td><td>SWEET_LUNG_CANCER_KRAS_UP</td><td></td><td>414</td><td>-0.20</td><td>-0.60</td><td>1.000</td><td>1.000</td><td>1.000</td><td>4330</td><td>tags=36%, list=33%, signal=52%</td></tr><tr><td class='lessen'>948</td><td>SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP</td><td></td><td>43</td><td>-0.23</td><td>-0.60</td><td>0.981</td><td>1.000</td><td>1.000</td><td>5251</td><td>tags=47%, list=41%, signal=78%</td></tr><tr><td class='lessen'>949</td><td>WANG_BARRETTS_ESOPHAGUS_UP</td><td></td><td>43</td><td>-0.23</td><td>-0.60</td><td>0.975</td><td>1.000</td><td>1.000</td><td>2715</td><td>tags=26%, list=21%, signal=32%</td></tr><tr><td class='lessen'>950</td><td>PEREZ_TP63_TARGETS</td><td></td><td>277</td><td>-0.20</td><td>-0.60</td><td>1.000</td><td>1.000</td><td>1.000</td><td>2719</td><td>tags=20%, list=21%, signal=25%</td></tr><tr><td class='lessen'>951</td><td>NIELSEN_LEIOMYOSARCOMA_CNN1_UP</td><td></td><td>17</td><td>-0.27</td><td>-0.60</td><td>0.945</td><td>1.000</td><td>1.000</td><td>4287</td><td>tags=35%, list=33%, signal=53%</td></tr><tr><td class='lessen'>952</td><td>SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_UP</td><td></td><td>12</td><td>-0.29</td><td>-0.60</td><td>0.936</td><td>1.000</td><td>1.000</td><td>4330</td><td>tags=42%, list=33%, signal=63%</td></tr><tr><td class='lessen'>953</td><td>HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_UP</td><td></td><td>31</td><td>-0.25</td><td>-0.60</td><td>0.967</td><td>1.000</td><td>1.000</td><td>3089</td><td>tags=23%, list=24%, signal=30%</td></tr><tr><td class='lessen'>954</td><td>BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C</td><td></td><td>69</td><td>-0.22</td><td>-0.59</td><td>0.985</td><td>1.000</td><td>1.000</td><td>3109</td><td>tags=25%, list=24%, signal=32%</td></tr><tr><td class='lessen'>955</td><td>OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_DN</td><td></td><td>10</td><td>-0.31</td><td>-0.59</td><td>0.912</td><td>1.000</td><td>1.000</td><td>5540</td><td>tags=60%, list=43%, signal=105%</td></tr><tr><td class='lessen'>956</td><td>BRUINS_UVC_RESPONSE_MIDDLE</td><td></td><td>70</td><td>-0.22</td><td>-0.59</td><td>0.984</td><td>1.000</td><td>1.000</td><td>3305</td><td>tags=19%, list=26%, signal=25%</td></tr><tr><td class='lessen'>957</td><td>HAMAI_APOPTOSIS_VIA_TRAIL_UP</td><td></td><td>462</td><td>-0.19</td><td>-0.59</td><td>1.000</td><td>1.000</td><td>1.000</td><td>2979</td><td>tags=16%, list=23%, signal=20%</td></tr><tr><td class='lessen'>958</td><td>NIKOLSKY_BREAST_CANCER_7P22_AMPLICON</td><td></td><td>25</td><td>-0.25</td><td>-0.59</td><td>0.969</td><td>1.000</td><td>1.000</td><td>157</td><td>tags=4%, list=1%, signal=4%</td></tr><tr><td class='lessen'>959</td><td>LIU_BREAST_CANCER</td><td></td><td>20</td><td>-0.26</td><td>-0.59</td><td>0.952</td><td>1.000</td><td>1.000</td><td>1754</td><td>tags=15%, list=14%, signal=17%</td></tr><tr><td class='lessen'>960</td><td>GENTILE_UV_RESPONSE_CLUSTER_D4</td><td></td><td>46</td><td>-0.23</td><td>-0.59</td><td>0.978</td><td>1.000</td><td>1.000</td><td>2625</td><td>tags=13%, list=20%, signal=16%</td></tr><tr><td class='lessen'>961</td><td>PENG_GLUCOSE_DEPRIVATION_DN</td><td></td><td>137</td><td>-0.20</td><td>-0.59</td><td>0.998</td><td>1.000</td><td>1.000</td><td>3681</td><td>tags=24%, list=28%, signal=33%</td></tr><tr><td class='lessen'>962</td><td>SCHLOSSER_SERUM_RESPONSE_UP</td><td></td><td>107</td><td>-0.21</td><td>-0.59</td><td>0.993</td><td>1.000</td><td>1.000</td><td>2268</td><td>tags=12%, list=18%, signal=15%</td></tr><tr><td class='lessen'>963</td><td>BAKKER_FOXO3_TARGETS_DN</td><td></td><td>143</td><td>-0.20</td><td>-0.59</td><td>0.998</td><td>1.000</td><td>1.000</td><td>1827</td><td>tags=10%, list=14%, signal=12%</td></tr><tr><td class='lessen'>964</td><td>DORN_ADENOVIRUS_INFECTION_24HR_DN</td><td></td><td>38</td><td>-0.23</td><td>-0.58</td><td>0.977</td><td>1.000</td><td>1.000</td><td>1176</td><td>tags=8%, list=9%, signal=9%</td></tr><tr><td class='lessen'>965</td><td>SANSOM_WNT_PATHWAY_REQUIRE_MYC</td><td></td><td>56</td><td>-0.22</td><td>-0.58</td><td>0.992</td><td>1.000</td><td>1.000</td><td>2533</td><td>tags=20%, list=20%, signal=24%</td></tr><tr><td class='lessen'>966</td><td>WEBER_METHYLATED_IN_COLON_CANCER</td><td></td><td>12</td><td>-0.29</td><td>-0.58</td><td>0.949</td><td>1.000</td><td>1.000</td><td>3737</td><td>tags=50%, list=29%, signal=70%</td></tr><tr><td class='lessen'>967</td><td>BHAT_ESR1_TARGETS_VIA_AKT1_DN</td><td></td><td>71</td><td>-0.21</td><td>-0.58</td><td>0.990</td><td>1.000</td><td>1.000</td><td>2735</td><td>tags=20%, list=21%, signal=25%</td></tr><tr><td class='lessen'>968</td><td>DAIRKEE_CANCER_PRONE_RESPONSE_BPA</td><td></td><td>44</td><td>-0.23</td><td>-0.58</td><td>0.982</td><td>1.000</td><td>1.000</td><td>2611</td><td>tags=18%, list=20%, signal=23%</td></tr><tr><td class='lessen'>969</td><td>BENPORATH_SOX2_TARGETS</td><td></td><td>567</td><td>-0.19</td><td>-0.58</td><td>1.000</td><td>1.000</td><td>1.000</td><td>3679</td><td>tags=21%, list=28%, signal=29%</td></tr><tr><td class='lessen'>970</td><td>SANSOM_APC_MYC_TARGETS</td><td></td><td>171</td><td>-0.20</td><td>-0.58</td><td>0.999</td><td>1.000</td><td>1.000</td><td>4446</td><td>tags=32%, list=34%, signal=48%</td></tr><tr><td class='lessen'>971</td><td>LIN_MELANOMA_COPY_NUMBER_DN</td><td></td><td>36</td><td>-0.23</td><td>-0.58</td><td>0.976</td><td>1.000</td><td>1.000</td><td>1407</td><td>tags=8%, list=11%, signal=9%</td></tr><tr><td class='lessen'>972</td><td>BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP</td><td></td><td>55</td><td>-0.22</td><td>-0.58</td><td>0.975</td><td>1.000</td><td>1.000</td><td>4108</td><td>tags=33%, list=32%, signal=48%</td></tr><tr><td class='lessen'>973</td><td>TERAO_AOX4_TARGETS_HG_UP</td><td></td><td>21</td><td>-0.25</td><td>-0.58</td><td>0.967</td><td>1.000</td><td>1.000</td><td>653</td><td>tags=5%, list=5%, signal=5%</td></tr><tr><td class='lessen'>974</td><td>MARTENS_TRETINOIN_RESPONSE_DN</td><td></td><td>592</td><td>-0.19</td><td>-0.58</td><td>1.000</td><td>1.000</td><td>1.000</td><td>3749</td><td>tags=20%, list=29%, signal=27%</td></tr><tr><td class='lessen'>975</td><td>SMITH_TERT_TARGETS_UP</td><td></td><td>127</td><td>-0.20</td><td>-0.58</td><td>0.998</td><td>1.000</td><td>1.000</td><td>2872</td><td>tags=15%, list=22%, signal=19%</td></tr><tr><td class='lessen'>976</td><td>LIN_NPAS4_TARGETS_UP</td><td></td><td>128</td><td>-0.20</td><td>-0.58</td><td>0.998</td><td>1.000</td><td>1.000</td><td>3249</td><td>tags=21%, list=25%, signal=28%</td></tr><tr><td class='lessen'>977</td><td>PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN</td><td></td><td>148</td><td>-0.20</td><td>-0.58</td><td>0.998</td><td>1.000</td><td>1.000</td><td>2266</td><td>tags=13%, list=18%, signal=15%</td></tr><tr><td class='lessen'>978</td><td>BROWNE_HCMV_INFECTION_4HR_DN</td><td></td><td>198</td><td>-0.19</td><td>-0.58</td><td>0.999</td><td>1.000</td><td>1.000</td><td>1506</td><td>tags=8%, list=12%, signal=9%</td></tr><tr><td class='lessen'>979</td><td>PETRETTO_HEART_MASS_QTL_CIS_DN</td><td></td><td>16</td><td>-0.27</td><td>-0.58</td><td>0.946</td><td>1.000</td><td>1.000</td><td>3086</td><td>tags=31%, list=24%, signal=41%</td></tr><tr><td class='lessen'>980</td><td>CHESLER_BRAIN_QTL_CIS</td><td></td><td>60</td><td>-0.22</td><td>-0.58</td><td>0.985</td><td>1.000</td><td>1.000</td><td>3843</td><td>tags=27%, list=30%, signal=38%</td></tr><tr><td class='lessen'>981</td><td>BROWNE_HCMV_INFECTION_14HR_UP</td><td></td><td>124</td><td>-0.20</td><td>-0.57</td><td>1.000</td><td>1.000</td><td>1.000</td><td>3980</td><td>tags=30%, list=31%, signal=43%</td></tr><tr><td class='lessen'>982</td><td>CHIARETTI_T_ALL_RELAPSE_PROGNOSIS</td><td></td><td>17</td><td>-0.26</td><td>-0.57</td><td>0.957</td><td>1.000</td><td>1.000</td><td>829</td><td>tags=12%, list=6%, signal=13%</td></tr><tr><td class='lessen'>983</td><td>JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER</td><td></td><td>32</td><td>-0.23</td><td>-0.57</td><td>0.968</td><td>1.000</td><td>1.000</td><td>6030</td><td>tags=59%, list=47%, signal=111%</td></tr><tr><td class='lessen'>984</td><td>CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3</td><td></td><td>554</td><td>-0.19</td><td>-0.57</td><td>1.000</td><td>1.000</td><td>1.000</td><td>4123</td><td>tags=31%, list=32%, signal=44%</td></tr><tr><td class='lessen'>985</td><td>MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP</td><td></td><td>17</td><td>-0.26</td><td>-0.57</td><td>0.960</td><td>1.000</td><td>1.000</td><td>5403</td><td>tags=59%, list=42%, signal=101%</td></tr><tr><td class='lessen'>986</td><td>CAFFAREL_RESPONSE_TO_THC_DN</td><td></td><td>21</td><td>-0.25</td><td>-0.57</td><td>0.966</td><td>1.000</td><td>1.000</td><td>4044</td><td>tags=33%, list=31%, signal=48%</td></tr><tr><td class='lessen'>987</td><td>VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_DN</td><td></td><td>12</td><td>-0.29</td><td>-0.57</td><td>0.947</td><td>1.000</td><td>1.000</td><td>7158</td><td>tags=92%, list=55%, signal=205%</td></tr><tr><td class='lessen'>988</td><td>WHITFIELD_CELL_CYCLE_M_G1</td><td></td><td>114</td><td>-0.20</td><td>-0.57</td><td>0.998</td><td>1.000</td><td>1.000</td><td>2228</td><td>tags=10%, list=17%, signal=12%</td></tr><tr><td class='lessen'>989</td><td>KIM_MYC_AMPLIFICATION_TARGETS_UP</td><td></td><td>162</td><td>-0.19</td><td>-0.57</td><td>0.998</td><td>1.000</td><td>1.000</td><td>2559</td><td>tags=15%, list=20%, signal=19%</td></tr><tr><td class='lessen'>990</td><td>BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING</td><td></td><td>187</td><td>-0.19</td><td>-0.57</td><td>1.000</td><td>1.000</td><td>1.000</td><td>3241</td><td>tags=21%, list=25%, signal=28%</td></tr><tr><td class='lessen'>991</td><td>FIRESTEIN_CTNNB1_PATHWAY</td><td></td><td>30</td><td>-0.24</td><td>-0.57</td><td>0.963</td><td>1.000</td><td>1.000</td><td>833</td><td>tags=7%, list=6%, signal=7%</td></tr><tr><td class='lessen'>992</td><td>SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL</td><td></td><td>59</td><td>-0.21</td><td>-0.57</td><td>0.993</td><td>1.000</td><td>1.000</td><td>4535</td><td>tags=46%, list=35%, signal=70%</td></tr><tr><td class='lessen'>993</td><td>SHEPARD_CRUSH_AND_BURN_MUTANT_UP</td><td></td><td>155</td><td>-0.19</td><td>-0.57</td><td>0.999</td><td>1.000</td><td>1.000</td><td>2045</td><td>tags=11%, list=16%, signal=13%</td></tr><tr><td class='lessen'>994</td><td>NGUYEN_NOTCH1_TARGETS_UP</td><td></td><td>28</td><td>-0.23</td><td>-0.57</td><td>0.968</td><td>1.000</td><td>1.000</td><td>1908</td><td>tags=18%, list=15%, signal=21%</td></tr><tr><td class='lessen'>995</td><td>SENESE_HDAC3_TARGETS_DN</td><td></td><td>401</td><td>-0.19</td><td>-0.57</td><td>1.000</td><td>1.000</td><td>1.000</td><td>3696</td><td>tags=24%, list=29%, signal=32%</td></tr><tr><td class='lessen'>996</td><td>PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP</td><td></td><td>66</td><td>-0.21</td><td>-0.57</td><td>0.993</td><td>1.000</td><td>1.000</td><td>3557</td><td>tags=23%, list=27%, signal=31%</td></tr><tr><td class='lessen'>997</td><td>LI_AMPLIFIED_IN_LUNG_CANCER</td><td></td><td>164</td><td>-0.19</td><td>-0.57</td><td>1.000</td><td>1.000</td><td>1.000</td><td>3845</td><td>tags=28%, list=30%, signal=39%</td></tr><tr><td class='lessen'>998</td><td>PECE_MAMMARY_STEM_CELL_UP</td><td></td><td>116</td><td>-0.20</td><td>-0.57</td><td>0.997</td><td>1.000</td><td>1.000</td><td>6574</td><td>tags=60%, list=51%, signal=122%</td></tr><tr><td class='lessen'>999</td><td>PARK_HSC_VS_MULTIPOTENT_PROGENITORS_UP</td><td></td><td>16</td><td>-0.26</td><td>-0.56</td><td>0.960</td><td>1.000</td><td>1.000</td><td>1931</td><td>tags=13%, list=15%, signal=15%</td></tr><tr><td class='lessen'>1000</td><td>KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_DN</td><td></td><td>35</td><td>-0.23</td><td>-0.56</td><td>0.979</td><td>1.000</td><td>1.000</td><td>1833</td><td>tags=11%, list=14%, signal=13%</td></tr><tr><td class='lessen'>1001</td><td>ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE</td><td></td><td>70</td><td>-0.20</td><td>-0.56</td><td>0.992</td><td>1.000</td><td>1.000</td><td>3344</td><td>tags=23%, list=26%, signal=31%</td></tr><tr><td class='lessen'>1002</td><td>KIM_ALL_DISORDERS_CALB1_CORR_UP</td><td></td><td>465</td><td>-0.18</td><td>-0.56</td><td>1.000</td><td>1.000</td><td>1.000</td><td>2606</td><td>tags=12%, list=20%, signal=15%</td></tr><tr><td class='lessen'>1003</td><td>PAL_PRMT5_TARGETS_UP</td><td></td><td>171</td><td>-0.19</td><td>-0.56</td><td>0.999</td><td>1.000</td><td>1.000</td><td>2817</td><td>tags=18%, list=22%, signal=23%</td></tr><tr><td class='lessen'>1004</td><td>GHANDHI_BYSTANDER_IRRADIATION_DN</td><td></td><td>10</td><td>-0.28</td><td>-0.56</td><td>0.951</td><td>1.000</td><td>1.000</td><td>924</td><td>tags=10%, list=7%, signal=11%</td></tr><tr><td class='lessen'>1005</td><td>WENG_POR_TARGETS_LIVER_DN</td><td></td><td>18</td><td>-0.25</td><td>-0.56</td><td>0.966</td><td>1.000</td><td>1.000</td><td>3891</td><td>tags=39%, list=30%, signal=56%</td></tr><tr><td class='lessen'>1006</td><td>TERAMOTO_OPN_TARGETS_CLUSTER_7</td><td></td><td>17</td><td>-0.26</td><td>-0.56</td><td>0.965</td><td>1.000</td><td>1.000</td><td>3324</td><td>tags=41%, list=26%, signal=55%</td></tr><tr><td class='lessen'>1007</td><td>ABBUD_LIF_SIGNALING_1_UP</td><td></td><td>42</td><td>-0.22</td><td>-0.56</td><td>0.977</td><td>1.000</td><td>1.000</td><td>3529</td><td>tags=29%, list=27%, signal=39%</td></tr><tr><td class='lessen'>1008</td><td>HOFMANN_CELL_LYMPHOMA_DN</td><td></td><td>34</td><td>-0.22</td><td>-0.56</td><td>0.981</td><td>1.000</td><td>1.000</td><td>237</td><td>tags=3%, list=2%, signal=3%</td></tr><tr><td class='lessen'>1009</td><td>GENTILE_UV_LOW_DOSE_UP</td><td></td><td>25</td><td>-0.24</td><td>-0.56</td><td>0.980</td><td>1.000</td><td>1.000</td><td>3584</td><td>tags=28%, list=28%, signal=39%</td></tr><tr><td class='lessen'>1010</td><td>BILANGES_SERUM_RESPONSE_TRANSLATION</td><td></td><td>32</td><td>-0.23</td><td>-0.56</td><td>0.982</td><td>1.000</td><td>1.000</td><td>797</td><td>tags=6%, list=6%, signal=7%</td></tr><tr><td class='lessen'>1011</td><td>YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP</td><td></td><td>45</td><td>-0.21</td><td>-0.55</td><td>0.989</td><td>1.000</td><td>1.000</td><td>3015</td><td>tags=18%, list=23%, signal=23%</td></tr><tr><td class='lessen'>1012</td><td>STEIN_ESRRA_TARGETS_UP</td><td></td><td>306</td><td>-0.18</td><td>-0.55</td><td>1.000</td><td>1.000</td><td>1.000</td><td>3742</td><td>tags=22%, list=29%, signal=30%</td></tr><tr><td class='lessen'>1013</td><td>VALK_AML_WITH_FLT3_ITD</td><td></td><td>34</td><td>-0.22</td><td>-0.55</td><td>0.980</td><td>1.000</td><td>1.000</td><td>3119</td><td>tags=32%, list=24%, signal=43%</td></tr><tr><td class='lessen'>1014</td><td>SESTO_RESPONSE_TO_UV_C1</td><td></td><td>57</td><td>-0.21</td><td>-0.55</td><td>0.998</td><td>1.000</td><td>1.000</td><td>3364</td><td>tags=26%, list=26%, signal=35%</td></tr><tr><td class='lessen'>1015</td><td>MALONEY_RESPONSE_TO_17AAG_DN</td><td></td><td>68</td><td>-0.20</td><td>-0.55</td><td>0.994</td><td>1.000</td><td>1.000</td><td>5680</td><td>tags=41%, list=44%, signal=73%</td></tr><tr><td class='lessen'>1016</td><td>HONMA_DOCETAXEL_RESISTANCE</td><td></td><td>29</td><td>-0.23</td><td>-0.55</td><td>0.979</td><td>1.000</td><td>1.000</td><td>4241</td><td>tags=31%, list=33%, signal=46%</td></tr><tr><td class='lessen'>1017</td><td>RAY_TARGETS_OF_P210_BCR_ABL_FUSION_UP</td><td></td><td>14</td><td>-0.26</td><td>-0.55</td><td>0.965</td><td>1.000</td><td>1.000</td><td>4368</td><td>tags=43%, list=34%, signal=65%</td></tr><tr><td class='lessen'>1018</td><td>VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP</td><td></td><td>56</td><td>-0.20</td><td>-0.55</td><td>0.998</td><td>1.000</td><td>1.000</td><td>4263</td><td>tags=29%, list=33%, signal=42%</td></tr><tr><td class='lessen'>1019</td><td>KIM_GASTRIC_CANCER_CHEMOSENSITIVITY</td><td></td><td>77</td><td>-0.20</td><td>-0.55</td><td>0.998</td><td>1.000</td><td>1.000</td><td>3722</td><td>tags=27%, list=29%, signal=38%</td></tr><tr><td class='lessen'>1020</td><td>SCIBETTA_KDM5B_TARGETS_UP</td><td></td><td>14</td><td>-0.26</td><td>-0.54</td><td>0.958</td><td>1.000</td><td>1.000</td><td>4081</td><td>tags=36%, list=32%, signal=52%</td></tr><tr><td class='lessen'>1021</td><td>KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP</td><td></td><td>18</td><td>-0.24</td><td>-0.54</td><td>0.969</td><td>1.000</td><td>1.000</td><td>4176</td><td>tags=50%, list=32%, signal=74%</td></tr><tr><td class='lessen'>1022</td><td>BROWNE_HCMV_INFECTION_10HR_UP</td><td></td><td>80</td><td>-0.19</td><td>-0.54</td><td>0.997</td><td>1.000</td><td>1.000</td><td>2584</td><td>tags=15%, list=20%, signal=19%</td></tr><tr><td class='lessen'>1023</td><td>RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN</td><td></td><td>15</td><td>-0.25</td><td>-0.54</td><td>0.967</td><td>1.000</td><td>1.000</td><td>4814</td><td>tags=47%, list=37%, signal=74%</td></tr><tr><td class='lessen'>1024</td><td>FRASOR_TAMOXIFEN_RESPONSE_UP</td><td></td><td>39</td><td>-0.21</td><td>-0.54</td><td>0.989</td><td>1.000</td><td>1.000</td><td>4604</td><td>tags=44%, list=36%, signal=67%</td></tr><tr><td class='lessen'>1025</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14</td><td></td><td>117</td><td>-0.19</td><td>-0.54</td><td>0.998</td><td>1.000</td><td>1.000</td><td>5297</td><td>tags=45%, list=41%, signal=76%</td></tr><tr><td class='lessen'>1026</td><td>JIANG_TIP30_TARGETS_DN</td><td></td><td>22</td><td>-0.23</td><td>-0.54</td><td>0.977</td><td>1.000</td><td>1.000</td><td>3037</td><td>tags=27%, list=23%, signal=36%</td></tr><tr><td class='lessen'>1027</td><td>PATTERSON_DOCETAXEL_RESISTANCE</td><td></td><td>26</td><td>-0.23</td><td>-0.53</td><td>0.985</td><td>1.000</td><td>1.000</td><td>2110</td><td>tags=15%, list=16%, signal=18%</td></tr><tr><td class='lessen'>1028</td><td>ZWANG_EGF_PERSISTENTLY_UP</td><td></td><td>20</td><td>-0.23</td><td>-0.53</td><td>0.978</td><td>1.000</td><td>1.000</td><td>1751</td><td>tags=15%, list=14%, signal=17%</td></tr><tr><td class='lessen'>1029</td><td>HORTON_SREBF_TARGETS</td><td></td><td>23</td><td>-0.23</td><td>-0.53</td><td>0.982</td><td>1.000</td><td>1.000</td><td>4094</td><td>tags=48%, list=32%, signal=70%</td></tr><tr><td class='lessen'>1030</td><td>FOSTER_KDM1A_TARGETS_DN</td><td></td><td>165</td><td>-0.18</td><td>-0.53</td><td>1.000</td><td>1.000</td><td>1.000</td><td>3219</td><td>tags=19%, list=25%, signal=25%</td></tr><tr><td class='lessen'>1031</td><td>POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN</td><td></td><td>43</td><td>-0.21</td><td>-0.53</td><td>0.995</td><td>1.000</td><td>1.000</td><td>6192</td><td>tags=53%, list=48%, signal=102%</td></tr><tr><td class='lessen'>1032</td><td>KANNAN_TP53_TARGETS_DN</td><td></td><td>20</td><td>-0.23</td><td>-0.53</td><td>0.975</td><td>1.000</td><td>1.000</td><td>4315</td><td>tags=45%, list=33%, signal=67%</td></tr><tr><td class='lessen'>1033</td><td>WANG_RECURRENT_LIVER_CANCER_UP</td><td></td><td>18</td><td>-0.24</td><td>-0.53</td><td>0.979</td><td>1.000</td><td>1.000</td><td>3230</td><td>tags=28%, list=25%, signal=37%</td></tr><tr><td class='lessen'>1034</td><td>XU_AKT1_TARGETS_6HR</td><td></td><td>22</td><td>-0.23</td><td>-0.53</td><td>0.982</td><td>1.000</td><td>1.000</td><td>4150</td><td>tags=27%, list=32%, signal=40%</td></tr><tr><td class='lessen'>1035</td><td>LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN</td><td></td><td>594</td><td>-0.17</td><td>-0.53</td><td>1.000</td><td>1.000</td><td>1.000</td><td>3856</td><td>tags=19%, list=30%, signal=26%</td></tr><tr><td class='lessen'>1036</td><td>KANG_FLUOROURACIL_RESISTANCE_UP</td><td></td><td>20</td><td>-0.23</td><td>-0.53</td><td>0.984</td><td>1.000</td><td>1.000</td><td>3119</td><td>tags=30%, list=24%, signal=39%</td></tr><tr><td class='lessen'>1037</td><td>FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN</td><td></td><td>459</td><td>-0.17</td><td>-0.53</td><td>1.000</td><td>1.000</td><td>1.000</td><td>3610</td><td>tags=25%, list=28%, signal=34%</td></tr><tr><td class='lessen'>1038</td><td>TIEN_INTESTINE_PROBIOTICS_6HR_UP</td><td></td><td>47</td><td>-0.20</td><td>-0.52</td><td>0.998</td><td>1.000</td><td>1.000</td><td>6662</td><td>tags=62%, list=52%, signal=127%</td></tr><tr><td class='lessen'>1039</td><td>NEWMAN_ERCC6_TARGETS_UP</td><td></td><td>17</td><td>-0.24</td><td>-0.52</td><td>0.969</td><td>1.000</td><td>1.000</td><td>2407</td><td>tags=24%, list=19%, signal=29%</td></tr><tr><td class='lessen'>1040</td><td>JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP</td><td></td><td>44</td><td>-0.21</td><td>-0.52</td><td>0.992</td><td>1.000</td><td>1.000</td><td>850</td><td>tags=5%, list=7%, signal=5%</td></tr><tr><td class='lessen'>1041</td><td>ABDULRAHMAN_KIDNEY_CANCER_VHL_DN</td><td></td><td>13</td><td>-0.25</td><td>-0.52</td><td>0.968</td><td>1.000</td><td>1.000</td><td>3257</td><td>tags=31%, list=25%, signal=41%</td></tr><tr><td class='lessen'>1042</td><td>ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP</td><td></td><td>70</td><td>-0.19</td><td>-0.52</td><td>0.999</td><td>1.000</td><td>1.000</td><td>4720</td><td>tags=41%, list=36%, signal=65%</td></tr><tr><td class='lessen'>1043</td><td>CREIGHTON_AKT1_SIGNALING_VIA_MTOR_DN</td><td></td><td>20</td><td>-0.23</td><td>-0.52</td><td>0.973</td><td>1.000</td><td>1.000</td><td>5963</td><td>tags=60%, list=46%, signal=111%</td></tr><tr><td class='lessen'>1044</td><td>HASLINGER_B_CLL_WITH_6Q21_DELETION</td><td></td><td>15</td><td>-0.24</td><td>-0.52</td><td>0.960</td><td>1.000</td><td>1.000</td><td>1840</td><td>tags=13%, list=14%, signal=16%</td></tr><tr><td class='lessen'>1045</td><td>KASLER_HDAC7_TARGETS_1_UP</td><td></td><td>164</td><td>-0.17</td><td>-0.51</td><td>1.000</td><td>1.000</td><td>1.000</td><td>2533</td><td>tags=12%, list=20%, signal=15%</td></tr><tr><td class='lessen'>1046</td><td>ZHAN_MULTIPLE_MYELOMA_SUBGROUPS</td><td></td><td>30</td><td>-0.21</td><td>-0.51</td><td>0.987</td><td>1.000</td><td>1.000</td><td>6031</td><td>tags=40%, list=47%, signal=75%</td></tr><tr><td class='lessen'>1047</td><td>MARSON_BOUND_BY_FOXP3_UNSTIMULATED</td><td></td><td>980</td><td>-0.17</td><td>-0.51</td><td>1.000</td><td>1.000</td><td>1.000</td><td>2252</td><td>tags=9%, list=17%, signal=10%</td></tr><tr><td class='lessen'>1048</td><td>DANG_MYC_TARGETS_UP</td><td></td><td>124</td><td>-0.17</td><td>-0.51</td><td>1.000</td><td>1.000</td><td>1.000</td><td>5101</td><td>tags=35%, list=39%, signal=58%</td></tr><tr><td class='lessen'>1049</td><td>NELSON_RESPONSE_TO_ANDROGEN_UP</td><td></td><td>75</td><td>-0.18</td><td>-0.51</td><td>0.999</td><td>1.000</td><td>1.000</td><td>4528</td><td>tags=39%, list=35%, signal=59%</td></tr><tr><td class='lessen'>1050</td><td>DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN</td><td></td><td>247</td><td>-0.17</td><td>-0.51</td><td>1.000</td><td>1.000</td><td>1.000</td><td>4070</td><td>tags=28%, list=31%, signal=41%</td></tr><tr><td class='lessen'>1051</td><td>ONGUSAHA_BRCA1_TARGETS_DN</td><td></td><td>12</td><td>-0.25</td><td>-0.50</td><td>0.980</td><td>1.000</td><td>1.000</td><td>1928</td><td>tags=17%, list=15%, signal=20%</td></tr><tr><td class='lessen'>1052</td><td>INAMURA_LUNG_CANCER_SCC_SUBTYPES_UP</td><td></td><td>10</td><td>-0.25</td><td>-0.50</td><td>0.977</td><td>1.000</td><td>1.000</td><td>3571</td><td>tags=30%, list=28%, signal=41%</td></tr><tr><td class='lessen'>1053</td><td>WONG_IFNA2_RESISTANCE_UP</td><td></td><td>13</td><td>-0.24</td><td>-0.50</td><td>0.985</td><td>1.000</td><td>1.000</td><td>775</td><td>tags=8%, list=6%, signal=8%</td></tr><tr><td class='lessen'>1054</td><td>MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5</td><td></td><td>22</td><td>-0.22</td><td>-0.50</td><td>0.988</td><td>1.000</td><td>1.000</td><td>740</td><td>tags=5%, list=6%, signal=5%</td></tr><tr><td class='lessen'>1055</td><td>BROWNE_HCMV_INFECTION_12HR_UP</td><td></td><td>83</td><td>-0.18</td><td>-0.49</td><td>1.000</td><td>1.000</td><td>1.000</td><td>3020</td><td>tags=17%, list=23%, signal=22%</td></tr><tr><td class='lessen'>1056</td><td>CAFFAREL_RESPONSE_TO_THC_24HR_5_UP</td><td></td><td>28</td><td>-0.20</td><td>-0.49</td><td>0.991</td><td>1.000</td><td>1.000</td><td>3102</td><td>tags=14%, list=24%, signal=19%</td></tr><tr><td class='lessen'>1057</td><td>WANG_CLIM2_TARGETS_UP</td><td></td><td>183</td><td>-0.16</td><td>-0.49</td><td>1.000</td><td>1.000</td><td>1.000</td><td>3317</td><td>tags=19%, list=26%, signal=25%</td></tr><tr><td class='lessen'>1058</td><td>MOHANKUMAR_TLX1_TARGETS_UP</td><td></td><td>342</td><td>-0.16</td><td>-0.49</td><td>1.000</td><td>1.000</td><td>1.000</td><td>4089</td><td>tags=26%, list=32%, signal=37%</td></tr><tr><td class='lessen'>1059</td><td>DAZARD_RESPONSE_TO_UV_NHEK_UP</td><td></td><td>203</td><td>-0.16</td><td>-0.49</td><td>1.000</td><td>1.000</td><td>1.000</td><td>1921</td><td>tags=8%, list=15%, signal=9%</td></tr><tr><td class='lessen'>1060</td><td>HASLINGER_B_CLL_WITH_17P13_DELETION</td><td></td><td>18</td><td>-0.22</td><td>-0.49</td><td>0.989</td><td>1.000</td><td>1.000</td><td>959</td><td>tags=6%, list=7%, signal=6%</td></tr><tr><td class='lessen'>1061</td><td>KIM_TIAL1_TARGETS</td><td></td><td>28</td><td>-0.20</td><td>-0.48</td><td>0.995</td><td>1.000</td><td>1.000</td><td>5580</td><td>tags=54%, list=43%, signal=94%</td></tr><tr><td class='lessen'>1062</td><td>BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN</td><td></td><td>26</td><td>-0.20</td><td>-0.48</td><td>0.995</td><td>1.000</td><td>1.000</td><td>4893</td><td>tags=35%, list=38%, signal=56%</td></tr><tr><td class='lessen'>1063</td><td>DAZARD_RESPONSE_TO_UV_NHEK_DN</td><td></td><td>251</td><td>-0.16</td><td>-0.48</td><td>1.000</td><td>1.000</td><td>1.000</td><td>4560</td><td>tags=27%, list=35%, signal=41%</td></tr><tr><td class='lessen'>1064</td><td>MENSSEN_MYC_TARGETS</td><td></td><td>44</td><td>-0.18</td><td>-0.48</td><td>0.998</td><td>1.000</td><td>1.000</td><td>5441</td><td>tags=43%, list=42%, signal=74%</td></tr><tr><td class='lessen'>1065</td><td>HEIDENBLAD_AMPLICON_12P11_12_UP</td><td></td><td>30</td><td>-0.19</td><td>-0.47</td><td>0.996</td><td>1.000</td><td>1.000</td><td>4462</td><td>tags=37%, list=34%, signal=56%</td></tr><tr><td class='lessen'>1066</td><td>LE_NEURONAL_DIFFERENTIATION_UP</td><td></td><td>15</td><td>-0.22</td><td>-0.47</td><td>0.990</td><td>1.000</td><td>1.000</td><td>2687</td><td>tags=27%, list=21%, signal=34%</td></tr><tr><td class='lessen'>1067</td><td>LIU_SOX4_TARGETS_DN</td><td></td><td>248</td><td>-0.15</td><td>-0.47</td><td>1.000</td><td>1.000</td><td>1.000</td><td>4291</td><td>tags=24%, list=33%, signal=35%</td></tr><tr><td class='lessen'>1068</td><td>BENPORATH_NANOG_TARGETS</td><td></td><td>775</td><td>-0.15</td><td>-0.47</td><td>1.000</td><td>1.000</td><td>1.000</td><td>3679</td><td>tags=19%, list=28%, signal=25%</td></tr><tr><td class='lessen'>1069</td><td>ROESSLER_LIVER_CANCER_METASTASIS_DN</td><td></td><td>40</td><td>-0.19</td><td>-0.47</td><td>0.998</td><td>1.000</td><td>1.000</td><td>4311</td><td>tags=30%, list=33%, signal=45%</td></tr><tr><td class='lessen'>1070</td><td>GRADE_COLON_AND_RECTAL_CANCER_UP</td><td></td><td>231</td><td>-0.16</td><td>-0.47</td><td>1.000</td><td>1.000</td><td>1.000</td><td>3845</td><td>tags=21%, list=30%, signal=29%</td></tr><tr><td class='lessen'>1071</td><td>NOUZOVA_TRETINOIN_AND_H4_ACETYLATION</td><td></td><td>99</td><td>-0.16</td><td>-0.46</td><td>1.000</td><td>1.000</td><td>1.000</td><td>2095</td><td>tags=7%, list=16%, signal=8%</td></tr><tr><td class='lessen'>1072</td><td>GRADE_COLON_CANCER_UP</td><td></td><td>670</td><td>-0.15</td><td>-0.46</td><td>1.000</td><td>1.000</td><td>1.000</td><td>4497</td><td>tags=25%, list=35%, signal=37%</td></tr><tr><td class='lessen'>1073</td><td>MARSON_BOUND_BY_FOXP3_STIMULATED</td><td></td><td>813</td><td>-0.15</td><td>-0.46</td><td>1.000</td><td>1.000</td><td>1.000</td><td>2252</td><td>tags=9%, list=17%, signal=10%</td></tr><tr><td class='lessen'>1074</td><td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP</td><td></td><td>21</td><td>-0.20</td><td>-0.46</td><td>0.996</td><td>1.000</td><td>1.000</td><td>3018</td><td>tags=19%, list=23%, signal=25%</td></tr><tr><td class='lessen'>1075</td><td>BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN</td><td></td><td>23</td><td>-0.19</td><td>-0.46</td><td>0.996</td><td>1.000</td><td>1.000</td><td>3258</td><td>tags=22%, list=25%, signal=29%</td></tr><tr><td class='lessen'>1076</td><td>FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN</td><td></td><td>78</td><td>-0.17</td><td>-0.46</td><td>1.000</td><td>1.000</td><td>1.000</td><td>1725</td><td>tags=9%, list=13%, signal=10%</td></tr><tr><td class='lessen'>1077</td><td>GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN</td><td></td><td>120</td><td>-0.16</td><td>-0.45</td><td>1.000</td><td>1.000</td><td>1.000</td><td>4956</td><td>tags=33%, list=38%, signal=54%</td></tr><tr><td class='lessen'>1078</td><td>RASHI_RESPONSE_TO_IONIZING_RADIATION_3</td><td></td><td>43</td><td>-0.18</td><td>-0.45</td><td>1.000</td><td>1.000</td><td>1.000</td><td>2228</td><td>tags=9%, list=17%, signal=11%</td></tr><tr><td class='lessen'>1079</td><td>PENG_GLUTAMINE_DEPRIVATION_DN</td><td></td><td>284</td><td>-0.15</td><td>-0.45</td><td>1.000</td><td>1.000</td><td>1.000</td><td>5888</td><td>tags=45%, list=46%, signal=81%</td></tr><tr><td class='lessen'>1080</td><td>MEISSNER_NPC_ICP_WITH_H3K4ME3</td><td></td><td>15</td><td>-0.21</td><td>-0.45</td><td>0.996</td><td>1.000</td><td>1.000</td><td>5555</td><td>tags=53%, list=43%, signal=93%</td></tr><tr><td class='lessen'>1081</td><td>KAPOSI_LIVER_CANCER_MET_UP</td><td></td><td>17</td><td>-0.20</td><td>-0.45</td><td>0.994</td><td>1.000</td><td>1.000</td><td>2165</td><td>tags=12%, list=17%, signal=14%</td></tr><tr><td class='lessen'>1082</td><td>RODRIGUES_NTN1_TARGETS_UP</td><td></td><td>13</td><td>-0.21</td><td>-0.45</td><td>0.991</td><td>1.000</td><td>1.000</td><td>3440</td><td>tags=31%, list=27%, signal=42%</td></tr><tr><td class='lessen'>1083</td><td>TIAN_BHLHA15_TARGETS</td><td></td><td>14</td><td>-0.21</td><td>-0.45</td><td>0.985</td><td>1.000</td><td>1.000</td><td>3867</td><td>tags=29%, list=30%, signal=41%</td></tr><tr><td class='lessen'>1084</td><td>LEE_LIVER_CANCER_SURVIVAL_DN</td><td></td><td>144</td><td>-0.15</td><td>-0.45</td><td>1.000</td><td>0.999</td><td>1.000</td><td>3179</td><td>tags=16%, list=25%, signal=21%</td></tr><tr><td class='lessen'>1085</td><td>ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN</td><td></td><td>18</td><td>-0.20</td><td>-0.45</td><td>0.997</td><td>0.998</td><td>1.000</td><td>5237</td><td>tags=44%, list=40%, signal=75%</td></tr><tr><td class='lessen'>1086</td><td>DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER</td><td></td><td>90</td><td>-0.16</td><td>-0.44</td><td>1.000</td><td>0.997</td><td>1.000</td><td>10896</td><td>tags=100%, list=84%, signal=630%</td></tr><tr><td class='lessen'>1087</td><td>HEDENFALK_BREAST_CANCER_HEREDITARY_VS_SPORADIC</td><td></td><td>41</td><td>-0.17</td><td>-0.44</td><td>0.999</td><td>0.996</td><td>1.000</td><td>3696</td><td>tags=20%, list=29%, signal=27%</td></tr><tr><td class='lessen'>1088</td><td>HOSHIDA_LIVER_CANCER_SUBCLASS_S2</td><td></td><td>105</td><td>-0.15</td><td>-0.43</td><td>1.000</td><td>0.996</td><td>1.000</td><td>3790</td><td>tags=19%, list=29%, signal=27%</td></tr><tr><td class='lessen'>1089</td><td>ELVIDGE_HYPOXIA_DN</td><td></td><td>122</td><td>-0.15</td><td>-0.43</td><td>1.000</td><td>0.995</td><td>1.000</td><td>4486</td><td>tags=30%, list=35%, signal=46%</td></tr><tr><td class='lessen'>1090</td><td>KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN</td><td></td><td>751</td><td>-0.14</td><td>-0.43</td><td>1.000</td><td>0.994</td><td>1.000</td><td>4536</td><td>tags=27%, list=35%, signal=40%</td></tr><tr><td class='lessen'>1091</td><td>DANG_REGULATED_BY_MYC_UP</td><td></td><td>59</td><td>-0.16</td><td>-0.43</td><td>1.000</td><td>0.993</td><td>1.000</td><td>3038</td><td>tags=22%, list=23%, signal=29%</td></tr><tr><td class='lessen'>1092</td><td>CHEOK_RESPONSE_TO_HD_MTX_DN</td><td></td><td>21</td><td>-0.19</td><td>-0.43</td><td>0.999</td><td>0.992</td><td>1.000</td><td>2890</td><td>tags=14%, list=22%, signal=18%</td></tr><tr><td class='lessen'>1093</td><td>KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP</td><td></td><td>75</td><td>-0.16</td><td>-0.43</td><td>1.000</td><td>0.991</td><td>1.000</td><td>3156</td><td>tags=17%, list=24%, signal=23%</td></tr><tr><td class='lessen'>1094</td><td>WELCSH_BRCA1_TARGETS_DN</td><td></td><td>118</td><td>-0.15</td><td>-0.42</td><td>1.000</td><td>0.991</td><td>1.000</td><td>4779</td><td>tags=31%, list=37%, signal=49%</td></tr><tr><td class='lessen'>1095</td><td>GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11</td><td></td><td>49</td><td>-0.16</td><td>-0.42</td><td>0.999</td><td>0.990</td><td>1.000</td><td>4950</td><td>tags=43%, list=38%, signal=69%</td></tr><tr><td class='lessen'>1096</td><td>STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN</td><td></td><td>396</td><td>-0.14</td><td>-0.42</td><td>1.000</td><td>0.989</td><td>1.000</td><td>5074</td><td>tags=31%, list=39%, signal=49%</td></tr><tr><td class='lessen'>1097</td><td>DAZARD_UV_RESPONSE_CLUSTER_G2</td><td></td><td>24</td><td>-0.18</td><td>-0.42</td><td>0.997</td><td>0.988</td><td>1.000</td><td>3462</td><td>tags=25%, list=27%, signal=34%</td></tr><tr><td class='lessen'>1098</td><td>KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP</td><td></td><td>649</td><td>-0.13</td><td>-0.41</td><td>1.000</td><td>0.987</td><td>1.000</td><td>3059</td><td>tags=13%, list=24%, signal=16%</td></tr><tr><td class='lessen'>1099</td><td>IVANOVSKA_MIR106B_TARGETS</td><td></td><td>74</td><td>-0.15</td><td>-0.41</td><td>1.000</td><td>0.987</td><td>1.000</td><td>4577</td><td>tags=31%, list=35%, signal=48%</td></tr><tr><td class='lessen'>1100</td><td>SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM</td><td></td><td>127</td><td>-0.14</td><td>-0.41</td><td>1.000</td><td>0.986</td><td>1.000</td><td>6562</td><td>tags=46%, list=51%, signal=92%</td></tr><tr><td class='lessen'>1101</td><td>SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY</td><td></td><td>30</td><td>-0.16</td><td>-0.40</td><td>0.999</td><td>0.985</td><td>1.000</td><td>2305</td><td>tags=10%, list=18%, signal=12%</td></tr><tr><td class='lessen'>1102</td><td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP</td><td></td><td>92</td><td>-0.14</td><td>-0.40</td><td>1.000</td><td>0.984</td><td>1.000</td><td>4624</td><td>tags=29%, list=36%, signal=45%</td></tr><tr><td class='lessen'>1103</td><td>BENPORATH_MYC_MAX_TARGETS</td><td></td><td>653</td><td>-0.13</td><td>-0.40</td><td>1.000</td><td>0.983</td><td>1.000</td><td>5096</td><td>tags=31%, list=39%, signal=49%</td></tr><tr><td class='lessen'>1104</td><td>SESTO_RESPONSE_TO_UV_C0</td><td></td><td>95</td><td>-0.14</td><td>-0.40</td><td>1.000</td><td>0.983</td><td>1.000</td><td>3264</td><td>tags=17%, list=25%, signal=22%</td></tr><tr><td class='lessen'>1105</td><td>CHUANG_OXIDATIVE_STRESS_RESPONSE_UP</td><td></td><td>24</td><td>-0.17</td><td>-0.39</td><td>1.000</td><td>0.982</td><td>1.000</td><td>2982</td><td>tags=21%, list=23%, signal=27%</td></tr><tr><td class='lessen'>1106</td><td>MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP</td><td></td><td>13</td><td>-0.19</td><td>-0.39</td><td>0.996</td><td>0.981</td><td>1.000</td><td>5766</td><td>tags=54%, list=45%, signal=97%</td></tr><tr><td class='lessen'>1107</td><td>HU_GENOTOXIC_DAMAGE_24HR</td><td></td><td>31</td><td>-0.16</td><td>-0.39</td><td>1.000</td><td>0.980</td><td>1.000</td><td>5706</td><td>tags=48%, list=44%, signal=86%</td></tr><tr><td class='lessen'>1108</td><td>SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_UP</td><td></td><td>10</td><td>-0.18</td><td>-0.36</td><td>1.000</td><td>0.980</td><td>1.000</td><td>4474</td><td>tags=40%, list=35%, signal=61%</td></tr><tr><td class='lessen'>1109</td><td>BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2</td><td></td><td>57</td><td>-0.13</td><td>-0.36</td><td>1.000</td><td>0.979</td><td>1.000</td><td>6357</td><td>tags=56%, list=49%, signal=110%</td></tr><tr><td class='lessen'>1110</td><td>SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP</td><td></td><td>407</td><td>-0.12</td><td>-0.36</td><td>1.000</td><td>0.978</td><td>1.000</td><td>4490</td><td>tags=24%, list=35%, signal=36%</td></tr><tr><td class='lessen'>1111</td><td>ZHANG_RESPONSE_TO_CANTHARIDIN_DN</td><td></td><td>59</td><td>-0.13</td><td>-0.35</td><td>1.000</td><td>0.977</td><td>1.000</td><td>6289</td><td>tags=51%, list=49%, signal=99%</td></tr><tr><td class='lessen'>1112</td><td>KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP</td><td></td><td>578</td><td>-0.11</td><td>-0.35</td><td>1.000</td><td>0.976</td><td>1.000</td><td>4277</td><td>tags=21%, list=33%, signal=30%</td></tr><tr><td class='lessen'>1113</td><td>BORCZUK_MALIGNANT_MESOTHELIOMA_UP</td><td></td><td>257</td><td>-0.11</td><td>-0.35</td><td>1.000</td><td>0.975</td><td>1.000</td><td>5016</td><td>tags=31%, list=39%, signal=50%</td></tr><tr><td class='lessen'>1114</td><td>HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR</td><td></td><td>42</td><td>-0.13</td><td>-0.33</td><td>1.000</td><td>0.975</td><td>1.000</td><td>1662</td><td>tags=7%, list=13%, signal=8%</td></tr><tr><td class='lessen'>1115</td><td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN</td><td></td><td>22</td><td>-0.14</td><td>-0.32</td><td>1.000</td><td>0.974</td><td>1.000</td><td>6388</td><td>tags=50%, list=49%, signal=99%</td></tr><caption class='table'>Table: Gene sets enriched in phenotype <b>na<b>&nbsp<a href='gsea_report_for_na_neg_1439144934464.xls'>[plain text format]</a></caption></table></div><br></body></html>